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pC-TAC, UMR 8638 CNRS, Faculté de Pharmacie de Paris, Paris-Descartes University,
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Throughout organic chemistry, and especially in natural prod-
ucts (NPs), where new bioactive metabolites are frequently iso-
lated in minute, oen sub-milligram quantities, nuclear
magnetic resonance (NMR) has become the primary tool for
structure determination. Typically, practitioners “extract” the
structural information from NMR spectra that were generated
via Fourier Transformation (FT) of free induction decays (FIDs),
James (Jim) McAlpine received
a PhD from UNE, Armidale,
Australia, and undertook post-
doctoral studies at Northwestern
University Medical School, on
the biochemistry of macrolide
antibiotics. In 1972, he joined
Abbott Laboratories and worked
on macrolides, aminoglycosides,
and quinolones before heading
up their natural product project
1981–1996, which discovered
Tiacumicin B, the API of
Fidaxomicin®. He joined Phytera Inc. as VP Chemistry in 1996,
discovering drugs from manipulated plant cell cultures, and in
2002 joined Ecopia BioSciences as VP Chemistry and Discovery
using genomics to discover novel secondary metabolites. He has co-
authored 130+ papers, is inventor on 50 U.S. patents, and
a Research Professor at UIC since 2011.
Guido F. Pauli is a pharmacist
with a doctorate in pharmacog-
nosy and holds the Norman R.
Farnsworth Professor of Phar-
macognosy and is Directors of
PCRPS at the UIC College of
Pharmacy, Chicago (IL). His
interests are in metabolomic
analysis, where he develops
innovative bioanalytical meth-
odologies that can help address
challenges posed by nature's
metabolomic complexity. Using
cross-discipline approaches, his research involves natural health
products including (ethno)botanicals, anti-TB drug discovery, and
dental biomodiers. His publication portfolio comprises 190+
peer-reviewed articles and an h-index of 43 (Scopus).
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 37
























































































which represent the actual (raw) spectroscopic data from the
excited nuclear spins in the NMR experiment (“spin choreog-
raphy”). The deduction of structural information entails not only
human interpretation and viewpoints (Fig. 1), but commonly also
involves a signicant loss of information (e.g., signal phase, peak
shape, and signal multiplicity in tabulated representations),
which leads to the inability to reprocess the spectra ab initio and/
or employ computational tools to derive additional information
from the same experimental data. For example, extracting the
complete information contained in the FID of themost basic and
sensitive NMR experiment, 1D 1H NMR, can avoid the ubiquitous
nondescript designation of “multiplet” and exemplies the
concept of exploiting raw NMR data for additional information
(e.g., Section 3 Structure Revision). The importance of extracting
all of the information contained in an experimental data set is
exemplied by the simple analogy presented in (Section 1.2
Dimensionality and Completeness).
This community-driven review calls for a re-examination of
NMR-based structural analysis of NPs and represents the logical
next step in the NMR Raw Data Initiative that commenced in
2016.1 The seven major rationales used to organize this text
evolve from the urgent need for raw NMR data dissemination and
are explained in Section 2 Introduction to the Organization of
this Review. This led to the separation of the material into
sections that cover chemical structure (Sections 3–5), analytical
methodology (Sections 4–7), followed by applications and future
perspectives (Sections 8–10) of raw NMR data. Located at the
heart of the intent to promote the free dissemination of raw NMR
data, Section 10 Conclusions & Outlook should be of particular
interest to scientists increasing the use of NMR in NP research.
1.2 Dimensionality and completeness
Consider a picture of a Rubik's cube: the full 3D object cannot be
captured by a single 2D picture, as it only provides a projection of
the original object. The reduced dimensionality makes the
representation incomplete, as observed in Fig. 1, and the
incompleteness may lead to false conclusions. E.g., projection A
(Fig. 1) does not permit conclusions on solving the puzzle. No
faithful conclusion is possible until at least ve faces have been
examined, which requires at least two projections since no more
than three facesmay be observed at once. A single projectionmay
lead to an erroneous conclusion. Further projections increase the
amount of available information, which may either conrm the
original hypothesis or refute it (B vs. C, respectively, in Fig. 1).
Now consider a molecule. Each NMR experiment can be seen
as a projection of the original spin system. The structural
elucidation may require several projections/experiments to
reconstruct the full picture, i.e., approach the complete
Hamiltonian as closely as possible. Note that, for the Rubik's
cube, ve of the total of six faces is sufficient for absolute
certainty. In chemistry, however, structures are sometimes
postulated on the basis of a single 1H NMR spectrum, oen
erroneously. Moreover, it is not possible to predict how many
experiments will be required. Instead, the researcher will
perform experiments based on budget, time, and the possibly
the expectation that the analysis is complete once the rst
possible solution that matches all the available constraints (e.g.,
chemical shis, multiplicity, and correlations) has been found.
Oen, solutions are proposed based on previous results ob-
tained for similar molecules; yet other solutions may exist and
further experiments be required to single out the correct
structure. Thus, an“elucidated” structure can be viewed as
a possible solution that ts the available experimental data.
While other factors may contribute to erroneous structural
assignments, the urge to stop aer an apparent solution and
failure to recognize that more than one structure can be equally
or more consistent with the experimental data is likely the root
cause of the errors. Computer-Aided Structure Elucidation
(CASE) soware2 is invaluable for overcoming this limitation by
nding all structures which are consistent with the available
data. Moreover, CASE tools are capable of ranking candidate
structures by comparison of experimental and empirically pre-
dicted 1H and 13C chemical shis, and remaining ambiguities
can be resolved by inclusion of DFT calculations.3
Once an incorrect structure has been detected, the correct
structure may still not be obvious, particularly if the structure is
unusual.4 In such cases, CASE soware can be valuable by
providing probable structures for further consideration. While
this can potentially be done using the tabulated correlation data,
access to the raw NMR data it is valuable or even essential for this
process. Collectively, the uncertainty inherent to structure
Fig. 1 The rigor and integrity of structure elucidation and chemical identity depend not only on the type of data used to build the evidence, but
importantly also on the point of view from which they are analyzed. This can be symbolized by looking at Rubik's cube from various viewpoints:
perspective (A) may lead to the conclusion that the cube is solved. The two other projections, (B) and (C), are both compatible with (A) and
isometric. Both increase the amount of visible information, but while B confirms the original hypothesis derived from (A), (C) refutes it. Following
this analogy, the availability of raw (NMR) data enables researchers to view the entire “cube of evidence” from the same and/or from different
angles. Thus, raw (NMR) data is an important means of enhancing transparency, reproducibility, and integrity, and even empowers investigators
to use existing evidence to generate new scientific insights.
38 | Nat. Prod. Rep., 2019, 36, 35–107 This journal is © The Royal Society of Chemistry 2019
























































































elucidation is signicant. Moreover, new structures are pub-
lished daily without their corresponding experimental support,
or with the compressed molecular formula strings (e.g., Simpli-
ed Molecular Input Line Entry System [SMILES]), making peer-
review a difficult or an almost impossible task. In this context it is
safe to assume that the literature may contain erroneous struc-
tures and that a strategy is needed to deal with this issue.
1.3 Human and machine processing of NMR data
Progress in cheminformatics permitted the building of tools to
help validate assignments and, thus, unveil incorrect struc-
tures.5–8 Indeed, computers may calculate all the solutions
allowed by a potentially incomplete set of constraints. Soware
already exists that can handle all aspects of interpretation of
NMR spectra, from peak-picking and chemical shi predic-
tion9,10 to assignment and elucidation.6,7,11–14 The last two
heavily rely on the accuracy of the chemical shi prediction,
which in turn heavily relies on the quality and amount of known
structure assignments available for training algorithms. As
a consequence, most automatic spectral interpretation
programs rely on large databases of previously assigned spectra;
tools such as LSD [http://www.univ-reims.fr/LSD] or CCASA15
developed by Nuzillard et al. are notable exceptions. Ensuring
that these data are correctly assigned is essential to avoid
continual propagation of structural errors. Therefore, even with
the assistance of cheminformatics, the challenge of peer-
reviewing published spectral interpretations still remains. But
there may be another approach.
Acknowledging the fact that several signals can be assigned
from integration and correlation constraints alone11,12 paves the
way for unsupervised self-learning procedures that interpret
spectra completely from scratch.13 During the rst iteration, the
procedure tries to assign as many atoms’-signal pairs as
possible without the help of chemical shi constraints. In other
words, assignment is performed based on signal area, multi-
plicity and correlations, and only unambiguous assignments
are stored. These assignments link the observed chemical shis
to the assigned substructures, providing new knowledge to the
chemical shi predictor. In a second iteration, the algorithm
will reassign the same data, but this time using chemical shi
constraints inferred from the knowledge just acquired. Itera-
tions continue until a steady state is reached, i.e., no new atom-
NMR signal pairs can be assigned. When new data is submitted,
the system assigns it and may run a new iteration. Hence, the
algorithm builds its own database of assigned spectra without
any human intervention.
Peak-picking should be implemented as part of this self-
learning loop also. Indeed, modied data must be consid-
ered a representation of the original. A missing signal
because of low signal to noise ratio or an additional signal
from a poorly identied impurity are common errors that
affect the outcomes of such a system. Although assignment is
performed on peak-picked data, automatic peak-picking
itself should be seen and implemented as an iterative
process that ends when a successful assignment is found.
Having brought assignment, prediction and peak-picking
into a self-learning loop allowed the demonstration that
a program may be conceived to avoid any human assump-
tions and faithfully generate all the solutions to the assign-
ment problem. A similar approach can be implemented that
applies CASE2 strategies and DFT calculations3 to generate all
possible solutions to the elucidation problem and verify
them. Such a program would see all possibilities allowed by
the visible faces of the cube and allow thorough review of
published assignments. That is, as long as the full, raw,
unprocessed and unassigned data are published.
Hence, articial intelligence may be applied to automatic
structure elucidation. However, any operation performed on the
truly raw, original NMR data (FID and associated information), as
saved initially by the NMR spectrometer, can alter the nal
representation of the spectrum and may introduce errors. Conse-
quently, any modication of the raw data should be considered
part of the elucidation procedure and regarded as a process that
can be improved. For this reason, only raw datamust be input into
the learning procedure of the automatic structure elucidator.
Thus, developing new tools to assist researchers in their daily task
requires large sets of high quality data stored in a correct manner.
This goal can only be reached if the dissemination of original data
becomes a standard component, if not a requirement, of estab-
lished publication mechanisms.
1.4 Molecular transparency
Traceability and reliability of analytical results (detailed knowl-
edge of total error and method specicity) as well as analytical
data comparability are of utmost importance to make science
transparent on a global level. This holds especially true if such
results are key in decision making, as in medical diagnosis, food
and feed safety, environmental pollution tracking, and many
more areas. Even in the 21st century, the scientic base of such
undertakings is oen not transparent, albeit that peer reviewed
publications are daily business in applied and basic science.
Lacking or incomplete information on the technologies used, or
unclear declaration of utilized reference materials, hampers not
only scientic progress, but also complicates the transfer from
science to routine applications. Once an analytical strategy is
applied in, and validated for, routine use, vagueness in the basic
cornerstones of an assay, including (1) lack of information on
identity and purity of reference materials, (2) a poorly docu-
mented chain of traceability in calibrator materials, and (3)
missing clear-cut communicated measurement conditions, can
all lead to unnecessary platform bias and an overall increase in
inter-laboratory data scattering and inconsistency. As many
scientists are involved with the establishment and execution of
LC-/MS-driven assays for routine analysis, the importance of
NMR in the total analytical process is unclear or unknown.
However, NMR specialists are already aware of the power of
“their” methodology.
Aside from X-ray crystallography, NMR spectroscopy is still the
only spectroscopic method accepted for an unambiguous struc-
ture elucidation (not only for identication) of a molecular scaf-
fold, especially in the realm of organic compounds. Today, high-
resolution 1H and 13C NMR spectra become more widely
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 39
























































































recognized as being “molecular ngerprints”, which can even be
predicted computationally. While two-dimensional 1H-detected
experiments allow the transformation of 1H and 13C NMR reso-
nances into molecular scaffolds, contemporary technologies still
do not automate this process. Finally, while carbon–carbon
connectivity mapping would complete NMR based molecular
cartography, and despite recent progress with these experi-
ments,16–18 this approach is limited by sensitivity and not used
widely.
1.5 Molecular topography
By analogy, it is well known that modern terrestrial cartography
has changed dramatically recently. Traditionally, the painstaking
work started with planes doing analogue aerial photography and
technicians deriving a (nally digital) terrain model thereof. This
model still is a framework for detailed and accurate maps lled
by information derived from the photographs or from terrestrial
reconnaissance, oen by foot. Such maps, used by almost
everyone moving through the environment, have been replaced
by highly automated processes relying on space technology based
surveying by the “shuttle radar topography mission“ (SRTM) data
gathered by the space shuttle Endeavour in 2000. Users who lack
detailed knowledge of the involved technologies rely on the
assumption that the “maps” involved are reliable. It is assumed
that they are comparable and demand that the presented infor-
mation is representing “the true” environment. However, in
reality these claims are quite oen not met. Traveling distances
do vary, road conditions encountered are discrepant to mapped
ones, and hiking maps are too oen lacking detailed terrain
visualization. Whenever “maps” are involved in legal processes,
e.g., when we use cadastral maps as planning tool, it is assumed
that certain mapping products are accurate and precise two-
dimensional presentations of the three-dimensional open
space. It must not be overlooked, that these assumptions are
made because the production of such maps is traceable to an
agreed digital terrain model, the technological process of the 3D
to 2D transformation is well described and its error margins are
understood and communicated.
NMR spectroscopy is also a “mapping tool”, just on
a molecular scale level. It is based on scientic inventions and
breakthrough processes made 50+ years ago; its modern digital
version, the FT NMR technology, has been on the market for
more than four decades. Due to its technological complexity
and costs, access to NMR spectroscopy has been limited to
a very small number of practitioners. The latest “so revolu-
tion” in the application of NMR spectroscopy reached the public
about twenty years ago, meanwhile very successful rst
attempts have been made to transfer the NMR data interpreta-
tion from UNIX or Linux operated work station environments to
desktop computers integrating NMR data into the everyday
office. Now, for this type of soware the Gardner hype cycle
“trough of disillusionment” (which was very shallow) has been
successfully transversed and a stable, productive working
environment has been achieved.
Parallel to the development of NMR technologies, the
interpretation of the NMR data is also experiencing constant
change. Beginning from reporting selected NMR signals with
molecular position annotations based on increment rules and
similar estimation tools relying on conclusion by analogy, the
introduction of high-resolution cryogenic magnets and the
Nobel prize winning innovation of FT-NMR based 2D NMR
spectra, changed the situation remarkably. Complete correla-
tion of NMR signals and molecular positions became a must in
describing a novel compound. Especially in NP science,
comprehensive data representation was understood as
mandatory whenever new NPs were claimed. In organic
synthesis, standards were kept lower for signicant periods of
time, some prominent and well-ranked journals did not even
request molecular position assignments of any of the NMR
signals in spectral data. About a decade ago, Nicolaou and
Synder19 showed in a comprehensive study that, in the process
of NMR-based structure elucidation, erroneous structures
resulted with noticeable frequency and ultimately reected
inadequate structure elucidation efforts.
Very recently, Wolfgang Robien affirmed this postulate by
running the 13C NMR database CSEARCH against recently
published structures. He again was able to show that erroneous
assumptions in the structure elucidation process (e.g., lacking
spectral evidence, no 2D methods performed) were leading to
incorrect structures.20
2 Introduction to the organization of
this review
The numerous scientic rationales that support the urgency of
public dissemination of raw NMR data fall into the following
groups:
2.1 Rationale 1 – structure revisions
This represents the largest group and many cases can be
grouped into sub-categories, the largest comprises structures
originally proposed with an incorrect ring closure. Another,
somewhat embarrassing subgroup, consists of structures which
are blatantly incorrect or where, even with a cursory examina-
tion, of available data never should have been proposed. In
these cases, the raw data would have allowed a reviewer to
recommend changes and/or detect issues. A nal set involves
other types of revisions.
2.2 Rationale 2 – impurity detection and quantication
For several decades, the majority of NP research has been fueled
by the search for bioactive compounds, drugs (human and veter-
inary), herbicides and other pesticides. This quest was focused on
the use of bioactivity-guided fractionation. Here, a purity assess-
ment of the nal product assigned the bioactivity is critical, as
high potency minor impurities invalidate the conclusions. Hence,
both quantication and identity of impurities are critical.
2.3 Rationale 3 – dereplication
The bane of most NP chemists' endeavors is the “rediscovery” of
a known compound. The schemes and protocols developed to
40 | Nat. Prod. Rep., 2019, 36, 35–107 This journal is © The Royal Society of Chemistry 2019
























































































avoid, or at least minimize, this occurrence have oen been
complex and varied. They have aimed at detecting known
compounds as early in the discovery process as possible.
However, none has ever had claims of sterling success. The fact
that 1D 1H NMR and 13C spectra can serve as unique nger-
prints of a given compound (for 1H methodology, see Sections
3.3 and 5.1) makes NMR a highly specic tool for dereplication,
and whenever this can be applied early during fractionation (see
Section 5.3), it provides a quantum leap in discovery.
2.4 Rationale 4 – enabling new methodology
Science advances with the development and use of new
approaches and methods. This section features recently devel-
oped and utilized methods, which can provide the scientist with
valuable tools to interpret spectra from raw data.
2.5 Rationale 5 – other nuclei
This section adds the perspective of 19F, 15N, and 31P NMR
spectroscopy. Although uorine occurs rarely in NPs, it is
frequently introduced into derivatives to improve drug phar-
macokinetics. Its high magnetic moment, broad chemical shi
dispersion, and extensive coupling make 19F NMR spectroscopy
almost a sub-specialty. Similar considerations apply to phos-
phorus, and the raw data from these spectra are every bit as
data-intensive as those from a 1H NMR spectrum. Nitrogen is an
important heteronucleus in many NPs, but 15N sensitivity has
restrained a more widespread application to date. Raw data can
play an important role to overcome this limitation by expanding
the utility of valuable existing 15N NMR data with regard to
structural interpretation.
2.6 Rationale 6 – data repositories
Raw NMR data only reaches its maximum potential if it is
universally accessible. Unfortunately, chemists have fallen
behind the geneticists in the establishment and general
acceptance of a universal database. Although, several lauda-
tory efforts have assembled databases, with some described
here, the amount of NMR data generated around the world
makes the compiling of a single database for each nucleus
a growing, and already gargantuan, task, discussed further in
the conclusions.
2.7 Rationale 7 – clinical applications
Most readers of this review will probably nd this section alien
to their everyday interests. However, those who have had need
to take advantage of this foray of physics into the medical eld
will surely appreciate its capabilities and enjoy reading of how
the raw data has its role here also, and the optimistic view
anticipating quantum leaps forward in medicine from progress
in this area.
3 Structure revision
Structural revision can occur at three points of scientic
discovery, preferably prior to publication, either in the origi-
nating laboratory or at the manuscript review process, or less
ideally post publication. One example which was only pub-
lished aer an initial misassignment was discovered in house
is represented by the neolignan fromMagnolia grandiora L.21
This is an excellent example of the Rubik's cube philosophy
discussed above. The structure, 1, originally proposed on the
basis of HRMS, 1H NMR and 13C NMR was questioned on the
basis of biosynthetic considerations. A further examination of
2D NMR, specically one-bond and long-range correlations
from HMBC and HSQC experiments, respectively led to
a revision to structure 2,21 but this revision would not have
been possible from the 1D data alone. In most cases of
Structure Revision that see the light of day, the initial incor-
rect structure is not corrected in-house but published as
such, and correction comes when another group isolates
and/or studies the same compound. While one can only
speculate about the likelihood of a published structure being
incorrect, recent systematic studies employing relatively fast
parametric/DFT hybrid computational methods have found
substantial mismatches between predicted and published
data.22–24 For a series of nearly 100 sesquiterpenes, discrep-
ancies occurred for as many as 14% of the published struc-
tures and indicated the need for substantial structural
revision.
Moreover, concerns were expressed as early as in the mid/
late 1970s by Zimmerman and co-workers (see footnotes 12 in
ref. 25 4 and in ref. 26) regarding the exclusive use of spectro-
scopic structure elucidation methods while not including more
classical approaches involving chemical synthesis and/or
chemical degradation together with bulk analytical methods
such as elemental analysis for a more thorough approach to
structure elucidation. Similar concerns regarding the integra-
tion of chemical and spectroscopic structural analysis were
expressed by Faulkner (page 1433 in ref. 27) and Robinson (in
a letter to Chavrarti, as referred to in ref. 28). Following some
(undocumented) statistical analyses, Zimmerman raised the
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potential apprehension that relying on spectroscopic evidence
alone carried with it a substantial probability of structural
misassignment. While a classical approach involving total
synthesis may not be feasible within a reasonable time frame in
NP research, it is of interest to compare Zimmerman's predicted
probabilities of erroneous structures of 10–22% with the ca.
14% incidence rate found very recently by Kutateladze and co-
workers.22–24 These ndings conrm the validity of the
cautionary notes raised 40+ years ago,25,26 and demonstrate the
importance of purity and residual complexity29 in both analyt-
ical and NP chemistry: classical bulk analysis methods such as
microanalytical and (mixed) melting point determinations are
more sensitive to minor impurities than many of the contem-
porary spectroscopic methods. Notably, the demand for purity
of bioactive NPs and other chemicals is essential for rigor and
reproducibility of research outcomes.
Here, raw NMR data plays important roles in documentation
by enabling the retrospective determination of the purity of
previously investigated materials. Notably, the need for re-
assignment of NMR spectra and/or achievement of a complete
assignment of at least the full chemical shis and coupling
constants of the 1H and 13C framework, can be estimated to be
much greater. Reecting on the general gap in the assignment
of the relatively complex 1H NMR signal patterns, this consid-
eration affects the scientic context of structural correctness,
the resulting reproducibility of downstream research, intellec-
tual property issues, and their collective economic impact. The
role of (raw) NMR data in the structural revision of NPs has been
highlighted prominently in a recent review by Kubanek and co-
workers.30
3.1 Incorrect ring closures: furan vs. pyrone ring systems
The putative new compound 2-heptyl-5-hexylfuran-3-carboxylic
acid (HHCA; CAS 1256499-01-0, compound 3 in Fig. 2A) is
produced by the rhizosphere bacterium Pseudomonas sp. strain
SJT25.31 HHCA exhibits broad antifungal activity against several
phytopathogens and was considered a new promising bio-
pesticide. This led to further fermentation studies32 and
a patent being led and granted in 2012.33 However, biosyn-
thetic considerations raised doubts about the structure. With 18
carbon atoms it was assumed that HHCA was generated by nine
acetate units but these units could not be lined up, by a single,
or a two chain-mechanism to give upon cyclization HHCA. A
database search using the molecular sum formula pointed to
pseudopyronine B, an a-pyrone-based compound with an
identical NMR data set, that is produced also by several Pseu-
domonas species.34–37 Indeed, the UV-absorption (208 and 290
nm) spectrum and the 13C NMR data of pseudopyronine B (4)
were nearly the same as those for other 3,6-disubstituted 4-
hydroxy-2H-pyran-2-one-based compounds.38–42 Thus, the
structure of HHCA has to be revised to that of 4 (Fig. 2A/B).
Unfortunately, the authors assigned the carbon atom C-6,
resonating at 167.3 ppm in the 13C NMR spectrum together
with a broad singlet signal at 10.31 ppm in the 1H NMR
spectrum to a putative free carboxylic acid moiety, bound to
a disubstituted furan ring. This conclusion was thought to be
corroborated by IR absorption at 1635 cm1 and a loss of m/z
44 (loss of the COOH group by decarboxylation, in the MS
spectrum (Fig. 2C)). However, actually, the carbon atom C-6 of
HHCA (d 167.3 ppm) corresponds to C-4 of pseudopyronine B;
and the OH group of the COOH of HHCA (d 10.31 ppm) equals
the OH group bonded to C-4 of pseudopyronine B. Further-
more, the observed broad IR absorptions at 1635 cm1 repre-
sents an overlapping signal which is generated by the
stretching frequencies of the tautomeric C]O bond13 and
C5]C6 of the a-pyrone ring.43,44 In the MS spectrum, the loss
a CO2 group is commonly observed from the pyrone ring
system (Fig. 2D).45,46
In the original report of HHCA, the tri-substituted furan
ring was deduced on the basis of 13C NMR shi values and
HMBC correlations observed between H-4 and C-2, C-3, C-5
and C-100, while the linkages of the alkyl chains were
deduced from HMBC correlations from H2-10 with C-2, C-3
and C-6 and from H2-100 with C-4 and C-5. Regarding the
1H–13C HMBC correlations, the pair H2-10–C-6 suggests
a questionable 4JC,H coupling, which indicated already that
the original core was wrongly determined, because the HMBC
experiment is in a standard setup optimized for 2–3 bonds.
The observation of long-range coupling over four bonds is not
impossible (e.g., foremost in aromatic systems or as a W-
coupling in planar aliphatic systems) but commonly pres-
ents a weak signal. In the case of a strong signal, it could be an
indicator for a misassigned structure. The authors presented
in the ESI† the HMBC map, however only a section from 0–
120 ppm in the f1 dimension is shown, and the decisive range
(150–170 ppm) is regrettably not visible. The availability of
NMR raw data could have claried this issue. During the
course of the study of the biosynthetic origin of pseudopyr-
onines, the Gross group re-isolated congener B (4) and
observed no correlation between H2-10 (d 2.44 ppm) and C-6 (d
167 ppm) from the 1H–13C HMBC NMR map (Fig. 3). It should
be noted that a variety of more recent 2D NMR experiments
improve the detection and/or distinction of 2/3/4JC,H
42 | Nat. Prod. Rep., 2019, 36, 35–107 This journal is © The Royal Society of Chemistry 2019
























































































couplings, such as H2BC, LR-HSQMBC,47–49 and HSQMBC-
COSY/TOCSY50 experiments (see also the review by Breton and
Reynolds51).
Nevertheless, such a correlation can be much better ratio-
nalized by the pyrone than a furan ring structure. Finally, Gross
and coworkers conducted labeling experiments employing
doubly 13C-labeled acetate and conrmed in this way the
structure by the determination and localization of intact acetate
units via measurement of JC,C.37 Similarly, Reibarkh et al. have
emphasized the utility of uniform 13C labeling of microbial NPs,
Fig. 3 1H–13C HMBC NMR spectrum of pseudopyronine B (4); insert show details of the 160 ppm region.
Fig. 2 The putative (A) and revised (B) structure of 2-heptyl-5-hexylfuran-3-carboxylic acid (HHCA; 3), which was reported as pseudopyronine-
B. Arrows in A and B indicate 1H–13C HMBC correlations; red color indicates 4JH,H coupling of interest. Panel C shows the putative explanation of
the MS/MS fragmentation of HHCA in negative mode; fragmentation of the pseudomolecular ion [M  H] ¼ m/z 293.2. Panel D provides the
correct true explanation for the observed MS/MS fragment. The arrow with the solid line in (C) and (D) directly shows the decarboxylation
process.
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which becomes feasible via the availability of uniformly 13C
labeled glucose.52
3.2 Incorrect ring closures: the lipopeptide arthrofactin
In 1993, Imanaka and co-workers reported the isolation of the
cyclic lipo-undecapeptide, arthrofactin from the bacterium
Arthrobacter sp. MIS38. This compound possesses a high
surface activity and was assigned the structure 5.53 Later, the
corresponding biosynthetic gene cluster was characterized.54
The gene cluster (arfABC) coded for the expected 11 NRPS
modules, required for the assembly of the linear lipo-
undecapeptide portion and a terminal tandem thioesterase
(TE-I/TE-II). Particularly, the TE-I enzyme system is responsible
for the hydrolysis and cyclization of the linear lipopeptide
precursor. Nowadays, it is possible to predict the cyclization
process by bioinformatics because the TE's reveal clades of
enzymes that reect the cyclization step. Bioinformatic analyses
with the TE-I of ArfC led to the hypothesis that the ring closure
occurred between Asp11 and Thr3 to give structure 6 instead of
a lactone ring between Asp11 and the 3-hydroxy group of the
fatty decanoic acid side chain as originally suggested.55
A re-analysis of the 1H–13C HMBC correlation map and the
1H–1H NOESY correlations, enabled by the availability of the
raw data, would have revealed problems with the rst inter-
pretation. The closure of the cyclic peptide between Thr3 and
Asp11 was demonstrated using the following evidence: the
carbonyl carbon of Asp11 shows a HMBC correlation with the
Asp11 Ha and Thr3 Hb hydrogens (Fig. 4A). Furthermore, the
Thr3 Hg shows a NOESY correlation with the Asp11 Ha
(Fig. 4B). Therefore, the closure of the ring must be situated
between the Asp11 carbonyl group and the Thr3 hydroxyl group.
3.3 Incorrect ring closures: the case of aquatolide
The initial structure for the sesquiterpene aquatolide (7)
described in Asteriscus aquaticus,56 contained an unusual
bicyclo-hexane ring structure. This was revised recently to 8 by
additional NMR experiments, X-ray diffraction analysis and
quantum chemical computations,4 as well as by independent
total synthesis.57,58 However, a thorough analysis of just the 1H
NMR spectrum, enabled by the availability of the raw data,
would have revealed problems with the rst interpretation. The
feasibility of this approach was demonstrated via HiFSA (1H
iterative Full Spin Analysis) from the FIDs of the original 1D 1H
NMR spectra,59 obtained with both the re-isolated natural4 and
synthetic57 material. Using the PERCH soware tool and an
established HiFSA workow,60–62 it was possible to extract no
less than seven coupling constants from signals that had only
been described as “multiplets” in the original work (see
example of H-5a in Fig. 5). Some of these are surprising from
either the original or the revised structure. E.g., aquatolide
shows a 4J coupling of 7.2 Hz through saturated carbons, but
this is fully consistent with the quantum mechanical calcula-
tions from the revised structure. While being unexpectedly large
and not leading to a “hidden” signal splitting, the 7.2 Hz
coupling could be fully explained as being due to the spin–spin
interaction between two bicyclic bridgehead hydrogens via two
44 | Nat. Prod. Rep., 2019, 36, 35–107 This journal is © The Royal Society of Chemistry 2019
























































































routes. It is important to note that the tabulated NMR data
were/are not an adequate tool for the reader to verify the
assignments, whereas the digital 1H NMR data provided this
opportunity. NOESY and 13C NMR spectra were also impor-
tant for differentiating between the initial and revised
structures.
Evolving from the aquatolide study, was also the intro-
duction of Quantum Interaction and Linkage Tables
(QuILTs),59 which provide a checkerboard presentation rather
than a classical table as a means of rapidly viewing the rela-
tionship between coupling constants and bonding proximity.
The combination of available digital data and a more intuitive
representation of the interpreted data, such as in QuILTs,
would have pointed out the inconsistencies in the original
structure that were in fact expressed in the J-coupling patterns
and signal multiplicities. It should be noted that HiFSA
proles enable the calculation of NMR spectra at any desired
resonance frequency, meaning that the NMR information
extracted from a given spectrum becomes independent of the
magnetic eld strength. This is particularly useful for 1H NMR
based dereplication, when reported data has used a different
magnetic eld. Compiling HiFSA data in the form of QuILTs
has the added advantage of being a more intuitive represen-
tation for human interpretation and providing a tabular
format that is closely related to the data matrices of spin
simulation tools.
Although QuILTs provide a good check on the structure
elucidation and a more comprehensive description of the 1H
NMR spectra, they do have to be considered together with
congurational arrangements. Chemical synthesis and X-ray
crystallography will remain the nal arbiter of structure
determination. However, the former in particular will be
greatly simplied by starting with the correct structure, and
the initial structure is almost invariable the outcome of
spectral analysis. The aquatolide case exemplies the need
for thorough and complete analysis of NMR spectra, and the
need to go beyond rst order visual analysis of a processed 1H
NMR spectrum. It also reminds researchers of the illustrious
quote the astronomer, Carl Sagan, whereby “extraordinary
claims require extraordinary evidence”, which is widely
considered a variation of the principle by the Bayesian stat-
istician, Pierre-Simon Laplace, according to which “the
weight of evidence for an extraordinary claim must be
proportioned to its strangeness”.63 Finally, the case high-
lights the power of advanced post-acquisition processing in
structure elucidation.
Fig. 4 Selected regions of 2D NMR spectra of arthrofactin (6). (A) The
1H–13C HMBC 2D NMR spectrum indicated that both Ha of Asp11 and
Hb of Thr3 are coupled with the carbonyl of Asp11. (B) The 1H–1H
NOESY spectrum exhibited key NOE correlations between Hg of Thr3
and Ha of Asp11, indicative of the ring closure between Thr3 and Asp11.
Fig. 5 Comparison of the results of typical 1H NMR processing with
spectrometer default settings (exponential multiplication [EM] with LB
¼ 0.3 Hz; often the default processing scheme in NMR spectrometers)
and lineshape-enhancing methods such as Gaussian–Lorentzian plus
zero filling (LG) shows that raw data availability enables the analysis of
what otherwise would be considered a multiplet or “br d” of H-5a in
aquatolide (8). Representing a ddddq signal of near first order, a wealth
of structural information can be extracted from raw data as simple as
a 1D 1H NMR spectrum, for each of the hydrogen signals, yielding an
almost complete structural picture of the aquatolide molecule from
<200 kB of raw data.
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3.4 The case of coibamide A
The cyanobacterial coibamide A (9) is a highly N,O-methylated
depsipeptide (1287 Da), comprising 11 residues with 13
stereogenic centers, that was originally proposed as the “all-L”
diastereomer (10) in 2008.64 Ensuing attempts at total synthesis
were initially plagued by inefficient coupling of the sterically
Fig. 6 Partial 1H NMR spectra of the authentic natural product64 (A) and synthetic [D-Hiva2], [D-MeAla11]-coibamide66 (B).
Fig. 7 Downfield portion of the 1H NMR spectra of the authentic natural product (A),64 synthetic [D-Hiva2], [D-MeAla11]-coibamide (B),153 all-L-
coibamide (C),68 and [D-MeAla11]-all-L-coibamide (D).69
46 | Nat. Prod. Rep., 2019, 36, 35–107 This journal is © The Royal Society of Chemistry 2019
























































































hindered N-methyl amino acids, which promotes racemization
and diketopiperazine formation,65 and requires tedious residue-
specic optimization of coupling reagents and conditions.
Ultimately, Yao et al.66 reported the congurational revision of
coibamide A (9) in 2015, with inverted conguration of both the
[Hiva] and [MeAla] residues compared to the originally assigned
structure. The published 1H NMR spectra for this [D-Hiva2], [D-
MeAla11]-coibamide A (9) and the NP were very similar (Fig. 6),
while the 13C NMR spectra matched perfectly. The McPhail
group collected and fully assigned comprehensive 2D NMR data
for this synthetic product, conrming the match with the NP.67
However, the complexity of the 1H NMR spectrum for coiba-
mide A, and their experience with 1H NMR analyses of synthe-
sized methylated oligopeptides, highlighted the potential
difficulty in discerning differences between the crowded 1H
NMR spectra for closely related diastereomers of a NP with the
size and number of stereocenters of coibamide A. Consider-
ation of the potential for multiple N-methyl conformers
(rotamers), and/or diastereomers arising from sluggish
coupling reactions, as well as the presence of impurities, was
critical in evaluating synthetic products and moving ahead with
SAR studies. Before the congurational revision of coibamide A
was reported, He et al.68 achieved the total synthesis in 2014 of
the proposed “all-L” diastereomer 10, which yielded 1H and 13C
NMR data that clearly did not match those for the NP (Fig. 7),
and was 1000-fold less cytotoxic. Notably, structure 10 also
appeared to be more exible than the NP (in CDCl3), as indi-
cated by apparent N-methyl conformer signals, as judged by the
chemical shi pattern and signal areas. Concurrently, while
investigating the synthesis and SAR of coibamide A, Fujii and
coworkers produced [D-MeAla]-epimer 11,69 as well as several
unpublished diastereomers. The latter diastereomers vary by
single stereocenters and are under investigation for their vari-
able biological activity, with potential uncoupling of cytotoxicity
from their primary mechanism of action as inhibitors of cellular
protein secretion70 involving the Sec61 translocon.
Accurate verication of the absolute structure of each
synthetic product is, thus, critical. Thus far, the 1H NMR data
for published diastereomers do show discernible differences
and consistencies relevant to conguration (Fig. 7), especially
when raw data is processed consistently and directly overlaid for
comparison to detect slight chemical shi discrepancies and
changes in signal shape of overlapped resonances. Access to raw
NMR data for synthetic products has also allowed specic
integration of minor and/or major signals for quantitative
evaluation of the contribution of N-methyl conformers, diaste-
reomers and impurities, which substantially affect the biolog-
ical activity of coibamide compounds.
3.5 The structure of aldingenin B
The initially reported structure of aldingenin B (12), con-
taining a highly unusual intramolecular ketal, was assigned
based on extensive analysis of NMR spectral data (COSY,
HMQC, HMBC).71 The reported structure was recently deter-
mined to be incorrect by total synthesis of 12 72 An alternate
ve-membered hemiacetal structure (13), was proposed based
on computational simulations of the 1H NMR spectrum of
both the originally reported structure and the revised
proposed structure with comparison to the experimental
NMR data for the synthetic material corresponding to the
reported structure and the original NMR spectrum of aldin-
genin B.73
Inspection of models of the reported structure reveals the H-
6–H-5 dihedral angle to be 90 (2); the expected coupling of
such vicinally orthogonal hydrogens is <2 Hz. The natural
sample displayed an 8.4 Hz coupling between these nuclei,
while there was no detected coupling between H-5–H-6 in the
synthetic sample. Furthermore, the reported coupling constants
for the “bridgehead” hydrogens H-6 and H-2 in the natural
sample were reported as 9.0, 8.4 and 9.6, 6.3 Hz respectively.
The expected value of coupling constants of such bridgehead
hydrogens is <4 Hz, as observed in the couplings of H-2 (J ¼ 3.6,
1.8 Hz) and H-6 (br.s) in the synthetic sample and similar
structures reported by Dudley.74 Additionally, the HMBC
correlation map of the natural sample did not display an H-2–C-
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8 correlation, whereas this vital HMBC signal was observed in
the synthetic sample.
A major complicating factor with analysis of the NMR data
for aldingenin B was interpretation of the coupling constants
for the H-1 and H-2 hydrogen signals. The H-1 signal was re-
ported as a multiplet and the H-2 signal J values were mis-
interpreted due to their non-rst-order nature. Computation of
the spin–spin coupling constants for the reported structures
and the proposed structure (Table 1) reveal a tight correlation of
the proposed structure with the calculated values.72 The origi-
nally reported H-2 apparent J's, 9.6 and 6.3 Hz, which are
signicantly different from those obtained by calculation (11.3
and 4.4 Hz), are more in line with the original bridged acetal
structure, while the calculated values t well with the proposed
structure where the six membered carbocycle is more chair-like.
It is noteworthy that the sum of the apparent J's, 9.6 + 6.3 ¼
15.9 Hz, is very close to the sum of the constants obtained from
the multiplet simulation (Fig. 8), 11.2 + 4.8 ¼ 16 Hz, and that of
calculated J's for the proposed hemiacetal structure (11.3 + 4.4
¼ 15.7 Hz; Table 1; Fig. 9).
Had the raw electronic FID been available, once the original
structure was in question, a reanalysis could have revealed the
incorrect interpretation of the H-1, H-2 coupling constants and
signicantly simplied the structural revision. This case further
exemplies the clear need for thorough and careful analysis of
NMR spectra when assigning structure and highlights the need
to look past rst order analysis of 1H NMR data. This example
demonstrates the continued need for synthetic (or X-ray crys-
tallographic) verication of structure and illustrates the power
of computational methods in structural assignment.
A major part of the theme of this review is the need to be able
to extract all of the data pertaining to a proposed structure,
especially from 1H NMR spectra. However, in the context of the
structures discussed here, it is critical to emphasize that NMR-
centric elucidation work does not exclude the need to examine
other data, in particular data related to the molecular formula.
It is obvious that the initial investigators71 did not critically
consider the mass spectrum, by quoting an HR-EIMS of
346.0748 and not considering the challenges associated with
the EIMS of highly halogenated compounds.
3.6 Clearing the literature of blatantly incorrect natural
product structures
NPs present a colorful palette of functional groups, and it is
indeed difficult to nd totally “abiotic” combinations of atoms,
at least between those unreactive with water, the milieu of life.
Phosphines and azides are among the most remarkable exam-
ples, but unusual functional groups that are unprecedented or
very rarely documented in synthetic compounds can occur as
NPs. One such case is that of b-lactam antibiotics: at the time of
their original structure elucidation, it took long to dispel the
proposal of considering them being oxazole derivatives.75 While
it is, in principle, possible that NPs could “anticipate” the
existence of some functional groups or combination of func-
tional groups overlooked by synthesis or by the known biosyn-
thetic pathways,76 formulas that are chemically impossible or
too unstable for isolation are still reported as NPs, despite
continuous and signicant advances in spectroscopic
techniques.
Table 1 Experimental and calculated 1H,1H coupling constants (J in Hz) of aldigenin B (12/13)a
Match Match








1 m (overlap) 14.8, 8.8, 4.4 14.2, 2.5, 2.4 14.5, 2.4, 2.2
14.8, 11.3, 8.5 14.2, 3.7, 2.0 14.5, 3.8, 2.1
2 dd (9.6, 6.3)c 11.3, 4.4 2.5, 2.0 2.5, 2.0
11.2, 4.8
4 dd 14.5, 9.6 14.6, 9.6 14.1, 8.1 13.7, 7.9
dd 14.5, 4.7 14.6, 5.2 14.1, 7.2 13.7, 7.5
5 ddd 9.6, 8.4, 4.7 9.6, 9.0, 5.2 8.1, 7.2 8.1, 7.5
6 dd 9.0, 8.4d 9.0, 8.8, 8.5 3.7, 2.4 br.s.
9 t 13.5 13.4, 12.9 13.1, 12.8 13.0, 12.6
dd 13.5, 3.6 13.4, 4.6 12.8, 4.9 12.6, 4.6
10 dd 13.5, 3.6 12.9, 4.6 13.1, 4.9 13.0, 4.6
a Calculated J's are listed in descending order with a cutoff value of 2 Hz. b For consistency, an experimental 1H NMR spectrum of aldingenin B in
CDCl3 was used.
c Second order multiplet, simulation gives 11.2, 4.8 Hz with these simulated constants, calculated J's for hemiacetal 13 match the
experimental with rmsd ¼ 0.46 Hz. d It seems that this ddd (pseudo-quartet) was misreported as dd in ref. 71.
Fig. 8 Simulation of the H2 multiplet (3.99 ppm) of aldingenin B with
J1a,2 ¼ 11.2 Hz and J1b2 ¼ 4.8 Hz (apparent constants: 9.6 and 6.3 Hz,
reported by Crimmins et al.96).
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Correction sometimes requires only basic knowledge of
organic chemistry. For example, the doubling of NMR reso-
nances in the spectra of the amide 14 was ascribed to equili-
bration with its “isomer”, 15.77 The latter is actually a resonance
form of 14, and the equilibration process detected in the NMR is
what has to be expected for the rotameric interconversion of
E-and Z-amide stereoisomers. Also doubtful is the isolation of
the acyl chloride 16, since this functional group is unstable in
water and unlikely to exist in Nature.78
In other cases, correction can be achieved via re-analysis of
the NMR data, which typically requires the raw NMR data to be
available. Several examples exist, such as folenolide (17)79 which
violates Bredt's rule; the “isoprenoid” core of the antifungal
18,80 which is geometrically impossible in any isomeric form; or
the trans-cycloheptene structure assigned to the peroxide, 19.81
A re-evaluation based on the tabulated data of chemical shis,
coupling constants, and 2D correlations can lead to a successful
revision.82 However, this kind of re-evaluation is generally
difficult as documented spectroscopic assignments can be
biased, as “problematic” signals might have been overlooked
originally, or entire sets of signal have been misassigned. As
a result, even with the availability of a synthetic version of the
alleged formula, comparison of tabulated NMR spectroscopic
data alone is insufficient for a structural revision, leaving the
issue unsettled. The availability of the original FIDs wouldmake
such revisions possible without the need of synthesizing a non-
existent NP.19 This would accelerate correction of wrong struc-
tures and minimize their appearance via peer review by making
the NMR data fully transparent to peers, reviewers, editorial
teams, and subsequently to readers.
3.7 Bredt's rule as a check on structure correctness
Research into the structure determination of monoterpenes by
Julius Bredt in the late 1800's, early 1900's, gave rise to the term
Bredt's rule. This rule states that the terminus of a double bond
can not exist at bridgehead positions (i.e., branching position)
of a bridged bicyclic system (Fig. 9).83–85 Interestingly, however,
it was the physical organic chemistry community that laid out
empirical guidelines for anti-Bredt systems,86–91 which became
the holy grail of synthetic chemists for decades. Meanwhile, the
area became somewhat foreign to the NP community. Classi-
cation of NPs with a bridgehead double bond as anti-Bredt or
not was difficult, because the underlying aspect of Bredt's rule
was stability and the large majority of NPs are stable.92 The
Williams group became intrigued with a report by Cong et al.,
reporting the isolation of neoveratrenone (20).93 The structure
presented caught their attention because it contained a bicyclo
[3.3.1] moiety with a bridgehead double bond. Although, the
parent bicyclo[3.3.1] anti-Bredt system had been previously
synthesized it was reported to be unstable. It was possible that
physical properties of the entire NP skeleton enhanced stability,
or the structure had been misassigned. Williams and Sav-
chenko82 turned to the elucidation data, however, only 1H, 13C,
HMBC and NOESY NMR data were presented in the article, with
no ESI† available (i.e., no additional 1D and 2D NMR data).
Without the full gamut of 1D and 2D digital data, considerable
detective work was required to interrogate the proposed struc-
ture. Nevertheless, they were able to reassign the structure of
neoveratrenone, as 21, based on a combination of the available
data, comparison with related synthetic analogues (e.g., 22, and
the co-isolation of verapatuline (23)) by Cong et al.82 The latter
Fig. 9 Generalisation of a caged skeleton containing a bridgehead
double bond (bicyclo[m.n.o]).
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lending substantial biosynthetic support to the proposed reas-
signed structure 21.
By serendipity they later isolated EBC-219 (24), containing
a bridgehead double bond, but in a larger macrocycle.94 This led
Krenske and Williams to develop in silico parameters based on
olen strain (OS) energies that now enable the NP community to
cross check the validity of NPs that are proposed with bridge-
head double bonds.95
3.8 Correct analysis of coupling constants
As fast and accurate computational methods become available
to organic and NP chemists, there is an increasing demand for
high quality NMR data available for examination and process-
ing in different ways. The need for raw FID data is most pressing
in 1D 1H NMR spectra, where signal overlap and second order
effects oen present challenges in transcribing the complexity
of the spectra into neat tables. Oen complex multiplets are
interpreted with oversimplication. Few research groups report
nuclear spin–spin coupling constants (SSCCs) with due dili-
gence and high precision. It is common to encounter a doublet
of doublets with two SSCCs differing by asmuch as 2 Hz or more
described as a triplet with an average coupling constant re-
ported. The accuracy of computational predictions of SSCCs has
reached 0.3–0.5 Hz.96–98 Oen, one faces a situation where
a difference in 1–2 Hz is the only criterion for differentiating
between two candidate structures. Computations may provide
the answer but, without experimental data reported with
appropriate accuracy, this becomes a moot point. In addition to
this, typos and other errors made in the process of transcribing
spectra into publication tables are inevitable, while the low
quality images of these spectra in the ESI† section do not help,
and serve mostly as a quality/purity control.
An example is the zoanthamine-type alkaloid 5a-iodozoan-
thenamine (25), from Zoanthus kuroshio.99 DU8+ computa-
tions22,23 of its NMR spectra identied irreconcilable differences
between the computed and the experimentally reported 1H
SSCCs, implying a misassignment. However, the predicted 13C
NMR chemical shis satisfactorily matched the experimental
values. Closer examination of the SSCCs from a 600 MHz
experiment revealed that many of them deviate from the
calculated values by a factor of 1.5. For example, the constants
for H-1 through H-14a needed multiplication by 1.5 to reconcile
them with the computed values; H-14b did not need such
correction, while most of the remaining SSCCs needed it again.
As the 1H NMR spectra for several alkaloids reported in this
paper were run at either 600 or 400 MHz, it was hypothesized
that a “clerical” error had been introduced by measuring the
line spacing on a hard copy spectrum and multiplying it by the
wrong working frequency of the spectrometer. Revisiting the
raw FID data with NMR processing soware would have allevi-
ated all problems.
Qinan-guaiane-one, (26) a guaiane sesquiterpene isolated
from Aquilaria sinensis,100 is another representative example
where raw NMR data would have helped alleviate confusion
with structure assignment. The reported geminal spin–spin
coupling constant J6a–6b ¼ 10.3 Hz differs from the calculated
value by almost 2.5 Hz (Jcalc ¼ 12.7 Hz). This error is probably
not a typo, but rather it is due to the fact that the multiplets are
not rst order and therefore more sophisticated line tting of
themultiplets is needed to extract the actual SSCCs here. Qinan-
guaiane-one is also an instructive example of the importance of
accurate determination of small constants. The signal for H-13
is accurately described as a 2.3 Hz triplet. It does not have
vicinal neighbors and therefore the conguration of the C-13–
OH group is more difficult to assess. Luckily, the calculated
allylic H-13–H-22 SSCCs for the correct (shown) stereoisomer,
2.4 and 2.1 Hz, are much closer to the reported experimental
value of 2.3 Hz than the calculated allylic constants for the
alternative epimer at C-13, 0.51 and 0.54 Hz. The combined
evidence, together with a good match of 13C NMR chemical
shis (rmsd ¼ 1.44 ppm) indicate that the originally reported
qinan-guaiane-one structure is correctly assigned, but the
discrepancy in the calculated and experimental values for
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geminal J6a–6b is most likely due to second-order effects which
are not accounted for in the authors' reporting the apparent
value for this constant.
Another common problem is misinterpretation of multiplet
shape in 1H NMR spectra. The terpene metabolite, ansellone C
(27) was isolated from the marine sponge Clathria gomba-
wuiensis.101 A multiplet belonging to H-19, critical for the
determination of the conguration at the fusion of rings C and
D, was reported as a dd 8.5 and 4.6 Hz, while the calculated
values were 4.7 and 4.3 Hz. In the copy of the spectrum in the
ESI,† this multiplet does not look like a dd 8.5 and 4.6 Hz, but it
is virtually impossible to extract any useful information from
the picture. In summary, the conguration of ansellone C (28) is
either misassigned or the H-19 multiplet is interpreted and re-
ported incorrectly. Raw FID data would have helped to resolve
this issue.
In general, 13C NMR spectra are less prone to the problems
outlined above, but even there one sees occasional misinter-
pretation of an impurity signal and typos in transcribed tables
of chemical shis are plentiful. For example, a complex diter-
penoid, gaditanone, (28) possessing an unprecedented 5/6/4/6-
fused tetracyclic ring skeleton, was recently isolated and char-
acterized by solution NMR,102 with its only carbonyl carbon, C-7,
assigned the chemical shi value of 206.6 ppm. The DU8+
calculated value for this carbonyl carbon is 213.8 ppm, indica-
tive of misassignment. However, a cursory look at the copy of
the spectrum in the ESI† revealed an unannotated extra signal
at 29–30 ppm, implying that acetone is an impurity in the
sample. It is plausible that the actual carbonyl signal belonging
to 28 was overlooked as it was too small. Exclusion of the
carbonyl signal from the statistics improves the match of the
experimental and computed 13C NMR chemical shis to rmsd¼
1.23 ppm. This excellent accuracy leaves no doubt that the
structure of the diterpenoid is correctly assigned. It also
suggests that the authors should examine the vicinity of 212–
214 ppm for the actual carbonyl signal belonging to gaditanone
(28).
3.9 Sulfones vs. sulnates
Chemical investigation of an Australian sponge, Aplysinella
rhax, led to the isolation of psammaplins A, I, and J.103 Psam-
maplin I (29) was rst isolated from Pseudoceratina purpurea
and formulated to contain a sulfone moiety, from IR data.104
The metabolite was later reported from a Jaspis/Poecillastra
sponge association without additional comment on its struc-
ture.105 The rst published NMR data reported the H-2 signals at
2.96 ppm (m) and 3.75 (s), and H-3 as a triplet of doublets (td)
centered at 3.62 ppm with J values of 6.5 and 2.0 Hz. Sulfones
are not normally chiral since two of the substituents attached to
sulfur are oxygen, therefore each set of the methylene hydro-
gens at C-2 and C-3 should have been equivalent. Data acquired
at 500 MHz in CD3OD by the Garson group revealed diaster-
eotopic 1H multiplets at 2.91 and 3.01 ppm assigned to the H-2
hydrogens, and a complex two hydrogen signal centered at
3.62 ppm for the methylene hydrogens at C-3; these data sup-
ported a methyl sulnate, as in 30.
Even despite the incorrect chemical shi value originally
reported for one of the H-2 signals, their data were inconsistent
with a sulfone functionality. Although the (H-3)2 signal super-
cially resembled the triplet of doublets as reported, it showed
ten lines on close inspection, and was best described as an AB
system (3.63 and 3.61 ppm) in which each line is split into
a triplet by two vicinal couplings of 6 Hz. Owing to signal
overlap, only ten of the predicted twelve lines were resolved.
Repeated acquisition of the 1H NMR data at 900 MHz conrmed
the complexity of the H-3 and H-2 signals. At 500 MHz, the two
chemical shis for H-3 were calculated as 3.630 and 3.614 ppm
with 2J ¼ 14.8 Hz, and at 900 MHz as 3.631 and 3.615 ppm with
2J¼ 14.9 Hz. Detailed modeling of the H-2 and H-3 spin systems
was carried out on the 900 MHz spectrum of psammaplin I (29).
The signal at 3.75 ppm for the OMe group of the methyl sul-
nate had been incorrectly assigned to H-2; however, the signal
integrated for 1.8H owing to partial transesterication by the
NMR solvent.
Concurrently with the above NMR study, the Ireland group
independently prepared two methyl sulnate ester derivatives
of psammaplin A, one of which had spectroscopic data identical
to psammaplin I.106However, their 1H NMR data were run at 500
MHz, as were the original data,104 so the nonequivalence of the
H-3 hydrogens that resulted from the presence of the chiral
sulfur atom in psammaplin I may not have been evident.
This case study highlights the valuable role of very high eld
NMR in the dereplication of marine NPs. When chemical shis
and coupling constants are reported accurately, the values can
be compared for a sample run at any eld strength.
The prediction of chemical shi values by quantum chem-
ical methods has provided valuable insights into NP structures,
including the correction of published structures. The Garson
group recently revised their published structure for acremine P,
a metabolite of Acremonium persicinum, following a comparison
of calculated and experimental NMR chemical shi data.107
When the originally published structure, 31,108 was examined
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using a combination of computational approaches that provide
13C NMR shis with mean absolute error (MAE) of 1.6 ppm,
there were deviations of 20.4 ppm for the alkene carbon (C-2)
and 23.0 ppm for the hydroxymethine carbon (C-7). Re-
evaluation suggested the signal at 95.0 ppm (C-7) had been
incorrectly assigned to a secondary alcohol instead of an acetal
or lactol. Furthermore, the alkene carbon signals (102.4 and
162.5 ppm) indicated a polarized double bond, likely enolised
given the number of oxygen atoms in the molecule. HMBC
correlations of both the lactol hydrogen at 5.83 ppm (d) and the
signal at 4.15 ppm (s) for the hydroxymethine hydrogen H-8 to
the acetal carbon at 99.0 ppm supported the revised planar
structure, 32.
DFT computations did not safely distinguish between four
proposed diastereomers of acremine P owing to the close
similarity of the calculated 13C NMR shi values. The calculated
chemical shis were further examined using the DP4+ compu-
tational approach developed by Sarotti et al.109 to assign the
most probable diastereomer.109 Using the 13C NMR data alone,
the probability was 99.7% that 32 was the correct diastereomer.
Coupling information, notably the zero coupling between the
vicinal lactol and hydroxymethine hydrogens, as well as JH7–H8
couplings calculated for each stereoisomer using the methods
of Kutateladze et al.,98 together with NOE data further supported
the relative conguration shown.
Garson et al. had earlier reported that hydrogenation of
acremine P yielded acremine A as the sole product;108 clearly
structure 31 could not be correct as the dioxolane ring of the
revised structure was incompatible with the tetrahydrofuran
ring previously ascribed to acremine P. The revision of the
structure of acremine P highlights the valuable role of
computational studies in evaluating the structures and cong-
uration of complex NPs. In each of these cases, the original FIDs
of both the 1H and 13C spectra can provide a basis for quantum
mechanical analysis and a rapid resolution of the structural
assignment problems.
3.10 Methylene signal assignments in the structural revision
of aromin to montanacin D
The originally proposed structure of aromin (33)110 an Anno-
naceous acetogenin,111,112 was revised recently to be montanacin
D (34) by total synthesis of the proposed structure of aromin,113
and re-examination of NMR data of synthetic montancin D114
and other related isomers,115 especially 13C NMR data using
CAST/C NMR Structure Elucidator,116 and MS fragmentation
analysis of TMS derivatives of 33 and 34.113
When comparing originally reported NMR data and
synthetic compounds, 13C NMR data with a tabulated 13C NMR
chemical shis of aromin and montanacins were insufficient
because exchangeable methylene signals were lumped together
in the region of 31.1–31.9 ppm for C-3, C-5, and C-6 of aromin,110
and in the wide range chemical shis such as 23.4–31.9 ppm for
thirteen carbon signals in the case of montanacins D and E.117
Complete assignments of severely overlapped methylene
signals in 1H and also 13C NMR were difficult or impossible in
some cases, but relevant information of exact chemical shi
values, number of signals, and intensities of them are very
important for comparison of NMR spectra directly among NPs
and synthetic compounds. Fig. 10 shows the 13C NMR spectra
for methylene regions of synthetic montanacin D and the
proposed structure of aromin are shown. From the viewpoint of
structural revision of aromin, the assignment of 23.28 ppm for
C-6 of 34 is critical as the methylene signal at the g-positions
from the ether oxygen in the tetrahydropyran ring, which is
absent in the spectra of the synthetic 33. In comparison
between 13C NMR data of 33 and 34, assignment of 29.15 ppm
for C-12 at the g-position from the carbonyl group at C-9 and the
d-position from the hydroxyl group on C-15 will be important to
determine the methylene chain length between C-9 carbonyl
and C-15 hydroxyl groups. Together with these assignments,
signal assignments of C-3, C-5, and C-6 for 33, and C-3, C-5, and
C-7 for 34 are important to characterize the partial structure
of the tetrahydrofuran or tetrahydropyran ring system,
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respectively. Exact 13C chemical shi values could be obtained
from raw NMR data readily and, e.g., are useful for direct
comparison and to create database queries for the CAST/C NMR
system. For acetogenins, 1H NMR raw data of intact compounds
are also useful, but also raw data of MTPA ester derivatives are
very important. These are required to determine the absolute
conguration of hydroxyl groups and relative congurations of
separated chiral centers.114,115
3.11 The case of aglalactone
The NMR based elucidation process generally follows two major
strategies, or a combination thereof. One strategy involves spin–
spin interactions utilized to generate different spin networks,
the other is focused on chemical shis and relies on increment
rules. The number of experimental data-points (chemical shis,
J-couplings, dipolar couplings) outnumbers the atoms present
in a molecule by far. This results in a high number of degrees of
freedom, and successful structure assignment requires
a combination of two major thought processes in parallel:
intuitive interpretation of all available data, and knowledge of
NP biosynthesis. Also, wherever expert reasoning is part of
a research strategy, errors are well within the realm of
possibility.
When investigating the genus Aglaia in the late 1990s, Hofer
and colleagues came across a molecular scaffold that was
unusual for the Meliaceae: a benzofuranone lactone congener
named aglalactone. It was determined to bear a lactone moiety
and appeared to t well into the biogenetic reasoning for far
more complex compound classes such as the panellins or a-
vaglins.118,119 Integrated analysis of HR-MS, IR, and NMR data
was straightforward and led to the assignment of structure, 35.
“Missing” NOE contacts were explained by congurational and
spatial considerations. However, when re-investigating the
aglalactone 13C NMR data by means of the CSEARCH database
(see also Section 8.2),120,121 it became evident that a single 13C
NMR shi value (a CH element resonating at about 81 ppm)
showed a signicant mismatch relative to the calculated value.
Hence, a reinvestigation of the structure elucidation process
was commenced. An alternative hypothesis was generated and
a set of possible regional isomers formulated. Independent
acquisition of additional spectroscopic evidence on a re-
isolated analyte was key for this strategy. Aer time
consuming procurement of the analyte, the generation of
a complete NMR data set including HMBC and NOE spectra as
well as a lanthanide induced shi (LIS) NMR data sets were
recorded. The new data strongly supported a new structural
hypothesis, 36, which was based on “inversion” of the lactone
moiety. Subsequently, the structure and the scaffold ring system
were revised from a 2,3-dihydrobenzofuran-2-one to a 3H-iso-
benzofuranone.122 Within the past decade, the isolation of
Fig. 10 13C NMR spectra (150 MHz) of methylene region for (A) the originally proposed structure for aromin (33) and (B) montanacin D (34).
Region for two methylenes at a-positions of ketone carbonyl group was omitted (48.74 (C8), 43.42 (C10) for 33, and 49.13 (C9), 43.76 ppm (C11)
for 34, respectively). Spectra were measured in CDCl3 solution at 25 C. Assignments were carried out by analyses of several 2D experiments
including HMBC data.
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aglalactone from several sources and the discovery of an addi-
tional congener123–125 represent an independent and strong
conrmation of the scaffold correction undertaken by Seger and
colleagues.
Although NMR data from the original investigation were
available at the time of the aglalactone revision, the data set was
deemed incomplete, as HMBC data was unavailable. While it
was possible to re-isolate the compound, the group of Hofer and
Greger experienced further difficulties. In one instance,
a collaborative effort was necessary,126 in another case, only total
synthesis was able127 to correct a structure.
Almost two decades aer the structural revision, the correct
structure of aglalactone is still not disseminated properly to the
scientic community, including in major resources and data-
bases. Notably, if NMR raw data sets would be available and
become a routine part of deposited data, it would be straight-
forward to correlate the structures and (different) structural
proposals via their ngerprint NMR spectra, independent of the
limitations of spectral gures in publications and their ESI.†
Furthermore, such raw data would enhance the traceability of
any novel congener claims relative to the rst reported congener
of a given compound class. In such instances, a series of NMR
data signals would typically show close matches between the
congeners, thereby proving unequivocally the relationship of
the compounds via spectral similarity. This kind of “similarity
feature” can be transferred from the analogue world of expert
reasoning to computer based similarity searches. The approach
is already very well-known from other research elds such as the
LC-MSn or GC-MS/MS based general unknown screening (GUS)
in toxicology128 or the spectral feature comparison approaches,
followed by IR/NIR based applications in clinical chemistry or
forensics.129
3.12 Diastereoisomers and rotamers
1H NMR spectra provide not only two-dimensional structural
information but also very detailed congurational data on NPs,
e.g., epimers or rotamers, which have been many times
neglected, as they were considered as signals due to impurities
and are thus not reported in the nal discussion on the struc-
ture elucidation. Some avanone glycosides and avone-8-C-
glycosides exemplify this problem.
In the past, avanones were believed to occur in nature as
levo-rotatory (2S)-isomers because the enzyme catalyzing the
conversion of chalcones to avanones is highly stereospecic.130
However, avanones and their glycosides are present as enan-
tiomeric and diastereomeric mixtures, respectively. Among
others due to ring-opening of avanones under basic condi-
tions131 or instability and rapidly recyclization to avanones in
a non-stereospecic manner.132 In the case of the aglycone of
a avanone, naringin, the presence of stereoisomers cannot be
observed in the 1H NMR spectra because naringenin has only
one chiral center (C-2), so the two enantiomers have identical
spectra. The attachment of a sugar yields various glycosides and
these represent the most abundant form of naringin in nature.
However, the introduction of one or more other enantiomeric
centers results in a mixture of different diastereoisomers with
different chemical properties and thus also different NMR
spectra. Similar to the naringin case, the 1H NMR spectra of
other avanone glycosides, like hesperidin and neohesperidin
are characterized by the clear presence of signals of two dia-
stereoisomers.133 In the 1H NMR spectrum the ratio between
diastereoisomers is easily calculated from the raw 1H NMR data.
For example, in the case of neohesperidin the 1H NMR spec-
trum shows a bigger difference in the ratio of the two stereo-
isomers of the molecule (1 : 4 between two isomers), as
compared to naringin (2 : 3 between two isomers).
Another group of isomers with different chemical properties,
are the rotamers which are generated from conformational
isomerism, in which the rotamers cannot easily be inter-
converted by rotation around a single bond. In nature, many 8-
C-glycosides of avonoids are oen found to have rotamers due
to steric hindrance at the C–C glycosyl avone linkage.134 In the
case of vitexin, the chemically equivalent H-20 and H-60 hydro-
gens show two broad signals due to rotamers. In the 1H NMR
spectrum of orientin, another avonoid 8-C-glycoside, signal
broadening is detected around 7.5 ppm (H-20) because of the
presence of rotamers. However, the isomers isovitexin and
isoorientin with C-glycosidic sugars at C-6 do not show the
presence of rotamers.
It is generally accepted that plant metabolites are produced
in a stereospecic way because of the involvement of enzymes in
many biosynthetic steps. However, different stereoisomers of
the same compoundmay exist in nature, either as side-products
of an enzymatic reaction or aer a chemical conversion. By
neglecting minor signals in the NMR spectra of NPs, by marking
them as impurities important information is lost. Not reporting
the full raw data, means that later colleagues might have
problems in purifying compounds as they are not aware of the
extra signals due to these situations. Therefore, any paper on
structure elucidation and identication of NPs, should give the
full raw NMR data.
3.13 Data ambiguity
The marine NP, gallinamide A (37) was rst isolated from
a cyanobacterial Schizothrix species collected from a reef near
Piedras Gallinas in 2009.135 The structural assignment used
classical 1D and 2D NMR and mass spectrometry methods. The
absolute conguration required a combination of chemical
degradation and chiral chromatographic analyses. Although
this was successful for most chiral centers, the absolute
conguration of the terminal (N,N-dimethyl isoleucine) residue
was not determined due to a lack of material, but was
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postulated as possessing the L conguration based on bioge-
netic arguments.136
Shortly aer this initial publication, a second compound
with the same planar structure was published.136 This new
compound, symplostatin 4 (38), possessed the same relative
conguration as gallinamide A at all the assigned chiral centers
(see chemical drawings). In addition, the absolute conguration
for the N,N-dimethyl isoleucine residue was determined, and
reported as L. A footnote in the manuscript describing the
discovery of symplostatin 4 stated that the NMR data between
symplostatin 4 and gallinamide A differed signicantly in the
N,N-dimethyl isoleucine region, and suggested that the two
compounds were therefore, logically, diastereomeric.
Subsequently, several groups have pursued total syntheses of
these structures.137–140 The rst, published in 2010 reported the
synthesis of symplostatin 4 and presented NMR data that
differed signicantly from those reported for gallinamide A,
particularly in the N,N-dimethyl isoleucine region (Fig. 11,
highlighted in red).139 Subsequently, this same group synthe-
sized all four possible diastereomers of gallinamide A in an
attempt to resolve the outstanding uncertainty about the
structure of this metabolite. In collaboration with the author
who originally isolated gallinamide A, all four of these
compounds were subjected to full de novo structure elucidation,
with the structures blinded to the chemist performing the
structure elucidation to eliminate bias in the assignments.
Surprisingly, when the resulting hydrogen and carbon chemical
shi values were compared to those for the NP, the values for
the L-isoleucine derivative were the only ones that matched the
data from the original gallinamide A data.138 Although initially
reported to have signicant variations in the N,N-dimethyl
isoleucine region, subsequent comparisons of the 1D NMR
spectra in CDCl3 show that the variations between the spectra
are minimal.138 Perhaps confounding the issue, the original
isolation of gallinamide A was tabulated in CD3CN in text, but
additionally provided the unannotated CDCl3 spectra in the
ESI.† Submission of the 1D FID les would have enabled more
accurate comparisons between the two spectra directly, helping
to minimize ambiguity of the data (Fig. 11).
As can be seen between the spectra of symplostatin 4 from
the initial and the later gallinamide A synthesis reports, and
studied thoroughly in (acyclic) peptides, effects of concentra-
tion and pH have substantial impact on the spectral charac-
teristics of compounds, even in the same solvent (Fig. 11,
highlighted in green).141–143 While beyond the scope of the initial
studies, providing spectra of compounds in several solvent
systems and under different conditions would still enable more
detailed studies into the effects of pH and concentration on the
spectra of a metabolite, and provide additional tools for inves-
tigators to more accurately dereplicate compounds under
a variety of conditions. Additionally, as time progresses and
data processing techniques are rened, tools such as deconvo-
lution algorithms and non-FT processing techniques could be
protably applied to retroactive analysis of existing data
sets.144,145
This vignette highlights the challenges associated with
determining relationships between structures from tabulated
data. Had all of the original data les been available, it would
have been possible to directly compare the NP samples, and
relate these to the synthetic materials. Instead, exhaustive
synthetic efforts demonstrated that gallinamide A possesses
a structure identical to symplostatin 4 (38).
3.14 The importance of details
Detailed analysis of the chemical shis and coupling constants
can not only elucidate the ne structures of complex natural
compounds, but also provide useful information to probe the
formation of the different intramolecular H-bonds in very
similar analogs. For instance, phainanoids B (39) and F (40),
possessed similar structures except for the different substitu-
ents at C-25 (Fig. 12). However, the chemical shis and coupling
constants of the OH-24 hydrogen showed major differences
(Fig. 13), which were believed to be caused by the formation of
different intramolecular H-bonds with the OR-25 moieties.146,147
For phainanoid B (39), the OH-24 resonated upeld with a large
coupling constant (d 2.26 ppm, d, J24,OH ¼ 10.1 Hz), suggesting
that the H-bond was formed between OH-24 and the oxygen
atom of OH-25 in a ve-membered cyclic interconnection
(Fig. 13A), in which the H-bond angle and length simulated for
OH-25 were 69 and 3.9 Å, respectively,148–150 and the dihe-
dral angle between H-24 and OH-24 were 50 as generated by
Hartree–Fock/3-21G.
In contrast, phainanoid (40) showed a stronger H-bond,
formed between OH-24 and the O-atom of the acyl carbonyl
furnishing a seven-membered ring (Fig. 13B), with a more
favorable H-bond angle and length of 148 and 1.7 Å,
respectively.148–150 This resulted in a downeld chemical shi
and a smaller coupling constant for the OH-24 signal (d
3.44 ppm, d, J24,OH ¼ 4.8 Hz) compared with those of phaina-
noid B (39), owing to the deshielding effects of acyl group and
the increased dihedral angle (69). The coupling constants of
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 55
























































































H-24/OH-24 and the dihedral angles in the simulated
conformers of 39 and 40 satised the Karplus equation.151,152
The other reported compounds of two subclasses with different
substitution patterns at C-25 were also consistent with this
interpretation.153 These insights became possible only via a full
analysis of the NMR data and highlight the importance of
careful analysis, especially of chemical shis and coupling
constants that together provided a useful tool for insight into
the ne structures and conformations of complex NPs in
solution.
3.15 Structural instability leads to dynamic complexity
In 2014, the Williams group disclosed the isolation of EBC-329
(41) and EBC-324 (42) from a plant collected in an Australian
rainforest, together with collaborators from EcoBiotics Ltd and
the QIMR Berghofer Medical Research Institute.154 EBC-324 (42)
Fig. 11 NMR profiles of (A) gallinamide A (37), as reported and adopted from;135 (B) synthetic gallinamide A (37) as reported and adopted from;138
(C) symplostatin 4 (38) as isolated and adopted from;136 and (D) synthetic symplostatin 4 (38) as reported and adopted from.139 Variations in the
spectra signals in the isoleucine region (1.0 to 3.0) led to speculation that the compounds were diastereomers. Further studies showed this was
not the case after investigation and direct comparison of the region (highlighted red) by Conroy et al.139 Variations in pH and/or concentration
give rise to other spectral differences, such as those seen in the NH region (highlighted green). The construction of this figure demonstrates the
challenge of reporting high quality, scalable comparison data without access to the original files.
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contained an unusually oxidized casbane (43) ring system,
whereas EBC-329 (41) was the rst example of a seco-casbane
reported. Some years aer a number of additional examples of
both the seco-casbane [EBC-328 (44) and EBC-363 (45)],155 and
casbane [EBC-304 (46) and EBC-320 (47)] series,156 were
discovered.
Approximately one year aer reporting EBC-329 (41),
Thombal and Jadhav described the synthesis of racemic 41 in 13
steps and 10% overall yield. However, the 1H NMR spectra data
was inconsistent with that reported for the NP, although, the
13C NMR appeared to match.157 Unfortunately, the raw digital
data was not available to analyze additional expansions that
would have facilitated further understanding.
Only by chance, the Williams group was also working on the
total synthesis of this molecule (i.e., 41), but lagged behind the
Jadhav team by two years. However their route was superior in
step count (7 steps), and was chiral, allowing the absolute
conguration to be determined.158 It was, however, a serendipi-
tous aw in this route that revealed why the Jadhav et al. 1H
NMR spectra did not match that reported in 2014 for 41. The
deployment of the Horner–Wadsworth–Emmons olenation
protocol here did not provide a high level of E/Z stereocontrol,
which led to a mixture of 41 and 48. The 1H NMR spectra of this
mixture was a match to the Jadhav spectrum, although the ratio
of 41 and 48 was different (i.e., Jadhav obtained a 1 : 1 mixture).
The Williams group were able to purify the target (i.e., 41) by
HPLC, and discovered that the puried material photo-
isomerized on exposure to laboratory light, giving an isomer
that matched an impurity in their spectra of an isolated sample
of 41 from 2014. Although it was not possible to unambiguously
determine the structure of the major impurity, it was most likely
either 49 or 50.
Fig. 12 The partial 1H NMR spectra of phainanoid B (39; A) and phainanoid F (40; B).
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3.16 Acetogenins-the difficulty of congurational
determination
Halogenated C15-acetogenins, containing at least 180
members, are widely present in the marine red algae of the
genus Laurencia, and oen feature one or more ether rings of
different sizes.159 Among them, the structures of elatenyne
(51) and its congeners, such as laurendecumenyne B (52),
were originally assigned with a pyrano[3,2-b]pyran unit,160,161
but were ultimately corrected to possess a 2,20-bifuranyl core,
which contain the carbon and hydrogen connectivity of
a pyrano[3,2-b]pyran unit.162 The overlapping signals in 1D
and 2D NMR spectra made the structure and conguration
elucidation difficult.
Elatenyne was initially isolated from L. elata by Hall and
Reiss in 1986 and originally identied as a pyrano[3,2-b]pyran
structure (51) from its NMR data.160 In 2007, Wang and co-
workers re-isolated elatenyne as a mixture with a structurally
related congener, laurendecumenyne B (52), from the marine
red alga L. decumbens, and the structures and relative congu-
rations of these two compounds were established as pyrano[3,2-
b]pyran derivatives by referring to the original structure and
NMR data of elatenyne.161 Later in 2010, the structures were
revised to 53 and 54, respectively, as being 2,20-bifuranyl
derivatives by Wang and co-workers,162 based on the total
synthesis and the 13C NMR calculations reported by Burton and
co-workers.163,164 However, the dibrominated 2,20-bifuranyl
structure, was assigned as a diastereomer of elatenyne, because
the 1H NMR data recorded in CDCl3 appeared different.162 Later
in 2011, Dias and Urban obtained elatenyne from L. elata and
recorded its 1H and 13C NMR spectra in both CDCl3 and C6D6,
Fig. 13 Chemical shifts (ppm) and coupling constants (Hz) of OH-24
in the phainanoids B (39) and F (40): the optimized 3D structures ((A):
OMe-25 represents phainanoid B; (B) OAc-25 represents phainanoid
F) generated by Hartree–Fock/3-21G showing the dihedral angles of
H–C–O–H (black) and H-bond angles (red) and lengths (Å).
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which indicated that the originally reported 1H NMR signals of
elatenyne in CDCl3 were incorrect and conrmed that the
dibrominated 2,20-bifuranyl metabolite obtained by Wang and
co-workers was indeed elatenyne.165
The most likely structure (53) for elatenyne produced by
DFT calculations of GIAO 13C NMR and its enantiomer were
totally synthesized by the Burton and Kim groups in 2012, and
their NMR spectra were compared with the raw spectra of the
isolated elatenyne, despite the unmatched specic optical
rotation values.166 Simultaneously, the relative congurations
of the revised laurendecumenyne B (54) and (E)-elatenyne (55)
were also conrmed by total syntheses,166,167 and the former
was further evidenced to be a stereoisomer of notoryne (56)
that was determined by NMR, EIMS, and chemical degrada-
tion methods.168 The 13C NMR signals of synthetic elatenyne,
laurendecumenyne B, and (E)-elatenyne (55) were usually in
good accordance with those of corresponding isolates.
However this was not always the case for the 1H NMR data
when the reported data was carefully rechecked.160,161,165–167
The splitting patterns and coupling constants of H-9 or H-10
are key to elucidate the relative conguration between the two
tetrahydrofuran rings, and they should be the same or similar
in view of the identical congurations around these two
positions in 53–56. However, most of the isolates and
synthetics (53–56) were reported to possess incongruous
splitting patterns and coupling constants of H-9 or H-10, as
summarized in Table 2. Thus, it is possible that either the
coupling constants were calculated inaccurately or the rela-
tive conguration between the two tetrahydrofuran rings was
assigned incorrectly. This is difficult to clarify with only
printed 1H NMR data, and would be achievable with raw or at
least digital shared data.
The splitting patterns of H-9 and H-10 in the 1H NMR
spectrum of the mixture of elatenyne (53) and lau-
rendecumenyne B (54) were originally reported as multiplets
by Wang and co-workers,161 but when re-processing the FIDs,
a distinct multiplicity was observed (Fig. 14). Even if the
signals of H-9 and H-10 of 53 and 54 are completely over-
lapped, they should still feature the same doublet of triplets
(dt) multiplicity, with coupling constants of 11.8 (t) and
5.9 (d) Hz. However, when the raw FIDs were processed with
Reference Deconvolution and Lorentzian–Gaussian multipli-
cation (LG) rather than the typical exponential multiplication
(EM; Fig. 14) as window function, the multiplicities of the
signal patterns were found to be more complex than one or
two overlapping dt signals and appeared to be slightly asym-
metric. Aer closer inspection, the resonances for H-9 and H-
10 were recognized as being partially overlapped, resulting
from A,B spin particles, and assigned to qdd (J ¼ 6.8, 3.3,
1.4 Hz) and qd (J ¼ 5.0, 2.8 Hz) splitting patterns, respectively.
This interpretation was supported by the expanded HMBC
correlations (Fig. 15). The overlap of the signals of H-9 and H-
10 have also been observed by Kim and co-workers, but were
assigned to identical chemical shis by others.160,161,165–167
Notably, all the above splitting patterns exclude the structures
of 51 and 52, although it remains difficult to deduce the
relative conguration between the two tetrahydrofuran rings
unambiguously when relying on the re-processing and visual
analysis of FIDs. Quantum mechanical full spin analysis (see
Sections 3.3 and 5.1) will be required for unambiguous
assignments. This also requires the availability of the raw
data. On a more general note, the case of 53/54 provides
another example, of why the ubiquitous use of the EM window
function with LB ¼ 0.3 is not a universally suitable post-
acquisition processing method for 1H NMR spectra. The use
of individually adjusted LG processing schemes typically
yields additional structural information. This again speaks
for the need to disseminate raw NMR data.
3.17 Second order coupling patterns with rst order look vs.
“multiplets”
Two prenylated chalcone antibiotics, 50-O-methyl-3-
hydroxyemingin A (57) and 50-O-methylemingin C (58)
occurring as enantiomeric mixtures, were isolated from the
Sarawak rainforest plant, Desmodium congestum.169 The
structures of 57 and 58 were determined using a combination
of NMR (1D 1H/13C and appropriate 2D experiments) and
HRMS.
During the 1H NMR assignment exercise, it was noted that
the non-equivalent methylene hydrogens H-400a + b displayed
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 59
























































































non-rst order coupling patterns (Fig. 16). Although the
chemical shi difference between H-400a and H-400b was only
0.18 ppm (108 Hz), one side of the multiplet for each
methylene resonance “appeared” as a dd (J ¼ 7.2, 10.2 Hz),
while the other side “appeared” as a t (J ¼ 8.7 Hz). This clearly
indicated that the methylene signals for H-400a and H-400b
exhibit 2nd or higher order effects, and that the measured line
distances (from the spectrum) are not reective of the true J
values. Given the relatively large difference between the
methylene resonances, this second/higher order coupling
pattern was unexpected and difficult to describe in terms of
conventional NMR data table format. Designation of the
signals as “multiplets” is common practice but not descrip-
tive in the sense that it fails to provide any reproducible
information. Retrieving raw NMR data from a repository
allows for reprocessing and data analysis (spin simulation,
Table 2 The 1H NMR resonances of H-9 and H-10 of elatenyne (51/53) and its congeners (d in ppm)
Compound Solvent Frequency [MHz] dH-9 (J in Hz) dH-10 (J in Hz) Ref.
Elatenyne (51) C6D6 199.5 3.84, m 3.84, m 160
51 CDCl3 500 4.15, m 4.15, m 161
51 C6D6 500 3.86, m 3.86, m 165
51 CDCl3 500 4.15, ddd (12.0, 7.0, 5.5) 4.15, ddd (12.0, 7.0, 5.5) 165
Elatenyne (53) C6D6 500 3.84–3.93
a, m 3.84–3.93a, m 166
53 C6D6 200 3.79–3.97
a, m 3.79–3.97a, m 166
53 CDCl3 500 4.17, ddd (12.0, 6.8, 5.5) 4.17, ddd (12.0, 6.8, 5.5) 166
53 CDCl3 200 3.91–4.29
b, m 3.91–4.29b, m 166
Laurendecumenyne B (52/54) CDCl3 500 4.15, m 4.15, m 161
ent-54 CDCl3 500 4.15, m 4.15, m 166
(E)-Elatenyne (55) C6D6 400 3.75, dddd (7.0, 6.9, 6.8, 0.6) 3.79, dddd (7.1, 7.0, 6.8, 0.6) 167
55 C6D6 500 3.73–3.83, m 3.73–3.83, m 166
55 C6D6 400 3.73–3.83, m 3.73–3.83, m 166
ent-55 C6D6 500 3.82, dddd (12.9, 12.9, 6.4, 6.4) 3.82, dddd (12.9, 12.9, 6.4, 6.4) 166
Notoryne (56) CDCl3 400 4.26, ddd (7.3, 7.3, 5.5) 3.98, ddd (8.3, 6.8, 5.5) 168
a Overlapping signals with H-13. b Overlapping signals with H-6, H-7, H-12, and H-13.
Fig. 14 Comparison of the 1H NMR signal splitting patterns of a mixture of elatenyne (53) and laurendecumenyne B (54) with different post-
acquisition processing. Spectrum A shows the typical “standard” processing with exponential multiplication (EM) using an LB value of 0.3 Hz.
Spectrum B was generated from the same FID in two steps: reference deconvolution for a 1.0 Hz lineshape optimization, followed by Lor-
entzian–Gaussian windows function (LG; LB ¼ 2.2 Hz, GB ¼ 0.25) for resolution enhancement. Both spectra were zero filled to 128k real data
points. The resolution enhanced spectrum B allows a more consistent assignment of multiplicities and resonance locations, in particular for the
key signals of H-9 and H-10.
Fig. 15 Expanded HMBC spectrum of a mixture of elatenyne (53) and
laurendecumenyne B (54).
60 | Nat. Prod. Rep., 2019, 36, 35–107 This journal is © The Royal Society of Chemistry 2019
























































































full spin analysis) leading to a precise evaluation of J
couplings in a second or higher order context (Fig. 16).
4 Impurity detection and
quantification
Notwithstanding the above case of “multiplets”, and in addition
to important but relatively straightforward structural revision,
raw NMR data (FIDs) also plays an important role by enabling
unambiguous reproducibility, as shown in the following cases
(Fig. 17).
4.1 Purication of thiotetronates
A major advantage to accessing raw NMR data lies in the
detection, identication, and quantitation of impurities.
Impurities can be variable depending on the isolation proce-
dures used as well as their physicochemical properties
compared to the target molecules. Occasionally, certain impu-
rity signals appear to be constantly observed in the NMR spectra
of a class of compounds isolated. The impurities in these cases
are oen structurally and/or chemically closely related to the
target molecules, likely derived from persistent co-elution or
chemical transformation. Thus, having access to the raw NMR
data, in combination with the increasing availability of
advanced NMR processing and analysis soware, can provide
benecial information about the amount and identity of this
type of impurity. Such information can be used to optimize
purication procedures and prevent chemical changes during
the isolation of the target molecules or analogues. The impu-
rities encountered during the isolation of thiotetronate antibi-
otics fall into this type, and reect both scenarios for generating
relevant impurities, i.e., co-elution of structurally similar
compounds hard to separate, as well as chemical changes of the
target molecules during purication.
Fig. 16 An expansion of the calculated (above) and experimental (middle) 1H NMR spectrum of 50-O-methyl-3-hydroxyflemingin A (57), as well as
the difference (residual; below); recorded in CDCl3 at 600 MHz. The table shows the relevant assignments, chemical shifts, and coupling
constants.
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Fig. 17 Comparison of the 1H NMR spectra of the target molecules to be isolated (59–63), the impurities contained, 67 and 71 and the mixture
initially isolated (A).
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Thiotetrnate antibiotics are potent fatty acid synthase
inhibitors bearing a thiolactone core structure. The isolation
and structure identication of several thiotetronate antibiotics
have been published.170,171 In comparison with the truncated 1H
NMR spectra (0–9.0 ppm selected) in the ESI,†170,171 shown in
Fig. 17B–F are the full-scale 1H NMR spectra (1.0 to 11.0 ppm)
of ve thiotetronates (59–63) regenerated from the raw NMR
FID les. Similar impurity proles are observed in the range
2.5–4.5 ppm of 59–63.
Whereas the chemical shis, integrations, and splitting
patterns of these impurities are not readily recognizable in the
original publications, the availability of the raw FIDs enabled
a exible, interactive, and facilitated analysis of the quantities
and identities of these impurities. Taking the NMR spectra of 63
as an example: the expanded range of 2.5–4.5 ppm in the 1H
NMR spectra (Fig. 17F) and analysis of the corresponding 2D
NMR spectra (Fig. 18) pointed to the g-butyrolactone class (e.g.,
64–67) as the source of the impurity signals.
The g-butyrolactones, common signaling molecules of the
genus Streptomyces, share structural similarity with the thio-
tetronates (59–63) and lack obvious UV absorption. Thus, the
isolation of a single symmetric signal from HPLC resulted in an
initial 1H NMR spectrum that contained a mixture of
compounds (Fig. 17A). Actually, a thorough analysis of the 1D
and 2D NMR correlation map of this mixture led, not only to the
identication of g-butyrolactone as an impurity but also to the
further optimization of isolation conditions. Through this
optimization, the target molecules 59–63 in improved purity
(Fig. 17B–F) were obtained, and a representative
g-butyrolactone 67 was also isolated for verication (Fig. 18G).
This success, combined with the identication of
g-butyrolactone from the NMR spectra of 63 discussed above,
exemplies that some information about the impurities is oen
only accessible from the raw NMR FID les.
Furthermore, a characteristic aldehyde signal is observed
around 9.5 ppm in the 1H NMR spectra of 59–62, which was not
included in the truncated spectra in the ESI† of the original
publications.170,171 A thorough and complete analysis of the 1D
and 2D NMR spectra of 59–62 containing this aldehyde impurity
suggested 68–71 as candidate compounds responsible for this
aldehyde signal and an associated singlet at 6.6 ppm. This
hypothesis was conrmed by the isolation of a representative
impurity 71 (Fig. 17H) from 62.172
An association of the intensity of the aldehyde signal with
the temperature and acidity used during the purication
process suggested that they were likely the oxidation artifacts of
the corresponding thiotetronates (59–62). Despite the unclear
mechanism underlying this process, the interpretation of the
aldehyde-containing impurity provided additional information
about the chemical stability of the target molecules and helped
to optimize the isolation procedure at the early stage of this
study. Thus, access to the raw FIDs of these molecules might
likewise enable others to gain more information for developing
suitable purication procedures.
Fig. 18 Expanded 2D NMR spectra of the thiotetronate (63) showing
the focused region of the impurity.
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To sum up, the availability of raw NMR FIDs not only accu-
rately indicates the purity of the target molecules isolated, but
also provides otherwise inaccessible information about the
identity of relevant impurities co-eluted with, or chemically
transformed from, the target molecules.
4.2 Dynamic equilibria between isomers
Another example dates back more than 20 years to work on
sesquiterpenoid lactones (STLs) in North American Star Anise
(Illicum) species. From leaves and fruits of I. oridanum (Florida
Star Anise), a variety of lactones of the seco-prezizaane (]seco-
allo-cedrane) type were isolated.173–176 In addition to several new
related STLs, the known pseudoanisatin (72a) was found, rep-
resenting one of the major constituents in both the leaves and
fruits. Its structure elucidation was based on NMR, whereas, the
X-ray crystallographic data had been published previously by
Kouno et al.177,178 The NMR data (pyridine-d5) of the isolated
constituent were identical with those published, but the isolates
(irrespective of the plant part from which they came) always
contained some 10% of an impurity whose signals clearly
indicated a structural relationship with the main component.
However, it was not possible to solve the structure of the minor
component on the basis of the available spectra. A number of
attempts were made to further purify 72a, especially since
bioassays were planned. However, none of these attempts led to
a diminution of the impurity but only to a loss of yield.
Later, the study on North American Illicium species was
extended to the leaves of I. parviorum from which a new
lactone with an unusual and unprecedented cyclic hemiketal
structure containing an oxygen bridge between C-4 and C-7 was
isolated and named cycloparviorolide 73b.175 This compound
was found to contain some 20% of an isomeric compound
which could be identied as 73a (parviorolide) lacking the
hemiketal ring and bearing the oxo and hydroxyl functions at C-
7 and C-4 respectively, thus representing a direct analogue of
72a. It became clear that the compound actually exists as an
equilibrium mixture between the two forms, which are hence
also inseparable from each other.
Given the almost identical structures of 73a and 72a it was
straightforward to expect that this type of equilibrium would
exist also in the case of pseudoanisatin 72a and a cyclic form
72b, which should then represent the 10% “impurity”. Re-
analyzing the NMR spectra of pseudoanisatin showed that the
signals of the minor constituent indeed correspond to the cyclic
hemiketal form, i.e., cyclopseudoanisatin 72b, and that this is
actually the reason for the inseparable “impurity”. While in case
of 73a/b, the 4,7-cyclo-form is the major isomer (80%, spectra
recorded in acetone-d6), in case of 72a/b the 7-oxo-form was
found to be predominant (with a ratio of approximately 80 : 20
in this solvent (Fig. 19)). It was subsequently demonstrated,
based on theoretical considerations, that the respective oxo-
isomers of both compounds are very likely the bioactive forms
responsible for the binding to insect GABAA receptors.179
Had the original spectra (a good copy of the 1D 1H and 13C
NMR spectra would certainly have been sufficient) of pseudoa-
nisatin been available, it would have been clear from the
beginning, that the “impurity” must also have been present in
the previous authors' isolate obtained from a different species,
I. anisatum. This could have given a hint that it was not just
some other STL present in minor amount but that it actually
represents another form of the pseudoanisatin molecule. Much
futile purication work could probably have been saved. It is
simply not possible to obtain NMR spectra of more than 90%
“pure” pseudoanisatin in the solvents used (pyridine-d5,
acetone-d6, D2O) due to this equilibrium in solution. In fact it
64 | Nat. Prod. Rep., 2019, 36, 35–107 This journal is © The Royal Society of Chemistry 2019
























































































was shown later that the equilibrium composition in both cases
is dependent on the solvent. It was found that water stabilizes
the cyclic hemiketal isomers and shis the equilibrium
composition in this direction, leading to an approximately 1 : 1
mixture in the case of 72a and 72b (Fig. 19).
4.3 Detection of rotamers
Guangnanmycin A (74a/b), a new member of the leinamycin
family of NPs, was isolated from Streptomyces sp. CB01883 by
the Shen group's efforts to target Nature's combinatorial
biosynthetic potential for the discovery of novel NPs.180 Unlike
the other members of this family, as exemplied by leinamy-
cin181 or leinamycin E1 182 that displayed a single set of signals
upon NMR analysis, 74a/b afforded two sets of signals, in a ratio
of2 : 1, in its 1H NMR spectrum recorded in DMSO-d6 at 298 K
(Fig. 20, panel A-II). Initially, it was not apparent if the
complication of the spectrum resulted from the presence of
impurities or two equilibrating rotamers, 74a and 74b.
Fig. 19 Low field region of the 1H NMR spectrum (500 MHz) of pseudoanisatin (72a + 72b). Top: spectrum in acetone-d6. Middle: spectrum of
the same sample in D2O; bottom: spectrum of the same sample re-dissolved in acetone-d6 after the measurement in water. All assignments
confirmed by 2D spectra. Signals of the cyclic hemiketal form 72b are marked with an asterisk. It becomes obvious from the signals of H-14b that
water stabilizes the latter. Full reversibility of the change in the equilibrium is demonstrated by the spectrum shown at the bottom. The change of
multiplicity of the H-3 signals is due to H/D exchange.
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 65
























































































We thus analyzed the 1H NMR spectrum of guangnanmycin
A in CD3OD at 298 K (Fig. 20, panel A-I), revealing that the ratio
of the two sets of signals changed to 3 : 1, hence suggesting
the presence of two rotamers rather than impurities. Other
NMR technologies were employed to support the attribution of
the two sets of signals to the presence of two rotamers of
guangnanmycin A (Fig. 20), as exemplied by the variable-
temperature NMR experiment, in which the signals of two
Fig. 20 NMR techniques that facilitate the identification of natural products existing as rotamers as exemplified by the structural elucidation of
guangnanmycin A (74a/b). (A) 1H NMR spectra of guangnanmycin A recorded in CD3OD (I) and DMSO-d6 at varying temperatures (II–VI). (B)
ROESY spectrum of guangnanmycin A with red signals denoting normal NOE correlations and black signals denoting the exchange correlation
signals between the two rotamers appearing in the opposite phase.
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rotamers tend to merge at elevated temperature and nally fuse
to one set at 393 K (Fig. 20, panel A II–VI), and the ROESY
experiment, in which the exchange cross-signals between the
resonances of rotameric forms, e.g., H-11 (at 7.00 and 7.10 ppm)
or H-15 (at 7.40 and 7.51 ppm), appear in the opposite phase
(shown in black), to that of normal NOE correlations between H-
11 (at 7.00 and 7.10 ppm) and H-15 (at 7.40 and 7.51 ppm)
(shown in red) (Fig. 20 panel B). While the varying NMR
experiments afford ultimate condence to the nal structural
assignments, analyzing the raw data of 1H NMR obtained in
different solvents at ambient temperature requires less time,
thereby highlighting its simplicity and usefulness in structure
elucidation of NPs that occur as rotamers.
5 Dereplication
5.1 Structural dereplication of proanthocyanidin A1 with
higher order spin systems
Comparison of basic 1H NMR parameters (chemical shis,
coupling constants, line widths, and signal integrals) of isolated
compounds with those of already reported structures is a stan-
dard method for a rapid structural dereplication. Proantho-
cyanidin A1 (PCA1, 75), is one of the most common dimeric
proanthocyanidins which has one A-type doubly linked inter-
avanyl bond (C–C and C–O–C). In a previous study, PCA1 was
isolated from the bark of Pinus massoniana, and the structure
was identied by interpretation of 1D and 2D NMR spectro-
scopic data in combination with an electronic circular
dichroism (ECD) experiment.183,184 The initial attempt at struc-
tural dereplication by comparison of reported 1H NMR data
failed due to inconsistency of the reported data caused by
difficulties of interpretation of higher order spin systems as
shown in Table 3. In the literature, chemical shis, coupling
constants, andmultiplicities continue to be described using the
tabulated (depicted) method, and this can cause confusion. Two
strongly coupled hydrogens (E-H-50 and E-H-60; split into d and
dd, respectively, following rst order analysis) were described
inconsistently in summaries. Even if NMR data are collected in
the same solvent and at the same temperature, the errors
between experimental and reported data, and between the
references are outside the acceptable range to be considered as
the same compound. Subtle differences considered to be
negligible could be from near identical but different
structures.60,183–185
These subtle differences can be easily overlooked when the
chemical shis and coupling constants are calculated by
a conventional manual measurement. In order to reduce the
errors, HiFSA (1H iterative Full Spin Analysis) was applied to
calculate the spectral parameters with high precision (dH, 0.1
ppb; J, 10 mHz).60 HiFSA from the FID data can produce accu-
rate NMR parameters (chemical shis, coupling constants) for
even in higher order spin systems (Table 3, Fig. 21). Fig. 22
illustrates the higher order effects as a function of the various
distances between the coupled hydrogens (E-H-50 and E-H-60),
which shows the disappearance of d and dd multiplicities upon
decreasing Dd between these two hydrogens. This case study
clearly emphasizes the fact that tabulated summaries can lead
to repetitive spectral misinterpretation; therefore, it is necessary
to provide access to raw FID data for rapid and accurate struc-
tural dereplication of previously identied compounds.
5.2 HSQC as a dereplication tool
A critical aspect of modern NP research is the rapid, efficient
and accurate dereplication of known compounds.186 With some
50 000 NPs reported in AntiMarin187 and 139 000 in the Dictio-
nary of Natural Products,188 there exists a signicant likelihood
that a newly isolated substance may be identical or related to
a known NP. Unless re-isolation or verication is the ultimate
goal, it is typically a poor utilization of laboratory and human
resources to spend signicant amounts of time in the isolation
and complete structure determination of an NP only to nd that
it was previously reported. A caveat to this, however, is that
isolation of a compound of novel biology can be a signicant
scientic contribution even if the structure is known; never-
theless, one wants to establish this as quickly as possible. A
variety of techniques have been utilized effectively for this,
including biological assay proles, variations of LC-DAD-MS
analysis,189,190 and NMR metabolomics.191 It was with this goal
in mind that a method to categorize the similarities in NMR
spectra between different NPs as sought, as an additional basis
of automatic dereplication of known NPs and their analogues.
This contribution focuses on the 1H–13C HSQC spectrum as
the critical NMR data set as the most robust yet cleanly charac-
teristic of a givenmolecule, in part because of the high resolution
created in the 2D NMR data set between all hydrogenated
carbons and their respective hydrogens, and in part because
there are fast NMR methods, such as Non-Uniform Sampling
(NUS),192 ultrafast NMR,193 and Ernst angle-based signal intensity
optimization methods194 for acquiring full 2D data sets. Further,
the use of a deep Convolution Neural Network (CNN) with
a Siamese architecture has a more robust ability to learn the
features of different classes of images even when there are only
a few images per image class, as well as to recognize patterns or
objects in images even in the presence of artifacts (Fig. 22).195
However, to provide the deep CNN with an adequate training
set, required the accumulation of a few thousand of such
1H–13C HSQC spectra, which were found in the ESI† pages of the
Journal of Natural Products. While the spectra are there, they
are present in many different formats, with grid lines or
without, with assignment annotations, and presence of signal
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 67
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color for phase-edited HSQC experiments. In order to use these
to teach a deep CNN, they needed to be extensively cleaned of
this extraneous content. Whereas this could be achieved using
post-processing image modifying soware such as GIMP (GNU
Image Manipulation Program; gimp.org), it would have been
highly desirable to have direct access to the raw untransformed
data, in which case it would have been possible to optimize
transformation and plotting parameters to produce standard-
ized image les of the highest comparability (i.e., neat 2D HSQC
spectra with a xed scale in each dimension).
Nevertheless, a modied deep CNN, was populated and
designated the Small Molecule Accurate Recognition Technology
(SMART) platform, with these rened HSQC spectra, and then
this trained system was utilized to analyze new spectra and place
them in a location within the SMART map that assists in their
structure identication.196 To demonstrate and authenticate
SMART (Fig. 23), a series of molecules isolated from two different
marine cyanobacteria, a Rivularia sp. from Vieques, Puerto Rico,
and aMoorea producens from American Samoa, were analyzed by
NMR and their HSQC spectra rapidly recorded using NUS pulse
sequences. When queried by SMART, these were placed in close
proximity to a couple of series of related cyanobacterial cyclic
lipopeptides, namely the viequeamides197 and veraguamides.
Ultimately, the compounds were fully characterized by a variety of
spectroscopic methods, and their structures shown to be closely
related to the viequeamides (Fig. 23).198
5.3 Dereplication during fractionation
The NMR spectrum of a fraction is a ngerprint of its entire
chemical composition and, therefore, never lies about the
composition of fractions. While 1H-NMR has been frequently
used in metabolite ngerprinting of NPs, the advent of high
eld instruments together with cryoprobes and small volume
tubes (3 or 1.7 mm NMR tubes) have addressed the previous
limitation of low sensitivity so that NMR spectra of fractions can
be directly analyzed to identify constituents. The deposition of
raw data and the associated FID data will allow complete
analysis of fractions. The advantages can be two-fold: to easily
and quickly identify known compounds within fractions
without further isolation, and to identify signals that are not
within known compounds in the search for novel molecules.
The aim of this example was to develop NMR ngerprints to
identify novel compounds by rst demonstrating the value of
NMR ngerprints of fractions to identify novel compounds
from a set of 20 sponges from the order Poecilosclerida. The
presence of a unique 1H NMR spectral pattern in only 5 of the
220 spectra allowed the isolation of the novel compound
iotrochotazine A (76) that was shown to have phenotypic activity
on cells from Parkinson's Disease patients.199
The NMR of an active fraction with LAT3 inhibition ensured
that the four compounds in the fraction were isolated. In this
case, LC-UV-MS proved to be of limited value as the compounds
Fig. 22 Simulation of higher order spin systems of E-H-50 and E-H-60
in proanthocyanidin A1 (PCA1, 75) with various distances between two
coupled-hydrogens. Simulation was performed with the PERCH
software tool.
Fig. 21 Case study of proanthocyanidin A1 (PCA1, 75) which shows
higher order effects. Quantum mechanical simulation (HiFSA) allows
producing accurate NMR parameters of the experimental spectrum
(Exp, in blue) and a perfectly fitted simulated spectrum (Sim, in red).
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 69
























































































had little UV absorbance and the ESI mass spectrum contained
mainly fragment ions. The 1H NMR spectrum, on the other
hand, revealed the presence of multiple compounds, providing
a comprehensive ngerprint of all of the small molecules con-
tained in the fractions. This resulted in the isolation of four
novel compounds, venulosides A–D (77–80), whose structural
relatedness had the advantage of providing SAR information.200
The metabolome of a termite-gut associated actinomycete
using NMR ngerprints identied six new NPs, namely, the
actinoglycosidines A and B (81 and 82), actinopolymorphol D
(83), and the niveamycins A, B, and C (84–86).201 The metabolic
ngerprinting approach in this publication reports the meth-
odology. It consisted of the generation, through RP-HPLC, of
ve LLE fractions for each of the eighty-four crude extracts (21
strains/four crude extracts: OMA, LFA, RFA, and GYES) using
parameters such as log P < 5 that permitted the retention of
molecules with lead and drug-like properties.202,203
NMR ngerprints allowed suppression of metabolites,
induction of new metabolites, and increased production of
minor compounds to be determined aer treatment with N-
acetyl-D-glucosamine in three sponge-derived actinomycetes.204
These examples demonstrate the need to establish a 1H NMR
NPs database of raw data that can be freely accessible in order to
focus on novel NPs. Moreover, they exemplify the need for NMR
raw data to allow NMR ngerprints to become a universal tool.
Typical NMR ngerprints of fractions are shown in Fig. 24 and
Fig. 23 Workflow for the Web-Based Small Molecule Accurate Recognition Technology (SMART). The workflow is divided into two parts;
‘development’ and ‘deployment’. In the development section, new HSQC inputs are curated by SMART and used to train the modified deep
Convolutional Neural Networks (CNN) algorithm. The training process is performed using cloud computing or a server machine. The training
data set is compiled, the CNN algorithm tuned, and the web framework maintained. The training data set is compiled by merging user uploaded
HSQC spectra and HSQC spectra obtained from literature publications. In the deployment section, HSQC spectra of newly isolated pure natural
product molecules are automatically embedded by SMART into a cluster space near similar, previously-characterized compounds in the training
data set. The resultant embedding in the cluster map is visualized in a 2D cluster map (nodes: HSQC spectra processed by SMART; node colors:
compounds from the same natural product family; internode distance: a quantification of molecular structural similarity).
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25, and can be analyzed using the proposed database of raw
les.
5.4 The conguration of lanciferine
The monoterpene indole alkaloid (MIA), lanciferine (87a), was
isolated in 1973 from the aerial parts of the New-Caledonian
plant, Alstonia boulindaensis Boiteau (Apocynaceae)205 and
belongs to the akuammiline family.206 Engendering numerous
complex scaffolds, the akuammiline MIAs have received much
attention by synthetic chemists owing to their molecular
structures and a broad range of biological activities.207 The
oxidized furoindoline motif in 87a is embedded within a poly-
cyclic framework, referred to as “indolinolid” in the original
report.205 Although the molecular framework of 87a was the rst
of its kind, the akuammiline MIAs have since been expanded by
nine congeners: picranitine,208 alstolactines A, B, and C,209
alstoniascholarines L and M,210 as well as scholarisines K, L,
and M.211
Research concerning the akuammilines has focused on
isolation and pharmacological studies212 with relatively less
emphasis on synthetic chemistry. However, synthetic endeavors
spanning the past 30 years have resulted in the design of elegant
and successful total syntheses. The asymmetric total syntheses
of the three akuammiline alkaloids, aspidodasycarpine, loni-
cerine and the proposed structure of lanciferine (87a), was
completed recently by Li et al.213 According to the authors, the
Fig. 24 NMR spectra of five lead-like enhanced (LLE) fractions of the extract Sauropus sp. The fraction samples were prepared from NatureBank
at the Griffith Institute for Drug Discovery (https://www2.griffith.edu.au/institute-drug-discovery).
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structural reassignment of their product was hampered by the
ambiguous and incomplete 1H NMR data disclosed in the
isolation report. In addition, the 13C NMR data were also
missing (in the mid 1970's, 13C NMR analysis was still very
much a specialist's technique and widely inaccessible to NP
research groups). However, a thorough analysis of just the 1H
NMR spectrum, enabled by the availability of the raw data,
would have revealed any inconsistencies with Ang Li et al.'s
interpretation. Indeed, the 1H NMR chemical shi of C18
methyl of the synthesized compound (87b, 19S) (1.4 ppm)
differed from that reported for natural lanciferine 87a (1.2
ppm). Furthermore, for the original isolation of 87a, the authors
reported the unambiguous assignment of the congurations of
all its chiral centers except that of C-19.214
In light of these data, it would seem that Ang Li et al.,
actually, did not synthesize 87a but a diastereoisomer, 87b.
Continuing interest of Beniddir's group in MIA chemistry led to
the development of a spectral database of a cumulative
collection of alkaloids, for dereplication purposes.215 Hence, it
was possible to retrieve the original sample of 87a and reacquire
reliable 1D and 2D NMR spectra. These data in conjunction
with a detailed NMR-based computational study using the CP3
parameter209 shed light on the congurational assignment of
lanciferine and conrmed the 19R and 19S congurations for
87a and 87b, respectively.216
In conclusion, this case of ambiguity would have been
removed if the raw data (i.e., FID) of the NMR of 87a had been
made accessible.1 Indeed, FIDs or spectra availability, would
have enabled the structure verication of 87a through
computer-assisted spectral assignment approaches.15 Finally,
this example brings out the need for new reporting standards
for NMR data and more globally, NPs' spectral properties.
5.5 Unraveling the J values of mycothiazole
Mycothiazole (MYC, 88)217 is a bioactive sponge-derived
polyketide-nonribosomal peptide synthetase (PKS/NRPS)
hybrid product of continuing interest as a lead for an anti-
cancer therapeutic.218,219
Fig. 25 NMR fingerprints of single active fractions from four taxa, Erylus amissus, Garcinia sp., Cryptocarya novoguineensis, and Styrax faberi.
The fraction samples were prepared from NatureBank at the Griffith Institute for Drug Discovery (https://www2.griffith.edu.au/institute-drug-
discovery).
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The current understanding of the exact pharmacophore
needed for its nM prole in cytotoxicity screening is incomplete
and is the subject of continuing study of analogs. MYC 1H and
13C NMR data acquired at 300 MHz in CDCl3 were mis-
interpreted. A subsequent re-evaluation took place prompted by
discrepancies in the 13C shis and optical rotation data between
natural and synthetic products.220,221 Further evaluation
involved data collected at 600 MHz.220 Shown in Fig. 26 is that
several resonances are broadened and overlapping. This
confounds the task of extracting many J values, so many signals
were listed as “m” in the original publication.217 The second
generation analysis at 600 MHz220 included obtaining NOE data
and remeasuring the J values for H-15 (5.62 ppm) as a dtt (J ¼
10.7, 7.5, 1.5 Hz) prompting the reassignment of the C-14, C-15
geometry from E to Z (Fig. 26).
New FIDs have been obtained for MYC and are available as
electronic information. Presented below are examples for which
obtaining new FIDs enable accurate measurement of JHH and
JHC values for the rst order or non-rst order multiplets. The
rst example involves closely overlapping resonances of olenic
hydrogens H-6, H-14 and H-15. Shown in Fig. 27 is a before-and-
aer data set with the new data provided by the two methods of
post-acquisition processing. This allowed the accurate
measurement of nine J values as shown in each of the panels.
The principal tool used here was the second derivative/
nonlinear tting algorithm “Resolution Booster” developed by
Mestrelab Research SL to reprocess the 1D NMR FID. Using this
algorithm along with the post-acquisition Resolution Booster
option, it was possible to clearly resolve all 16 multiplet lines of
H-15 with surprising improvement of resolution without intro-
ducing artifacts or shis in the spectrum. This enabled con-
dent multiplet assignment along with accurate measurement of
3JH-15–H-14 and
3JH-15–H-16 data shown (Fig. 27) that differed from
those reported in 2006 (see above). The data in Fig. 27C and D
provide additional coupling values for H-14 and H-16 previously
described simply as multiplets.217
Similar outcomes are shown in Fig. 28 and 29 that more
accurately describe the coupling patterns of olenic hydrogens
(H-5, H-17) and aliphatic hydrogens (H-30, H-7, H-70). The
previous data from measurement in CDCl3 reported most of
these resonances as multiplets. Alternatively, analysis of these
resonances by either rst order or non-rst order signal tting
accurately provided the eleven J values shown. These data
should be useful in the future as new MYC analogues are iso-
lated or synthesized. The value of obtaining and using HMBC-
derived 1JCH data to make functional group assignments for
compounds possessing ratios of H/(C + Z) < 0.5 was recently
demonstrated.222 It appears that accessing such data has
become a “forgotten art”, yet the measurement shown in Fig. 30
illustrates that this process can be done accurately and rapidly
when raw data is available. The coupling value shown here now
provides a more accurate estimate of the 1JC-15, H-15 ¼ 186.9 Hz
vs. the published value of 194 Hz.217
As shown in the next section, there are other direct and
indirect methods to obtain 1JC,H values from reprocessed FIDs,
representing another rationale for the collection and dissemi-
nation of raw NMR data.
6 New methodology
6.1 Data mining the one-bond heteronuclear coupling
constant, 1JCH
Assembling and assigning the common 1H NMR data parame-
ters is a typical prelude to linking nuclei (bond connectivity) by
2D and 3D NMR methods; a process familiar to chemists con-
ducting integrated structure elucidation.223 The undisputed
value of chemical shi for establishing the electronic environ-
ment of nuclei has driven the development of NMR instru-
mentation to higher elds to maximize dispersion. Assembling
molecular structures by interpretation of HSQC and HMQC, the
most widely-available heteronuclear 2D NMR experiments,
gives direct bonding information of 13C–1H couplets. The latter
Fig. 26 Mycothiazole (88) full 1H NMR spectra (CDCl3, 600 MHz) annotated with atom position numbers with output obtained by classical FID
work-up.
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are identied by the presence of cross correlations, but lost in
the process is another powerfully informative parameter: the
magnitude of 1JCH, itself. Out of a necessity to maintain the
signal to noise (S/N) in heteronuclear correlation experiments,
the latter is sacriced by abolishing the couplets through 13C-
broadband decoupling during acquisition of the FID. Never-
theless, 1JCH can be recovered, as has been amply demonstrated
through structure elucidation of numerous NPs, by the simple
expedient of recording the FID with no 13C-broadband decou-
pling. The so-called coupled HSQC experiment replaces single
cross correlations of each 13C chemical shi (or two, in the case
of diastereotopic CH2 groups) with two component-cross-peaks,
the 1JCH C–H couplets, where the value of the coupling constant
is revealed by their separation in Hz.
Oen overlooked in 1H NMR spectra, is the cryptic presence
of the one-bond heteronuclear coupling constants, 1JCH, seen as
‘13C-satellites’ of the 1H signals at the natural abundance of 13C,
1.1%. In fact, the utility of 13C satellites in 1H NMR spectra
was recognized by Truner and Sheppard as early as 1959, when
they analyzed the ne structure of the 13C satellites to determine
the coupling constants of hydrogen nuclei of adjacent carbons
that are chemically equivalent.224 Most likely, and especially for
NP applications, the low abundance of the 13C satellite signals
and the associated sensitivity challenge has been a major
impediment for a broader implementation of this approach.
Fig. 27 Mycothiazole (88) expanded 1H NMR spectra regions (CDCl3, 600 MHz) obtained from different FID processing. [A] H-15: top panel –
classic FID workup, middle panel– J (Hz) measurements, bottom panel– FID workup using second derivative/nonlinear fitting processing. [B] H-
15: top panel – J (Hz) measurements, bottom panel – FID reprocessing using a sign square apodization vs. that used for [A] bottom panel. [C] H-
6: top panel – J (Hz) measurements, bottom panel – classic FID workup. [D] H-14: top panel – classic FID workup, middle panel – J (Hz)
measurements, bottom panel – FID workup using second derivative/nonlinear fitting processing and suppression of H-6 resonance signals.
Fig. 28 Mycothiazole (88) expanded 1H NMR spectra regions (CDCl3,
600 MHz) for H-7/70 and H-3/30 obtained from FIDs processed using
second derivative/nonlinear fitting.
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Direct detection of 1JCH from uncoupled or ‘gated-coupled’
13C
NMR spectra still requires inordinately large samples and/or X-
nuclei direct detection cryoprobe instrument. While indirect
detection of 1JCH from HSQC spectra is relatively time-
consuming, the 13C-satellites of 1H signals reveal hetero-
nuclear couplings, in favorable cases, within the 1H NMR
spectrum, requiring no special treatment beyond inspection, or
facile post-acquisition processing of the FID at most. The
extraordinary value of the 1JCH magnitude and its application in
structure elucidation is underestimated and can be summa-
rized as follows:
(i) Hybridization at carbon. The magnitude of 1JCH is directly
proportional to the amount of s-orbital character (%s) in hybrid
atomic orbitals (%s for sp1 ¼ 50%; 33 1/3% for sp2; for 25% in
sp3) that combine to form the molecular orbitals of sigma
bonds. For olens and arenes, unlike ‘normal’ aliphatic
compounds, sp2-hybridized C have larger heteronuclear
couplings (1JCH  150–170 Hz), while the sp2-hybridized C in
terminal acetylenes consistently exhibit the largest magnitudes
of any 13C–1H couplets (1JCH  250 Hz). For example, the
terminal acetylene residue 3-hydroxy-2,2-dimethyloctynoic acid
(Dhoya, rst found in pitipeptolide (89)) from Lyngbya majus-
cula225 and several variants, from other cyanobacterial NRPS-
PKS NPs226 is a group which shows an unremarkable 1H NMR
chemical shi (1.96 ppm) due to diamagnetic shielding, but
a large 1JCH  250 Hz. A vexing technical issue in HSQC spectra
of terminal acetylenes is the acetylenic correlation signal is
oen ‘missing’. This is due to the large deviation of 1JCH in
terminal acetylenes from the nominal value of the one-bond ‘J
lter’ (1JCH ¼ 140 Hz) used in standardized parameters of the
pulse sequence, but the cross-peaks can be recovered with
appropriate re-parametrization. A combination of resonance
energy and electronegativity effects (see below) leads to excep-
tionally large couplings for ve-membered hetero-aromatic
rings (1,3-oxazole, imidazole, thiazole, etc.), compared to are-
nes, which can be readily identied from the 13C-satellites of
their 1H signals. For example, the H-5 signal (azole numbering)
in each of the three 1,3-oxazole rings of the trisoxazole macro-
lide (90) from the nudibranch, Hexabranchus sanguineus, as well
as that of the thiazole ring of jamaicensamide A (91) from the
sponge, Plakina jamaicensis, have 1JCH values of 198 and 190 Hz,
respectively. It was no small feat that the 1JCH could be
measured from 13C-satellites of a 33 mg sample using a micro-
cryoprobe at 600 MHz.
(ii) C–H groups associated with electronegative elements.
Whereas the one-bond homonuclear coupling constants of
unconstrained hydrocarbons and alkyl residues vary little from
a nominal and almost invariant value of 1JCH ¼ 125 Hz,
substitution by electronegative N, O, halogens and even the
polarizable S atom, increases the magnitude to 140–150 Hz. For
example, N-Me, O-Me and S-Me groups can be distinguished
from C-Me groups (e.g., an acetyl group, CH3(CO), J ¼ 128 Hz)
and assigned independently of the corresponding 1H NMR Me
chemical shi in non-obvious examples where interpretation is
equivocal, e.g., the assignment of a methylthio group (S-Me) in
varamines A and B, 92a, 92b (1JCH ¼ 140.5 Hz) and lepadines I
(93, 1JCH ¼ 140 Hz).227 In the latter cases, elimination of alter-
native C-Me constitutional isomers was confounded by predic-
tions of similar 1H NMR chemical shis for the Me groups;
a more common occurrence than generally assumed. An object
lesson is provided by synthetic compound, 94 (Fig. 31),228 which
has four Me groups – two attached to S, one to O and the fourth,
to C. The assignment of the O-Me group from 1H NMR chemical
shi, alone, is trivial (3.80, ppm), but the 13C-satellites also
reveal the largest associated coupling constant (1JCH¼ 147.6 Hz)
of the four. The remaining three signals are clustered and
Fig. 29 Mycothiazole (88) expanded 1H NMR spectral regions (CDCl3,
600 MHz) for H-5 and H-17 obtained from FIDs processed using
second derivative/nonlinear fitting.
Fig. 30 Mycothiazole(88) partial HMBC spectra (CDCl3, 500/125 MHz)
obtained by classic work-up of FIDS but expanded to show the faint
‘breakthrough’ correlations used to measure 1JC-11,H-11 ¼ 186.9 Hz.
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 75
























































































not readily assigned by chemical shi, alone, however, their
identities are revealed by heteronuclear coupling constants. The
resonances of the two S-Me groups are overlapped and have
essentially identical heteronuclear couplings (2.43 ppm s, 6H,
1JCH ¼ 141.3 Hz) that, incidentally, integrate for roughly twice
the O-Me 13C-satellites. Therefore, the remaining Me signal,
slightly more shielded group than the latter two, is associated
with the smallest heteronuclear coupling, and can be assigned
to the acetyl group (2.33 ppm, 3H, 1JCH ¼ 128.3 Hz).
(iii) Identication and assignment strained 3-membered and
4-membered rings in monocyclic, bridged and fused polycyclic
structures where, again, the coupling constants in cyclopro-
panes, cyclobutanes and heterocyclic small rings depart from
a nominal 1JCH ¼ 125 Hz to magnitudes of up to 1JCH  180 Hz
in the case of a di- or tri-substituted epoxide (oxirane) found in
meliatoxins A1 (95a) and B1 (95b) from Melia azedarach,229 or
the oxetane ring of paclitaxel (96) ex post facto of the original X-
ray structure.230 The latter method is particularly powerful as no
other reliably and independently establishes ring size in cyclic
NPs, and in many cases, can be used to resolve constitutional
isomers (e.g., the isomeric products of a Payne rearrangement).
Finally, electronic and ring strain factors that contribute to the
magnitude of 1JCH are additive. For example, the
1H and 13C
NMR spectra of the unique trans-chlorocyclopropyl ring in
muironolide A (97), a macrolide from a Western Australian
sponge, Phorbas sp., is associated with four large 13C–1H
76 | Nat. Prod. Rep., 2019, 36, 35–107 This journal is © The Royal Society of Chemistry 2019
























































































couplets (H-21, 1JCH ¼ 177 Hz; H-22a, 1JCH ¼ 173.4 Hz; H-22b,
1JCH ¼ 173.4 Hz; H-23, 1JCH ¼ 200 Hz)231 that uniquely identify
strain and electron-withdrawing effects within the ring. A useful
trend in the of 1JCH of the diastereotopic CH2 group of
the imidazolone ring found in the cyclic peptide, N,N0-methyl-
enodidemnin A from the Caribbean cyanobacterium Tridi-
demnum solidum observed, expanded by measurements of 13C-
satellites in the 1H NMR spectra of several imidazolone and
oxazolidine models.232 An unusual nding was that 1JCH in the
13C–1H couplets of the diastereotopic CH2 are oen non-
equivalent and, therefore, dependent on relative orientation.
Exploitation of 1JCH can be useful in alkaloid assignments;
for example, the presence of a 2H-azirine ring (azacyclopropene)
in dysidazirine (98),233 and related compounds234 is conrmed
by observation of the exceptionally large coupling constant (1JCH
Fig. 31 1H NMR spectrum of bis-(methylthio)-ester 94 (400 MHz, CDCl3). The X-scale is in Hz. (A) normalized Y-scale. (B) Vertical expansion of
(A). Note, coincidence of the two SMe signals (2.43 ppm, s). Sample and spectra, courtesy of M. N. Salib (UC San Diego).
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 77
























































































¼ 189 Hz) of the corresponding CH–C]N couplet. It is expected
that the extraordinary structure of cyclopropylazetidinone (99),
an ‘alkaloid’ obtained by Rainier and coworkers as an inter-
mediate in the synthesis of natural pyrroloindolines and
conrmed by X-ray crystal structure analysis, is expected to be
associated with an unusually large 1JCH for H-2 (5.85 ppm
CDCl3),235 interesting to measure, to say the least (in the
publication,235 the 13C-satellites [1H NMR, 500 MHz] are too
weak to be visible in the current PDF print format of the ESI†).
Extraction of 1JCH values from
13C-satellites of 1H NMR
spectra is limited by several instrumental and sample-related
factors that militate against their observation. Nevertheless,
access to the original FID of the spectrum can mitigate some of
the difficulties in ways that are illustrated in three major
groups:
(i) Poor S/N in 1H NMR spectra of small-sized samples. In
order for the 13C-satellites to ‘rise’ above the noise level, a good
quality 1H NMR spectrum of a ‘strong sample’ is required such
that the signal due to the natural abundance of 13C in the
sample exceeds the amplitude of random noise. With limited
sample, this can be challenging, but as mentioned elsewhere in
this review, the data content of the time-dependent periodic
function that constitutes the FID is a xed product of S/N and
resolution: one can trade one for the other, to some extent, by
judicious reprocessing. Careful use of apodization functions
prior to FT of the FID may regain S/N at the expense of resolu-
tion (line width) to reveal 13C satellites that are invisible from
rst inspection and in printed documents such as PDF les in
traditional ESI† format. As loss of resolution is almost always
inconsequential for measuring 1JCH, except for very weakly
dispersed signals, this can be an effective way to tease out
important information from FID data made available in digital
format.
(ii) Spectral overlap or complex multiplet structure. 13C
satellites that exhibit complex multiplet structures, due either
to overlaid homonuclear coupling (nJHH with n ¼ 2, 3, etc.), or
symmetry-related reasons, may completely ‘disappear’ beneath
the noise or be obscured by nearby 1H signals. Fortunately, only
one half of the 13C satellite doublet signal needs to be observed
as the 1JCH is reconstructed from twice its separation from the
dominant centroid 12C–1H signal (ignoring the slight isotope
shi of the former). Here, a caveat should be stressed: the
sample should be sufficiently pure that spurious impurity
signals are not mistaken for genuine 13C satellite signals.
Regrettably, with very noisy spectra, ‘there is no such thing as
a free lunch’: little can be done if apodization of the FID, even at
an extreme level prior to FT, does not result in reliable
appearance and identication of the 13C satellites. In this case,
salvaging the 1JCH may only be achieved by re-recording the
1H
NMR with a more concentrated sample, in which case it is far
preferable to record the coupled HSQC.
(iii) Line-shape. In order to separate the 13C-satellites from
the base of the dominant 12C–1H signal, good NMR signal line
shape is required, especially at higher elds.
For the foregoing reasons, readily measurements of 1JCH
from 13C-satellite signals is most practical from 1H NMR signals
where signal complexity does not exceed singlet or doublet
splitting. Here, the low-abundance 13C–1H couplets can be
exploited best, delivering valuable new information on elec-
tronic environment, hybridization and ring strain for molecular
structure determination of an NP. All this, from no more than
a re-processed 1H NMR spectrum, accessed from archived
digital FID data. An enhanced HSQC experiment for an accurate
and more rapid assessment of one-bond proton-carbon
coupling constants has been reported very recently.236
A variety of 2D NMR methods have been developed that
enhance the utility of C,H-coupling information in NP research,
covering both direct (1JC,H) and longer-range (
$2JC,H) coupling
relationships. Examples are the ASAP variant of HSQC237 and the
establishment of NOAH supersequences238 for accelerated
acquisition, non-uniform sampling (NUS)239 and CRAFT 2D
processing240 techniques for enhanced resolution, as well as LR-
HSQMBC and HSQMBC-TOCSY for improving the detection of
long-range correlations.49,50
6.2 New analysis of published data by optimal processing of
the FID
NMR data can provide a wealth of information regarding a given
chemical structure and much of this information is frequently
overlooked. For instance, coupling constants (J) provide key
information, especially in congurational aspects. Conse-
quently, valuable details about structural identity are oen
misinterpreted and/or lost. In fact, deep analysis of a 1H NMR
spectrum oen obviates the acquisition of further experimental
data and enables a more efficient use of the NMR spectrometer.
In this regard, the availability of the raw NMR data plays a key
role in both the verication of interpretation and the extraction
of new information that otherwise is lost.
This affirmation can be illustrated by the measurement of
long-range (4–5J) coupling constants such as the ones between
a hydrogen nucleus of an aromatic ring and those of a side
chain. To access this information, FIDs should be multiplied by
resolution-enhancing window functions such as Gaussian or
sinebell. This is enabled by the availability of the digital NMR
raw data. This approach has been used by Lima et al. (2015 and
2016),241,242 Pederoso et al. (2008),243 Amoah et al. (2015),244 and
da Silva et al. (2015),245 for establishing the connectivity of
aromatic and side chain moieties of several NPs. In the case of
butein (100),242 for example, the shied sinebell multiplication
78 | Nat. Prod. Rep., 2019, 36, 35–107 This journal is © The Royal Society of Chemistry 2019
























































































(SINM) followed by an exponential multiplication (EM) of the
FID with a Lorentzian line broadening factor of 0.3 Hz instead
of the simple EM (default setting on most NMR spectrometers;
see also Fig. 5) prior to Fourier transformation revealed a small
additional coupling constant (J ¼ 0.5 Hz) correlating H-6 with
H-a (Fig. 32). This nding is supported by the reciprocal anal-
ysis of the signal of H-a. Thus, the molecular connectivity
between the aromatic ring with the double bond side chain in
butein could be established based only on the 1H NMR spectra
without the need of two-dimensional (2D) NMR experiments.
Furthermore, the processing of the raw NMR data can
bring information from even longer conjugated chains. The
polyacetylenes found by Buskuhl et al.246 and Pollo et al.247 are
good examples of this application. In these cases, the
employment of enhanced line shape processing permitted the
correlation of a long distance coupling (9J; Fig. 33). Such long-
range correlations can only be observed in situations where
the electronic density is high, such as on conjugated triple
bonds. Thus, advanced raw NMR data processing permitted
not only connecting moieties, such as in 100, through the
correlation of H-10 and H-80, but also determining the pres-
ence of triple bonds in the polyacetylene structures as in
vernonyine (101).
The same strategy can be used in 2D NMR correlation maps,
such as HMBCs. The original le, containing the raw NMR data
is of great importance once it allows counter level editing, which
permits observation of a correlation or lack of one. The
advanced processing of HMBC allowed the unequivocal estab-
lishment of the 13C NMR chemical shi assignments from C-20
to C-70 from the long-range 1H–13C correlation of H-10 and H-80
in these polyacetylenes (Fig. 33).
NMR-based techniques248 have enormous potential for NP
investigation since they provide unique and comprehensive
information for structure determination and dynamic of
chemical compounds. Therefore, advanced NMR processing
strategies can be valuable on those spectra acquired directly
from raw material as in gel-like systems through HR-MAS
NMR spectroscopy,249,250 because in these cases the spectral
resolution is naturally lower due to restricted molecular
mobility.
Nevertheless, the quality of the results from advanced NMR
data processing depends on spectra being acquired with suffi-
cient signal-to-noise ratio (S/N). This requires an appropriate
number of scans and high time-domain resolution (at least 64 K
data points). Additionally, the 1D spectra and nD correlation
maps need to be processed using a large number of zero-lling
(at least 128 K in 1D and 4 K per 1 K in 2D).
6.3 In-depth analysis of 1H and 13C NMR data of
smenospongidine
Smenospongidine (102), a biologically active quinone sesqui-
terpenoid, was isolated from the sponge Smenospongia sp. by
Kondracki and Guyot in 1989.251 The authors proposed the
structure of 102 based on analysis of HRMS, 1H NMR and 13C
NMR data, but omitted carbon chemical shi data from the
Fig. 32 Comparison of 1H NMR spectra processed with default
settings (i.e., EM with an LB value of 0.3 Hz) vs. the use of line shape
enhancement (i.e., SINM plus EM with an LB value of 0.3 Hz) for H-6 of
butein (100) at 7.11 ppm.
Fig. 33 Comparison of 1H NMR spectra processed with default
settings (i.e., EM with an LB value of 0.3 Hz) vs. the use of line shape
enhancement (i.e., SINM plus EM with an LB value of 0 Hz) for H-80 of
vernoniyne (101) at 1.97 ppm. Comparison of typical long-range
1H–13C correlation map processed with 1 K per 512 data (i.e., without
zero-filling) in F2 and F1, respectively and QSINE as window functions
in both dimensions and higher processed using EM of 0.0 Hz on both
dimensions and zero-filling to 4 K per 1 K in F2 and F1, respectively.
This is just a simple example, there are many other advanced ways to
process 2D correlation maps.
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 79
























































































manuscript. In 1992, Rodŕıguez et al. published the rst tabu-
lated 13C NMR data of 102.252 In the intervening years, 102 was
isolated from various sponge sources253–258 each reporting close
agreement to the published data. In 2002, an enantioselective
total synthesis of 102 was reported by Ling et al., which, in
addition to the usual statement about good agreement with
published data, was accompanied by ESI† with 1H and 13C NMR
spectra of the synthesized molecule.259 Recently, the Williams'
group also isolated 102 from Dactylospongia elegans and found
signicant discrepancies between their spectral data, and
previous reports. Herein, they summarize the discrepancies and
report corrected data for 102. This case story demonstrates the
value of depositing raw NMR data by showing how errors
(omission, assignment, typographical, etc.) propagate through
the literature when forced to rely on reproduced, tabulated, or
listed data. Moreover, it points out the difficulties in locating
original NMR data decades aer publication. Although 102 is
a specic example, the problems are nonetheless widespread
and persistent in the literature.
The spectral data of 102 obtained from this study are tabu-
lated (Table 4) against those reported by Rodŕıguez et al., who
did not report signals for the non hydrogen-bearing carbons C-
10, C-16 and C-18 in 102. Aside for that, the only major differ-
ence (>2 ppm) between the two 13C NMR data sets occurs at C-20
(150.0 vs. 154.7 ppm), with Williams' value of 150.0 being more
consistent with their data for the C-5 epimer of 102. The partial
1H NMR data reported in that manuscript has two main
inconsistencies. First, a singlet reported at 5.41 ppm assigned
as the hydroxyl hydrogen may instead be the olenic hydrogen
H-16 in the quinone ring. Second, a doublet at 0.77 ppm
assigned tomethyl hydrogens (H-13) is more characteristic of H-
10, an axial methine hydrogen at the trans-decalin junction in
quinone-containing analogs of 102 with identical congura-
tion.251 With access to the original spectra, these issues of
unreported or possibly misassigned signals are easy to resolve.
For example, the last issue (H-10 vs. H-13) could possibly be
distinguished by the integrals, multiplicity (d vs. dd) or the
magnitude of observed coupling as the axial methine H-10
should display a larger J value (>10 Hz), due to coupling with
the neighboring axial hydrogen (H-1), than the typical 7 Hz
observed from methyl doublets. It should be noted that it is
highly unlikely that even contemporary spectra exhibit
adequate resolution or sufficient peak-picked expansions to
resolve the matter when disseminated as ESI† material in the
currently customary PDF format.
To resolve these issues and clarify the identity of Williams'
sample of 102 with only hydrogen and carbon data of the
sample on hand, the reported synthesis was repeated. As is
typical, no specic hydrogen or carbon assignments are re-
ported in the manuscript describing the synthesis of 102 for
the listed chemical shis, so they have been assigned as
seemed best for this comparison (Table 4) with the major
differences highlighted in gray. Unfortunately, this data
raised more questions. Their listed 1H NMR data on S19 does
not include the signal for H-10, the hydrogen at the A/B ring
juncture possibly misassigned by Rodŕıguez et al., but does
include a signal at 0.97 ppm (d, 3H, J ¼ 6.0 Hz), here assigned
to H-13; a signal missing altogether from Rodŕıguez et al.'s
paper. Despite the inclusion of 1H NMR spectra in the ESI,†
the presence of these signals could not be conclusively
conrmed because of the unavailability of an appropriate
expansion of the spectrum. Other issues apparent from the
listed 1H NMR values are the mischaracterization of reso-
nances here assigned to the terminal exocyclic alkene H-11
(reported as 4.44 ppm, d, 2H, J ¼ 5.2 Hz) and H-2
(2.94 ppm, 2H, m). The latter resonance should be a triplet
as the hydrogens responsible for the signal are adjacent to
only two equivalent hydrogens, while the characterization of
the 4.44 ppm (d, 2H, J ¼ 5.2 Hz) resonance is clearly erro-
neous, as a J value of 1.2 Hz, typical of the coupling between
two non-equivalent hydrogens of the exocyclic terminal
alkene, can be calculated from peak-picking in the ESI.† The
13C NMR spectrum provided in the ESI† and the chemical
shi values extracted from the spectrum raise further ques-
tions on the interpretation of the NMR spectral data. Twenty-
seven unique 13C NMR resonances are expected for 102. The
ESI† of Ling et al. lists 25 signals for 102, omitting two
carbonyl signals. Of these 25 signals, only 7 out of 12 required
sp2 carbon signals are reported and the list includes signals at
69.0 and 65.9 ppm clearly inconsistent with the proposed
structure as it lacks oxygenated sp3 carbons. The 13C NMR
spectrum with the poor signal/noise included in their ESI†
sheds some light on the situation, but also raises questions as
it includes the two carbonyl signals omitted from their list.
The two carbonyl signals are labeled at 182.8 and 180.2 ppm
but both appear between the chemical shis of 181 and
182 ppm in the 13C NMR spectrum perhaps due to peak-
picking errors.
There is little question 102 was isolated or synthesized, as
published in these articles. The Williams' group has in fact
synthesized 102 from ilimaquinone using the method
described by Ling et al., and independently conrmed the
structure. Throughout the process, the corresponding authors
of those reports graciously offered assistance and searched for
their original data at Williams' request, but decades later were
unsurprisingly unable to locate it. The difficulties of indi-
vidual labs or departments maintaining NMR records over 40
years are signicant. The staff at University of Hawaii, Manoa,
receives frequent requests for copies of NMR data generated
by the late Paul Scheuer and Richard Moore with a success
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rate of less than 50%. Most recently, a request for data on the
cyanobacterial compound micromide could not be fullled
due to degradation of the CD backups. The fact remains that
our community's reliance on tabulated or summarized data
introduces the possibility of a litany of errors into the litera-
ture. Availability of raw NMR data would undoubtedly play
a major role in curbing propagation of these errors.
Table 4 Comparison of 1H and 13C NMR data of smenospongidine (102) in CDCl3
a Assignments were made by matching the hydrogen and carbon nuclei with the closest reported chemical shi values. None of the reported
chemical shi values could be assigned to carbon nuclei at positions 16, 20, and 30, whereas the signals at 69.0, 65.9 and 31.0 ppm were
deemed extraneous.
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 81

























































































7.1 Fluorine: paramagnetic and diamagnetic effects
Fluorine is commonly used in organic chemistry, especially in
medicinal chemistry andmaterials, because it is both small and
much more electronegative than the H and C atoms that make
up a good portion of organic compounds.260–262 Fortunately, 19F
is 100% naturally abundant and NMR active. 19F has a gyro-
magnetic ratio close to that of 1H, and a nuclear spin of 12, but
covers a much larger chemical shi range than 1H (400 ppm
for organouorines), meaning that signals tend to be well
resolved.263 Unfortunately, the shis of these uorines can be
difficult to assign if multiple uorines on a molecule are in
similar environments.
The shielding that leads to observed 19F shis arises, in part,
from both diamagnetic, and paramagnetic effects. The
diamagnetic term is based on the electron density around the
nucleus, while the paramagnetic term is based on the excitation
of electrons in uorine's p orbitals (not an issue for 1H).
Consequently, 19F NMR shis cannot be thought of as reporting
on the “nakedness” of the nucleus in question, as 1H NMR and
13C NMR shis oen are. Computational work by Christe and
coworkers conrmed that the paramagnetic shielding is
signicant, and can be crudely estimated by the computed
anisotropic shielding, although this value is dependent on
interactions between the uorine atom and solvent.264
These differences between 19F and 1H/13C shielding
contribute to the difficulty of assigning 19F signals, and asso-
ciated data reporting issues and errors in assigned structures.
E.g., Burdon and co-workers synthesized functionalized per-
uoroanthracenes and, based on the 19F NMR spectra of the
products, decided that they were able to substitute “mainly or
entirely in the 2 position”.265 Although 19F chemical shis and
splitting patterns were discussed in the text, no spectra or FID
data were provided. In a subsequent study by Baker and Muir,
computational results indicated that the initial experimental
data more closely matched computed data for products of
substitution at the 9 position, but direct comparisons with the
experimental data was not possible and ambiguity about the
structures still remains.266 This ambiguity could be resolved
through a comparison of raw data with that generated from
higher level quantum chemical computations. There are many
more recent examples in which only 19F shis are reported, with
no spectra reproduced or raw data made available. It is hoped
this situation will change soon, especially given the rise in
importance of uorine-containing organic molecules.260–262
7.2 Fluorine and its role in ADME
A growing area of research interest in the NP community is the
generation of “non-natural NPs” by using synthetic biology
approaches.267,268 The idea is to use the privileged scaffolds269
afforded by nature, and modify them to incorporate moieties
and/or atoms not commonly found in NPs.270–273 In particular,
the incorporation of an F atom is highly desirable, likely due to
its positive impact on the biodynamic properties of biologically
relevant molecules. Such analogues may affect one (or more)
properties, such as protein ligand recognition and interaction,
absorption, distribution, metabolism, elimination and toxicity
(ADME-Tox).262,274–276 Moreover, as true NPs, organouorine
compounds are exceedingly rare, with less than ten reported.276
Hence, the way in which this atom affects a NP's biological
activity and/or spectroscopic properties is rarely explored.
The chemical properties of 19F, including the atomic radius,
electronegativity and polarizability of the C–F bond262,275 all
contribute to its use in a suite of elds (i.e., pharmaceutical
industry, organic materials, and agrochemicals).277 In addition,
the magnetic properties of the 19F nucleus, outlined make this
nucleus an important tool for studying relevant biological
processes particularly via the use of NMR, in the study of struc-
ture and function of biomolecules, enzymatic mechanisms,
metabolic pathways, and ligand protein recognition.278,279
Some NP groups are striving to incorporate a uorine
atom.271–273,276,280–284 While most NP chemists are quite adept at
analyzing NMR data, there are some spectroscopic properties of
the molecule that change, sometimes dramatically, upon incor-
poration of 19F. As such, having the raw NMR data available
serves to educate this research community on how to work with
this nucleus in structure elucidation. For example, due to the
nuclear spin of 12, the
19F nucleus couples to 1H and 13C, yielding
signals with characteristic splitting patterns, many of which can
be analyzed to further verify (or refute) a potential structure.
Moreover, due to the high gyromagnetic ratio, the dipolar
couplings are stronger, giving origin to enhanced 1H–19F NOE
effects. Finally, the coupling constants (JCF) for
13C–19F are quite
large (up to 250 Hz), providing information about the location of
the F atom and the connectivity of adjacent atoms.278,285 In fact,
these large JCF couplings are very helpful in structure elucidation,
akin to using HSQC data to assign how a 13C signal can be
correlated with its attached 1H signals.280,286 Additionally, rela-
tively simple experiments, such as a 1H decoupled 13C experi-
ment, will display splitting due to the 13C–19F coupling, and upon
rst inspection, such data may be quite foreign, especially to
a student. In summary, with respect to incorporating 19F into
a NP, some changes to the NMR spectra are modest, while others
can be quite profound and/or even unanticipated; access to the
raw NMR les would facilitate a more thorough evaluation and
dissemination of such data.
A recent example highlights the value of 19F NMR in struc-
ture elucidation, where two uorinated peptaibols (analogues of
alamethicin F50) were biosynthesized via a site directed
building incorporation approach.280 In that study, Trichoderma
arundinaceum, a well know alamethicin F50 producer, was fed
with uorinated building blocks (o/m/p-F-DL-Phe), and the
biosynthesis of the uorinated analogues was monitored via in
situ MS and 19F NMR. The structure elucidation of the uori-
nated analogues was carried out using a set of spectroscopic
techniques, including 1H, 13C, and 2D NMR data. The incor-
poration of uorine in the nal product was conrmed by 19F
NMR, analysis of the prominent 13C–19F JCF values in the
13C
spectrum, and by comparison of these data with those obtained
for the synthesized standards (Fig. 34 and 35). The close match
between the 19F and 13C NMR data of the synthesized mono-
uorophenylalinols (MW 165) and that of these moieties within
82 | Nat. Prod. Rep., 2019, 36, 35–107 This journal is © The Royal Society of Chemistry 2019
























































































the large peptaibols (MW > 1900) is remarkable. While
members of this research team have performed thousands of
NMR experiments over the years, the 19F NMR experiment was
somewhat foreign. However, those data were extremely
straightforward to analyze, and it is easy to envision deriving
value from sharing those raw NMR les.
As noted previously, uorine containing secondary metabo-
lites are extremely rare in nature.276,287,288 Thus, when they are
reported, thorough peer review is needed to insure the validity
of the structure, (another compelling argument for the sharing
of raw NMR data). A recent report highlights where some
knowledge about 19F NMR would have likely prevented
a mistake in the literature.289 The organouorine compound [3-
(3,5-di-tert-butyl-4-uorophenyl)propionic acid] was reported
isolated from a Streptomyces sp. TC1,289 which suggested the
existence of an enzyme capable of mediating an aryl uorina-
tion reaction. This report attracted the attention of two different
groups, who via synthesis of the putative uorinated natural
product, and based on the analysis of 1H, 19F and 13C NMR
spectra, both demonstrated the absence of uorine in the
secondary metabolite.290,291 While those follow up studies
essentially refute the initial study, perhaps a more thorough
analysis of the NMR data at peer review, including examination
of raw NMR data, would have prevented the need for such
research.
These examples show the importance of a detailed analysis of
the NMR data, both when striving to generate uorinated
analogues and if/when naturally occurring organouorine
compounds are reported. A solid understanding of the NMR
properties of the 19F nucleus is needed to rationalize the structure
elucidation, and the raw NMR les would serve to both document
and disseminate these information, possibly giving fodder for
more detailed analysis as more advanced tools are developed.
7.3 The complex 19F NMR spectrum of 4,4-diuorinated
proline
Amino acids and peptides are important lead compounds in
drug discovery. However, such compounds usually undergo
some form of structural modication before they can be
considered viable drugs. Fluorination is one way to achieve
this.292 The benets of uorination in terms of ADME properties
are well known, and have been outlined in the previous section.
In addition, uorination can potentially enhance the target-
binding properties of lead compounds, through conforma-
tional control.293 For example, uorinating the 4-position of the
amino acid, proline, can effectively stabilize either the exo- or
the endo-pucker, depending on the uorine conguration (an
example of the “uorine gauche effect”).294 This conformational
biasing of proline has been exploited in the design of collagen
mimetics,295 enzyme inhibitors,296 and organocatalysts.297
Surprisingly, the closely related scaffold 4,4-diuoroproline
has been little studied. The derivative 103 (Fig. 36) has previously
been synthesized, and the 1H and 19F NMR spectra of this
compound have been recorded,298 but these NMR data were re-
ported only in condensed form with most signals simply
described as multiplets, and no raw NMR data were made
Fig. 34 The 13C NMR spectrum of the aromatic region of (A) m-F-L-
phenylalaninol standard (125 MHz in MeOH-d3), and (B) m-F-phenyl-
alaninol in m-F-Pheol-alamethicin F50 (175 MHz in MeOH-d3). The
prominent doublet (with a JCF of 243 Hz) indicated the point of
attachment of the 19F in the molecule. The other aromatic 13C signals
all display doublets due to long-range coupling to this 19F.
Fig. 35 The 19F NMR spectrum of (A) m-F-L-phenylalaninol standard,
and (B) m-F-phenylalaninol in m-F-Pheol-alamethicin F50. The
observed coupling constants are for JHF. Running the
19F NMR
experiment is a straightforward way to verify its incorporation. Both
spectra were obtained at 470 MHz in MeOH-d3.
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 83
























































































available at the time of publication. It would seem to be worth-
while to undertake a full analysis of the NMR spectra of 103, in
order to ascertain all of the J-values and thereby gain information
on the conformational behavior of this compound.299
Accordingly, the Hunter group recently synthesized 103
following a published protocol,298 and re-acquired the 1H and 19F
NMR spectra (Fig. 36). The spectra are complicated by the pres-
ence of Boc rotamers, giving twin sets of signals and possibly
explaining why a full analysis was not reported previously.298With
raw data now in hand, Hunter and co-workers performed an in-
depth analysis of the spectra through DAISY simulations, and
this revealed an unusual pattern of J-values of 103 (Fig. 36). The
two diastereotopic uorine atoms of 103 have identical chemical
shis; hence, the uorine atoms do not couple to one another,
and together they cause each of the signals corresponding to the
four vicinal hydrogens to be split into a higher multiple of an n +
1 triplet. Nearly identical sets of J-values are observed for both
rotamers of 103. Finally, Hunter and co-workers validated their
analysis by also acquiring 1H-decoupled 19F and 19F-decoupled
1H spectra (Fig. 36), which were also found to be accurately
simulated using the same J-values.
This elucidation of the J-values of 103 (Fig. 36) is a rst step
towards understanding the conformational behavior of this
potentially valuable uorinated building block.299 This informa-
tion may inform the ongoing development of drugs and biop-
robes that contain conformationally-biased proline residues.
7.4 Nitrogen: an underrepresented nucleus in the structural
investigation of natural metabolites
Nitrogen containing metabolites occur naturally in essentially all
terrestrial and marine organisms, and many of these compounds
Fig. 36 Partial 1H, 1H-decoupled 19F, 19F, and 19F-decoupled 1H NMR spectra of N-Boc-4,4-difluoroproline (103), showing all of the ring-
attached atoms in each case. Twin sets of signals are observed due to the presence of Boc rotamers. The indicated J-values (top) correspond to
the major rotamer of 103.
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exhibit important biological functions related to their N-substi-
tution. Unlike other nuclei, and despite the importance of
nitrogen in naturalmetabolites, the 15NNMRof these compounds
is rarely reported. In most, the nitrogen is a biologically essential
element. Therefore, while nitrogen plays an important role in NP
chemistry and biology (e.g., labeling of non-proteinogenic amino
acids), the NMR-detectable stable isotope 15N represents a spin 12
nucleus which has very low natural abundance of only 0.35%.300
Lowering NMR sensitivity even further, 15N has a gyromagnetic
ratio of only about 1/10th of that of 1H. These intrinsic properties
make 15N difficult to observe directly. However, its enormous
chemical shi dispersion of ca. 800 ppm offers a powerful source
of structural information. Additionally, the orientation of the
nitrogen lone pair of electrons is sensitive to the chemical and
magnetic environment of the rest of a molecule. This has large
effects on the observed coupling constants with nearby hydro-
gens. These coupling constants can have relatively large values,
both negative and positive in a Karplus relationship, and can be
used as evidence to distinguish two identical planar structure that
only differ in the orientation of the lone pair of electrons.
As NMR hardware, soware, and experimental techniques
have advanced, it has become possible to detect 1H–15N correla-
tion of sub-milligram samples of NPs by using inversed-detected
pulse sequences. Martin and Hadden301,302 as well as Marek
et al.303 have provided excellent general guidance in their
comprehensive reviews. While 15N chemical shis are oen
determined indirectly using 1H detected HSQC and/or HMBC
experiments to enhance sensitivity, this approach is limited in
terms of precision and oen also accuracy (lack of reference
marker). While DEPT and INEPT based experiments for direct
detection can overcome this limitation, they are not widely used
and pose specic sensitivity challenges for nitrogen atoms that
do not bear a hydrogen. A third approach for 15N detection is to
use the CIGAR-HMBC experiment introduced by Hadden et al.304
and modied by Kline and Cheatham.305 By sampling a range of
15N–1H coupling constants in a single spectrum, the CIGAR-
HMBC sequence minimizes the risk of missing key correlations.
Importantly, as new techniques emerge and become part of
routine operations, preservation of the raw data also becomes
increasingly important, as a means of safeguarding the valuable
structural information of the 15N spectra. As such, raw data
sharing of this heteronucleus is not only about the documen-
tation of experimental information, but more importantly
a means of expanding the utility of (15N) NMR in structural
analysis and, thereby, enhancing the reproducibility of NP and
chemical science.306 Additional rationales for the importance of
preserving raw 15N NMR data relate to the methods, precision,
and accuracy of 15N chemical shi reporting, the value of
structural information encoded in 15N NMR spectra, and the
relevance of the more abundant 14N nucleus for explaining 1H
NMR spin–spin coupling networks.
7.5 Nitrogen: chemical shi referencing, accuracy, and
precision
Unlike 1H and 13C chemical shis, which are reported relative to
TMS as the accepted reference, (frequently via residual solvent
signals), 15N NMR has no widely accepted single compound that
serves as the universal reference standard in both the small
molecule and the biomolecular NMR communities. Currently,
most reports reference 15N chemical shis via liquid ammonia
(NH3/NH4OH), either via direct measurement or by application
of a series of frequency conversion factors. The benet of
referencing with NH3 is that the resonance appears in the high-
eld portion of the 15N spectrum, avoiding resonance overlap in
the more populated lower eld. This approach explains why
almost all reported dN are positive numbers. However, liquid
NH3/NH4OH is typically used as an external reference, and
temperature will affect the calibration result by as much as
40 ppb per degree, which compares unfavorably with the 4 ppb
per degree variation of TMS in organic solvents.307 This is one
main reason why other reference compounds are used. Varying
in solubility and the effort required for sample recovery, nitro-
methane (90% in CDCl3; IUPAC recommendation for both
14N
and 15N), nitric acid, ammonium chloride, formamide, or
ammonium nitrate are oen used in NP research. Two 15N
resonances exist in ammonium nitrate, and both are used as
reference signals. Notably, in the NP literature, almost all 15N
chemical shis have been determined from the indirect
dimension, via inverse (1H) detection. Collectively, this explains
the substantial variation of reported dN values as a result of
inconsistent referencing. Accordingly, the reported dN should
be considered approximate values, and the availability of raw
data is one element that could help resolve this situation.
Another signicance of raw data in 15N NMR relates to the
accuracy of dN values, which are affected by the following
factors:308 (a) the magnetic susceptibilities of the solutions from
which the compared dN values originate are typically not iden-
tical. (b) The nature of the lock substance introduces a system-
atic variation/error. When using D2O, ND3NO3 or similar NMR
solutes to lock the eld frequency ratio, line-widths will
broaden, which causes dN variations in the range of 0.1 ppm. (c)
The temperature will affect chemical shis not only in 15N but
also other nuclides. For 15N, 0.4 ppm variation will be observed
in two experiments when they have 10 K difference in
temperature.
7.6 Nitrogen: NMR structural information encoded in 15N
NMR spectra
Although the 15N chemical shi range is almost four times
wider than that of 13C, the most interesting range of 15N reso-
nances of NPs falls into the 20 to 420 ppm window. Notwith-
standing the very low inherent sensitivity, it is also difficult to
generate excitation pulses that are short enough to cover
a 300+ ppm spectral window effectively, especially at the rela-
tively low observation frequency of 15N. On the other hand, with
the exception of oligo-(cyclo-)peptides, NPs oen contain only
one or very few 15N nuclei. For these collective reasons, the F1
range of a 2D NMR experiment is preferably limited to a narrow
spectral window. In order to achieve this goal, raw data become
invaluable as researchers can search available data(bases) and/
or perform in silico prediction with increased precision
provided raw data is available. Martin and co-workers have
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 85
























































































demonstrated several such cases, using both an NMR database
and a commercial algorithm to predict 15N chemical shis with
only 2 ppm error, while most unfavorable result produced
a variation as large as 50 ppm difference.309 Even long-range
1H–15N coupling constants are accessible through this
method, with analogous limitations of currently achievable
accuracy. As predictor algorithms depend on spectra derived
from (manually) interpreted data, this method will become
more accurate if the calculations could be based on raw NMR
data.
Consideration of 15N coupling constants adds another layer
to structural elucidation of nitrogen-containing molecules.
Although 1H–13C heteronuclear long-range couplings are
generally uniform, the same cannot be said about the corre-
sponding 1H–15N couplings. This is mainly due to the effect of
the lone pair electrons of nitrogen. The direction of the C–H
bond of a hydrogen that exhibits a long-range coupling to 15N
can have a signicant impact on the value of the 1H–15N
coupling constant. When the C–H bond direction is synclinal to
the orientation of the lone pair, the 1H–15N couplings tend to be
stronger and its long range HMBC correlations are detected
readily. In contrast, when the C–H bond direction is anticlinal,
the couplings will be much weaker and are more difficult to
observe in HMBC experiments. The large variation of long-
range 1H–15N couplings makes it more difficult to observe all
1H–15N correlation in a single HMBC experiment, because of the
challenge in optimizing the magnetization transfer delay
between 1H and 15N. So far, a universal approach has not been
established. In current practice, the coupling values are either
predicted in silico,309 or two different coupling values are chosen
as distinct magnetization transfer delays implemented into two
HMBC experiments.310
While 15N is the primary isotope related to the acquisition of
nitrogen NMR spectra, it should be pointed out that the prev-
alent nitrogen isotope, 14N, also plays a role in NMR spectra of
natural metabolites, namely in the spectral interpretation of 1H
NMR spectra. One recent example is the observation of a 1H–14N
coupling in the 1H NMR spectrum of ambiguine N isonitrile,311
a hapalindole alkaloid (104). This was discovered when
analyzing preserved raw data via 1H iterative full spin analysis
(HiFSA) with the PERCH soware tool, an algorithm based on
quantum mechanical calculations and iterative tting
procedures.62
The signal of the axial hydrogen, H-26a shows an unexpected
and rather complex splitting pattern. Only when considering
heteronuclear coupling, was it possible to explain the
involvement of H-26a in a 3J-coupling with the 14N nucleus of
the isonitrile group. The coupling of the hydrogen with 14N,
representing a spin-1 nucleus, leads to an additional signal
splitting to (pseudo-)triplets with a relative ratio of 1 : 1 : 1. Aer
including the 14N spin-particle and its coupling into the spin
simulation, a fully matched spectrum was obtained. Moreover,
the coupling constant of H-26b with the isonitrile nitrogen
could be determined to be as small as 1.13 Hz, which was
required to achieve convergence during the HiFSA iteration. It is
a reasonable hypothesis that similar evidence is prevalent to
other nitrogen-containing small molecules. Access to raw het-
eronuclear NMR data would much facilitate the analysis of high
quality original 1H NMR data of N-containing NPs. However,
most current databases do not support this kind of datamining,
because the stored data is interpreted information rather than
raw data. Recently developed repositories such as Protein
Chemical Shis312 are no exception. Other typical examples of
obscured NMR information is the use of “multiplets” (m) to
describe signals with more than two or three spin–spin
couplings. This particularly affects signals with small couplings,
such as the long range 1H–14N couplings, which otherwise could
help exploit the C–H orientation in three bond anticlinal or
synclinal arrangements relative to the lone pair electrons.
Collectively, the above points clearly support the importance
of raw NMR data for heteronuclear NMR in the nitrogen
domain, encompassing both 14N and 15N effects.
7.7 Phosphorus: 31P NMR in natural product structural
investigations
The structural nature of phosphorus present in naturally
occurring molecules may be identied by 31P NMR spectros-
copy.313–317 The 31P nucleus being 100% abundant, having
a broad chemical shi range of 800 ppm, and with a recep-
tivity 377 fold that of 13C,317 represents a sensitive tool for
deducing the structural nature of phosphorus when present.
The two main parameters associated with 31P NMR that are
used for assessing structural content are: (1) 31P chemical shi
which is typically used to identify the type of phosphorus (e.g.,
phosphate, phosphonate/phosphonic acid, or phosphinate/
phosphinic acid); and (2) 31P coupling constants to both 1H
and 13C. The latter information serves to pin down the “local
neighborhood” in which the phosphorus-containing structural
element resides. The information deduced from the 1H/31P J-
couplings, is useful for assessing 2- or 3-bond relationships
including congurational criteria, and may be extracted directly
from the 1-D 1H NMR data with the assistance of HiFSA.
Selective heteronuclear decoupling of the 31P contribution to
the 1H spin system would facilitate the HiFSA interpretation of
the 1H NMR spectrum. Moreover, the use of 1H homonuclear-
2D-J-spectroscopy can also be used as orthogonal NMR meth-
odology where, provided the digital resolution along the F2
dimension is optimized, the F2 projection results in a 1H-
decoupled 1H NMR spectrum but one which retains the
1H/31P J-coupling information. Examination of the fully coupled
31P NMR spectrum produced by gated decoupling of 31P will
also reveal the 1H couplings to phosphorus. Since most
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phosphorus-containing small molecule NPs contain but
a single phosphorus atom,318–323 this represents a very straight
forward approach to spectral analysis. The coupling of 31P to the
13C signals in the molecule further denes the structural envi-
ronment of the phosphorus substituent and can be evaluated
directly from the proton-decoupled 13C spectrum. If the NMR
spectrometer is so equipped, decoupling of 31P from 13C can be
achieved which unambiguously denes which carbon signals
are coupled to 31P, including very small couplings which may
reside within the linewidth of the carbon signal. Large
couplings will be collapsed and removal of small couplings will
lead to a sharpening of resonance lines with concurrent
reduction in the linewidth-at-half-height (w1/2). Because of the
large difference in the observation frequency between 13C and
31P nuclei in a molecule with only one phosphorus atom, with
broadband 1H decoupling, spectral interpretation of the 31P
coupling to the 13C is rst order. The coupling of 31P to 13C can
also be deduced from a 31P-detected 31P,13C-HMBC or 31P,13C-
HSQMBC experiment. If, however, there is more than one
phosphorus in the molecule and the phosphorus atoms happen
to be spin coupled, and have the same or similar chemical
shis, the spin pattern observed for the proton-decoupled 13C
spectrum arising from coupling to 31P will exhibit higher order
spin coupling effects (virtual coupling). Examination of 1H fully
coupled 31P NMR spectra can reveal the number and kind of
aliphatic groups attached to the phosphorus. For example, the
proton-coupled spectrum of the 31P signal of trimethyl phos-
phate exhibits a 10-line pattern arising in this case from spin
coupling to nine equivalent protons (n + 1). This provides
additional structural hooks.
Finally, it should be noted that the relatively high sensitivity
of the 31P nucleus make it attractive for the establishment of
quantitative 31P NMR (qPNMR) methods. This enables the
determination of impurity proles with high selectivity, as has
been demonstrated for phosphonomycin, 105, (now fosfomy-
cin), a broad spectrum antibiotic discovered from a Strepto-
myces species in 1969.324 It is used parenterally as the sodium
salt, or orally as the calcium or more commonly, as the tro-
methamine (trishydroxymethylaminomethane) salt. In either of
the rst two cases the only signicant degradation product
arises from opening the epoxide ring to give a mixture of the
(1S,2S and 1R,2R) diols 106a and 106b, collectively referred to as
“impurity A”. The lack of UV absorbance and the high hydro-
philicity of these compounds confounds the usual HPLC quality
analysis procedures and Jiang et al. have developed
a quantitative 31P NMR (qP NMR) method circumventing these
problems.325
Considering that the majority of investigated NPs are devoid
of phosphorus, it is even more important to realize that
(selective) 31P derivatization and subsequent qP NMR has great
potential to advance the analysis of complex NPs. One smart
concept targeted at expanding the utility of 31P NMR to
oxygenated NPs involves the in situ labeling of labile hydrogens
(aliphatic as well as phenolic and carboxylic hydroxyl groups)
with a phosphitylation reagent. Using 2-chloro-4,4,5,5-
tetramethyl-1,3,2-dioxaphospholane (Cl-TMDP) as reagent, the
proof of concept was demonstrated for the analysis of lignins,
which consists of condensed and uncondensed polyphenols.326
Recently, this method has been developed further into
a simultaneously qualitative and quantitative 31P NMR method
for the analysis of complex mixtures of condensed tannins
(proanthocyanidins, such as 75) in Acacia and Schinopsis
species.327 The method takes advantage of the large 31P chem-
ical shi dispersion of the derivatized groups, the structural
information from HSQC spectra of the derivatized materials,
and the favorable sensitivity and selectivity of qPNMR. Collec-
tively, this allowed the comprehensive characterization of
complex proanthocyanidins from crude mixtures, including the
quantication without the need for identical calibrants, both of
which represent major phytochemical challenges. Considering
the chemical complexity of such analytes, the availability of raw
31P data will predictably advance the knowledge base for
interpretation of qualitative and quantitative 31P NMR spectra.
In the context of the raw data focus of the present review, it
should nally be pointed out that 31P NMR reference spectra
have the potential to inform subsequent studies aimed at
solution structures of drugs binding to molecular targets. One
example is the complex of the antibiotic, nisin, and a shortened
version of the bacterial cell wall precursor lipid II (3LII), which
show differences in the 31P chemical shis of the free versus
nisin-bound forms of 3LII, as a result of intramolecular
hydrogen bonding.328 In the same study, overlaid 15N HSQC
spectra were also employed to map nisin binding.
8 Databases
8.1 Database introduction
Both the quality and resolution of NMR spectra have improved
since the introduction of the rst Varian commercial
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 87
























































































spectrometer, the HR-30, in 1952. However, most of the
contributors to this review never experienced the beginnings of
NMR before computer screens replaced the long scrolls of paper
sheets that were used. The digitization of NMR did simplify
tasks such as peak-picking, integration, phase correction, and
apodization functions. It also enables the sharing of spectra
over networks.
But this digitization also came with adverse side effects. As
every manufacturer developed new features, used different
digitization technologies, and different acquisition methods,
the complexity of the le formats increased. Current multi-
-vendor NMR soware accommodates up to 20 raw data
formats, not counting the different avors of each of these
formats. In addition to these differences, the storage methods
are different: some use a single le for the acquisition, others
require multiple les, whereas even others require a particular
directory structure to be functional. Current conversion solu-
tions oen involve juggling between several le formats and
soware tools in order to obtain input data that is compatible
with a given NMR soware. Such an elaborate process is detri-
mental to the integrity of both data and associated metadata, as
it implies conversion between different oating point and/or
integer encoding schemes and introduces rounding errors.
The Holy Grail is soware that will convert all of the other
formats into readable les without the loss of data. Unfortu-
nately, no such soware exists.
As long as a user can access a repository of data, and dig in
archives (implying the storage support remains active), and can
still open those les, everything should be ne, except when it
comes to sharing results. As this typically is done through
publications, it opens the question of how NMR results are
actually reported. Most frequently, as tables, which just may
include HSQC, HMBC, and NOE correlations, but sometimes
just as text (listings of chemical shis, coupling constants,
multiplicities, and assignments). Recently, it has become
customary to include printouts of spectra as ESI.† As this has
been limited to PDF format, these published spectra have been
“ltered” through various convoluted conversion processes
such as screen captures, lossy bitmap compression and/or
presentation soware, and other operations that involve
format changes and/or are associated with degradation of
information. The result is oen a small, highly pixelated bitmap
picture, which hides the details needed to examine a proposed
structure (coupling constants, satellites, purity). Beyond data
sharing, lurks the problem of theminimal information required
to elucidate and describe unambiguously a structure. While
publication platforms differ in their requirements, NMR users
would benet greatly from initiatives similar to those developed
in the Mibbi project,329 aimed at producing minimal reporting
guidelines for the biological and biomedical investigations.
Recently, pharmaceutical companies, manufacturers, so-
ware companies, universities, and others joined the Allotrope
foundation effort (allotrope.org). The foundation's objective is
to develop a single universal data format, linking the threemain
scientic productions: raw data, results and evidence. The
single le using the Allotrope Data Format (ADF), contains the
original data le, and the treated data (in a standardized but
still evolving form). Further, it provides a way for the equip-
ment, people, processes, geographical locations, and projects to
be linked and described. The foundation develops standardized
vocabularies and data descriptions. With the use of ontologies
and semantic web technologies, all of these elements can be
linked to other resources (online databases or internal reposi-
tories) and annotated appropriately. This joint effort aims to
unify current analytical data, including NMR data, and allow
NMR records to survive the test of time, crashing hard drives,
and the confusion of a myriad of formats.
8.2 The urgent need for spectral repositories and
automation support for peer-reviewing of spectral data
Structure elucidation of organic compounds starts with exper-
imental data, transformed into spectra, and translation into
present/absent structural fragments. The nal step combines
these fragments into a structure proposal tting the given
constraints derived from the experimental data. This process
can fail and lead to a wrong structure, because this sequence
can be broken at any point.19,121,330,331 In order to detect wrong
conclusions, it is oen necessary to trace back to the raw data.
Furthermore, there is a major need for validated reference
materials of authenticated chemical structures in order to build
spectral databases that can fully support the process of
upcoming structure elucidation problems. As long as the
scientic community relies on non-validated reference mate-
rials with potentially wrong structures, conclusions derived
remain uncertain. The unwanted consequence of this domino
effect is that the impact of non-validated results increases,
rather than decreases, by contributing to an increasing number
of potentially wrong structure proposals.
The following two case studies exemplify this tight rela-
tionship between research quality and the availability of raw
data: (i) aglalactone isolated from Aglaia elaeagnoiea, and (ii) the
identical NMR-data published for orientanol A and eryvarin A.
The wrong structure proposal for aglalactone, (35)118 has been
revised to 36 in a subsequent paper.122 The following situation
has not been corrected. Orientanol A (CAS-RN: 190381-82-9;
C21H24O7, 107)332 was published by Tanaka et al. for the rst
time having a 2,3-dihydroxy-3-methylbutyl side chain showing
13C chemical shi values of 27.1, 78.6, 72.9, 26.1 and 25.0 ppm.
In a later paper333 published by the same group, a new iso-
avonoid named eryvarin A (CAS-RN: 302928-70-7, C21H22O6,
108)333 was described having nearly identical carbon chemical
shi values (9 positions differing by 0.1 ppm each). The 1H
chemical shi values are also identical within 0.02 ppm; and the
coupling constants are within the range of the digital resolution
of a standard 1H NMR experiment. It is interesting to note that
even the labile hydrogens of both OH-groups in 108, are iden-
tical to those in 107. Formally, 108 is created from 107 by
cyclization of the side-chain and elimination of H2O. Despite
this cyclization, the chemical shi values of the carbons and
hydrogens in the sidechain of 107, which is now converted into
a six-membered dihydropyran ring system in 108, remain
unchanged. Table 5 compares the 13C NMR experimental values
of the ve carbons within the sidechain against their
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expectation ranges and the expectation ranges of the 2 possible
cyclization products. Table 5 also shows that the experimentally
determined chemical shi values t best to the sidechain
product named orientanol A (107), whereas the dihydropyran-
derivative 108, is a reasonable alternative structure to the
given data under the assumption that the resonances at 78.6
and 72.9 ppm have been misassigned despite measuring 2D
NMR-spectra. The spectral data of eryvarin A have been repeated
(compound 7 in ref. 334). There is no claim that either ori-
entanol A or eryvarin A is the correct structure proposal to this
set of spectral data, but the severe inconsistency in the under-
lying data material is clearly visible. It is also clear (Table 5) that
the alternative ring closure structure (109) is not viable.
This example demonstrates the urgent need to deposit raw
spectral data in an electronic format in a repository in order to
reinvestigate the whole process of structure elucidation starting
at the very beginning and allowing chemists to follow the whole
chain of decisions. It is also clear that there is not always an
absolute solution to the interpretation from any one source of
data. However, the availability of raw data offers a means of
clarifying such a discrepancy.
The CSEARCH-database (nmrpredict.orc.univie.ac.at/)
consists of some 700 000 13C-NMR spectra and a sophisticated
soware-package. The examples given here have been found,
when searching for identical spectra published by at least one
common author occurring in different literature citations
associated with different structures.
8.3 Databases for dereplication
The number of known NPs has grown, and continues to grow at
a remarkable rate, swelled by over a century of research into
terrestrial and marine plants, animals and microbes. A signi-
cant proportion of these NPs were rst described in the scien-
tic literature prior to, or in the formative years of NMR-enabled
structure elucidation. Notwithstanding the many impressive
feats of structure analysis achieved in those early years, where
available, published accounts of NMR data from this era pre-
dating modern high eld and 2D NMR spectroscopy, are limited
to tabulation of 1H NMR (and later, possibly 13C NMR) reso-
nances. By necessity, NMR assignments were oen either
incomplete or tentative, with some resonances described
merely as broad singlets or unresolved multiplets, and over-
lapping resonances collectively listed as “envelopes”, or not
listed at all. In an effort to enhance NMR characterization, early
authors sometimes published accompanying unannotated
images of NMR spectra, although these rarely offered added
insights into molecular structure. The limited NMR character-
ization of legacy known NPs remains an enduring problem to
this day, especially as current and future researchers seek to re-
investigate these structures, as a prelude to exploring their
chemical and biological properties. For example, modern
researchers typically re-isolate a known natural product, and
use this as a launchpad to explore a rare and unusual structure
class. The justication for such an investment is based on the
view that known NPs represent a legacy resource of considerable
Table 5 Experimental and predicted 13C NMR data for possible structures of orientanol and eryvarin. Either orientanol A (107) or eryvarin A (108)
(with an assumed assignment error) seem to be reasonable structure proposals to the given 13C NMR data, because all five signals are located
within or near their expectation ranges, whereas the possible dihydrofuran cyclization product, 109, shows large deviations. Experimental values
within 1.5 ppm of the expected range: green cell, 3 ppm: yellow cell; more than 3 ppm: red cell
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value, capable of accelerating the discovery and development of
new molecular products (e.g., as pharmaceuticals and
agrochemicals).
Illustrative of just such an investment, during a search for
new antifungals the Capon group recently isolated a large and
structurally complex (C56H102N3O15) natural product from
cultivation of a sheep-feces-derived Streptomycete. Based on
a preliminary spectroscopic analysis they determined that this
metabolite was most likely the guanidyl polyketide macrolide,
amycin B (110), rst reported last century from a Greek soil-
derived Streptomyces spp.335 The amycins are a remarkable
class of natural product that include niphimycin/scopa-
fungin,336 copiamycin,337 the azalomycins338,339 and guani-
dylfungins,340 neocopiamycin A,341 malolactomycin A,342 RP
63834,343 the shurimycins,344 RS-22s,345 the kanchanamycins,346
and the primycins.346Despite being known as NP antifungals for
over 50 years, chemical knowledge of amycin B (110), and other
members of this structural class remains limited to planar
structures, supported by modestly annotated and tabulated 1D
NMR data.
This is not an uncommon occurrence. There is without
doubt a great deal unknown about a great many known NPs. To
explore the antifungal potential of amycin B and related NPs it
was rst necessary to conrm (and if possible complete) exist-
ing structure assignments. Whereas the 1D and 2D NMR data
acquired on a re-isolated sample of 110, was an excellent rst
step (Fig. 37), lack of access to comparable data for other
members of this structure class severely limited the scope of
these investigations. This dilemma is compounded by the fact
that the original authentic samples of these and most other
known NPs are generally lost, and commercial sources are
largely non-existent (Fig. 37).
A possible solution to this problem lies in the observation
that modern NP researchers routinely detect, isolate, charac-
terize and identify known NPs, and in doing so acquire and
analyze high quality NMR data, oen vastly superior to pub-
lished data (as evidenced by the reisolation of 110). However, as
the constraints of modern scientic publishing preclude the
reporting of known NPs, this NMR data languishes as unpub-
lishable output in the archives of individual laboratories,
companies and institutions, albeit a very valuable resource.
With modern NMR data comprising electronic les that are
readily shared, processed, and analyzed by any number of free
and commercial sowares, there is a very strong case for
establishing a global NP NMR data repository. This repository
could accept, register, curate and facilitate free worldwide
access. In due course, scientic journals could make uploading
and registering of NMR data a condition of manuscript
submission, much as is already the case for X-ray crystallo-
graphic and genetic sequence data. The same could apply to
(post)graduate NP research theses, which are typically rich in
such data. In this scenario, researchers uploading data could be
acknowledged on a per data set basis, the registered entry could
be cited by future researchers, thereby forstering a collegial
culture of international, interdisciplinary, and intergenera-
tional recognition.
8.4 The importance of raw data in databases
This Raw Data Initiative is a continuation of previous efforts1
to initiate the creation of a repository for raw NMR data
dedicated to small molecules, especially those of biological
origin. One major goal is to minimize the time taken to
identify known molecules and therefore to avoid the dupli-
cation of structure determination efforts. Current practice
involves extraction, isolation/purication, time-domain NMR
data acquisition, conversion of these into the frequency
domain, extraction of spectral parameters (chemical shis
and coupling constants) and proposal of a chemical structure
by deductive reasoning. A search of available databases
provides a high probability that the compound is novel or
known. Even in the latter case the task is not nished until
a search of the literature conrms that the spectral data of the
isolated compound matches that of the known. The preser-
vation of FIDs opens the doors for re-processing with other
parameters and/or algorithms, which subsequently allows
extraction of more or better spectral parameters from the
same data. The same reasoning should encourage the
community to constitute reference samples repositories, thus
permitting the recording of new raw data sets by means of
emerging methodologies. Non-Fourier transformation of
FIDs are pertinent in many situations, especially for multi-
dimensional NMR data processing, in contexts such as non-
uniform sampling, covariance analysis or the extraction of
relaxation and diffusion parameters. Even transformed
data in the direct dimension may benet from processing
methods like reference line deconvolution. The possibility of
reprocessing time domain data therefore warrants the
possibility of obtaining better spectral data, better estima-
tions of spectral parameters and nally more reliable struc-
ture determinations.347
The Institute of Molecular Chemistry of Reims, France, is
putting together a focused library of raw, time domain NMR
data and transformed data that is linked with enhanced struc-
ture les, i.e., Structure Data Format (SDF) les in which atoms
may be arbitrarily tagged. These tags are connected to chemical
shis values and paired to coupling constant values. Data was
obtained from a small library of glucosinolates and of their
desulfated derivatives using the PERCH soware,62,348–352 in
a process that is similar to the constitution of the MetIDB
database. Such a protocol is the only one that ensures a realistic
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transposition of a 1D 1H NMR data from one static eld value to
another for comparison purposes.
The same research group has also designed a dereplication
workow based on 13C NMR data and is used for the analysis of
complex plant extracts.353 The 13C NMR spectra of the samples
produced by Centrifugal Partition Chromatography fraction-
ation are binned and the bin contents are classied according
to the resemblance of their chromatographic proles. Sets of
chemical shis with similar proles constitute keys to the
search for known compounds in a locally developed and
enriched database that links structures and 13C NMR chemical
shis. The latter are obtained by prediction from structures by
means of commercial soware. The availability of raw NMR
data reference compounds would contribute immensely to the
progression of efficient dereplication tools.
8.5 The breadth of databases and their use by chemists
The past 10 years have witnessed the development of a global
network for data sharing of spectroscopic and chromatographic
data in metabolomics.354,355 The principles behind this data
sharing network have been established over the past 20 years by
the molecular biology community in areas such as genomics
and proteomics.356 Since the eld of metabolomics is populated
by a considerable number of analytical chemists there is now
hope that the principles of free and open data sharing will be
more widely adopted by the quite conservative chemistry
community. This hope is supported by initiatives like the FAIR
data movement,357 which advocates for research data being
Findable, Accessible, Interoperable, and Reusable (FAIR), in
order to properly support the scientic methods. These are
gradually being adopted by major funding agencies such as the
European Commission, the National Science Foundation, the
National Institutes of Health and many other funding organi-
zations. The fundamentals of metabolomics data sharing are
not very different from those in NP chemistry. Data in Metab-
olites and other databases are composed of a core of raw data
surrounded by metadata aiding in the interpretation of the
experiment. Whereas the raw data consists of NMR, MS, and
chromatographic data, the metadata covers the whole range
necessary to understand how the study was conducted: the
species under investigation, which organism part the metabo-
lite was isolated from, which instruments were used, and which
parameters were used.
Every data point in the above-mentioned metadata is backed
by a term in a commonly used ontology, and the question which
type of metadata needs to be reported is dictated by the
minimum information standard. For metabolomics these
minimal information (MI) standards were created by the
metabolomics standards initiative around the year 2007.358
Most of theminimum information principles established by the
MSI are directly applicable to the NP community. Additionally,
information from the 2015 initiative to establish the minimum
information about a biosynthetic gene cluster are relevant.359
The molecular biology community, in establishing databases
Fig. 37 1H NMR (900 MHz, methanol-d4) spectrum for amycin B (107).
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like MetaboLights and the metabolomics workbench, has laid
the technological foundation for the archives necessary to
establish a raw data NMR sharing in NP chemistry. Metabo-
Lights, for example is completely based on open source tech-
nology, open data standards and open data formats, and
community-based reviews on the topic have appeared.360
Following the establishment of MetaboLights, the COSMOS
initiative361 has complemented the set of open data formats for
mass spectrometry such as mzML with a sister format for the
representation of raw NMR data, nmrML, which has been
established very recently.362 With clear signals by the major
NMR instrument manufacturers for the support of this new
open format, nmrML has the power to replace the age-old
JCAMP as a usable open data format in NMR spectroscopy.
The computational frameworks to hold and describe raw data
and metadata are equally in place. The ISA format, for example,
is widely used across domains in molecular biology and
metabolomics in particular.363 It is capable of holding all the
necessary metadata of an investigation, study and its underlying
assays (ISA ¼ Investigation, Study, Assay), in a spreadsheet-like
format, backed by a wide range of ontologies, including the
NMR term ontology established as part of the nmrML work.
There are indeed few differences in describing an NMR-
based metabolomics experiment and describing the isolation
and identication of a NP, the most important of which might
be the fact that the latter is hopefully based not on mixtures but
spectra of pure compounds. In summary, it is anticipated that
this work, embedded in a large, worldwide community inter-
ested in metabolomics data management over the past 10 years
will be instrumental in establishing a network and movement
for NMR data sharing in NP chemistry. Several publishers have
already embraced open data sharing for the articles published
in their journals, oen at additional burden for the researcher,
and dedicated data publications364 in certain journals are
a viable alternative to the typical reports about the isolation of
NPs found in more traditional outlets.
8.6 Raw NMR data formats
The recently introduced mzML, nmrML, sibling formats for MS
and NMR, respectively, aim at integrating two analytical tech-
niques that are essential for metabolomic analysis. The utility of
NMR and the importance of open data formats in advancing the
contextualization of metabolomic data in pharmacognosy
research has been highlighted by some of the authors.365 While
well-intended at the time of implementation, existing imple-
mentations of the IUPAC JCAMP-DX spectroscopy standard into
NMR soware vary in adherence to the standards and inter-
operability. In practice, JCAMP data are not fully compatible
between the various soware platforms. More comprehensive
data standards exists, such as the ISA363 and ADF (allotrope.org)
formats that are fully capable of including NMR metadata and
even provides the ontology of nmrML, but their broader
implementation is pending and complicated by their broader
scope.
One very recent effort approaches the standardization of NMR
data format for instruments and soware through a process
driven by an extensive consortium of manufacturers of analytical
equipment and its user base, representing a variety of elds in
research and application: the Allotrope Foundation
(allotrope.org) has developed a universal raw data format, the
Allotrope Data Format (ADF), which also accomodates the storage
of derived results. Another effort, co-led by one of the present
authors,366 is the NMReDATA initiative (nmredata.org)367 and
combines forces from the NMR scientic community consisting
of individuals, soware manufacturers, and the journal,
Magnetic Resonance in Chemistry (MRC). One tangible recent
result is that MRC requires the dissemination of digital NMR
spectra and data for assignment articles submitted since early
2018. Moving forward, the MRC editors also intend to require
that authors supply raw NMR data as a means of result
verication.368
The establishment and widespread implementation of
universal data formats in science is a major challenge. Creation
of the actual formats and their acceptance are both evolutionary
processes, which can be predicted to take time. In fact, progress
may depend more heavily on the success of consensus building
mechanisms than on the scientic mechanics of the actual
format denition, for which the above initiatives have already
paved the way. As this process continues to unfold, it is
important to realize that the data produced by NMR instru-
ments already represent a “native” form of raw NMR data and
are readily available for use. One key message of this Raw Data
Initiative is that there is no reason for procrastination.
Archiving and dissemination of raw instrument data is feasible
and practiced by an increasing number of scientists. Albeit
somewhat proprietary, the single FID/SER les and pre-dened
folder structures can be read by many soware tools, even when
produced by older hardware, and transcription to the future raw
data standard(s) will almost certainly be straightforward via
automated conversion tools.
9 Clinical uses
9.1 Expanding raw data concepts from chemistry to clinics:
moving from NMR to MRS
Thirty years ago, the idea of bringing NMR into a clinical setting
using magnetic resonance spectroscopy (MRS) generated
considerable excitement. Despite this enthusiasm, MRS is still
not widely used, in part due to nancial considerations (billing
for time on scanners), lack of expertise in radiology depart-
ments, vendor reluctance to develop new soware, and possibly
foremost, because the number of metabolites identiable is
small. Today, the main use for MRS is to distinguish a brain
lesion as a tumor or non-tumor. The most common metabolite
signals used to identify a tumor are a decreased N-
acetylaspartate/choline and increased lactate-to-lipid ratios.
Reecting the belief that the power of MRS for chemical
imaging of the brain and other organs is enormous, raw MRS
data is being revisited with machine learning and other math-
ematical tools, beginning with a large database of pediatric
brain tumors. Starting with this particular database is impor-
tant as recent technical improvements in MRS allow the iden-
tication of other tumor-specic markers that can help classify
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tumor biochemistry,364,369–372 and by progress in applying new
analytical tools to increase the number of identiable signals.
Using newly developed normalization and other mathematical
tools,373 proof of concept has been generated for the identi-
cation of >90 signals from brain MRS data of pediatric
concussion subjects.374 The MRS ngerprints enabled differen-
tiation of healthy children from those with concussions. The
tools were applied to processed, post-FT data, neglecting the
imaginary numbers in the data, so that pre-processed data
represents a largely untapped source of information. While
optimization of the data analysis tools is work in progress, the
results already suggest the value of revisiting raw MRS data,
which are oen not stored and, thus, lost.
Current approaches to MRS data analysis carry assumptions
about which chemicals contribute to an in vivo spectrum.
However, these are incomplete or even awed. Importantly, they
diminish the capability of detecting metabolic features that are
not inserted a priori in the underlying MRSmodels. Future work
will group patients into clinically relevant subgroups
(responders vs. non-responders to certain therapies) and look
for common chemical signals, thereby bypassing any assump-
tions. If successful in the long-term, this research will provide
readily obtainable (noninvasive 30 min scan on any state-of-the-
art MR scanner) metabolic signatures at the time of diagnosis
that lead to personalized therapy.
Collectively, the availability of raw MRS data is crucial for the
ability to extract new insights from existing measurements that
are performed daily, on a routine basis. Similar to NMR in
chemical analysis, rawMRS data contain a plethora of untapped
information, which can be unraveled. Notably, because NMR
and MRS share the same underlying nuclear resonance mech-
anisms, insights derived from chemical NMR analysis could
potentially inform clinical MRS applications, and vice versa.
Similar prospects for the utility of raw NMR data disseminated
via an open database concern other forms of in vivo NMR
spectroscopy, including a 1D 1H or 31P experiments aimed at the
chemical analysis of tumor and other pathological tissues. The
ability to quantitatively assess contributions from certain
identied metabolites can provides valuable information for
subsequent patient treatment and open opportunities for
individualized medicine.
10 Conclusions & outlook
10.1 Decades of manual mining prove the concept
Comparing the development of mass spectrometry (MS) and
NMR spectroscopy in terms of databases and computational
tools clearly indicates that data simplicity has been the main
driver of the use of such data: both the ions in MS and the
singlets of 1H broad band decoupled 13C NMR data can be
represented as x,y-pairs (MW or chemical shi, respectively,
and intensity) and, thus, can readily be transformed into search
algorithms. As coupling or other connectivity/spatial relation-
ship information is invovled in nearly all other 1D and 2D, NMR
spectra are inherently more complex and mostly evade
a simplistic treatment.
However, the development of the CSEARCH database (http://
nmrpredict.orc.univie.ac.at/) for the systematic mining and use
of 13C NMR data can serve as an excellent example of the
information content of NMR spectra in general. Especially for
13C NMR, the chemical shi value of a given carbon atom is
highly characteristic of its chemical environment in a given
molecule. In fact, deviations are so small (in the low ppb range)
that even the absolute conguration of monomeric building
block in oligomeric compounds can be achieved183,184 and subtle
differences in the diastereoisomerism of closely related conge-
ners can be recognized.60 Importantly, for general applications,
13C NMR enables structural dereplication with extremely high
degree of certainty, provided that adequate acquisition condi-
tions are employed to ensure comparability of the data sets (e.g.,
concentration range, solvent, temperature). The CSEARCH
database clearly highlights both, the dereplication of 13C NMR
and the necessity to make NMR raw data accessible to the
scientic public. The database has been built over decades by
transferring tens of thousands of assigned NMR data sets in
combination with the structures derived, from peer reviewed
journal sources into a digital format. From this starting point,
data comparison, and shi value statistics and shi value-
structure motif correlations were made possible. Taken
together these two contributions, which do cover more than
a decade of scientic progress, prove that improvements in
NMR data handling, data interpretation and data presentation
are still needed. It must not be overlooked, that the mere
presentation of processed NMR spectra in the ESI,† as advo-
cated by many scientic journals, was only a rst step forward.
The shortcoming of printed ESI† has been a subject of discus-
sion in other scientic communities, such as genetics.375 It does
not sufficiently address the problem, since both spectral overlap
and low resolution graphics usually allow no unequivocal
analysis of spectral identity or special spectral features. Raw
NMR data, especially for 2D NMR spectra, are usually a few
megabytes only and even desktop-grade IT infrastructure will
allow its swi dissemination. The “so revolution” in NMR
technologies allows the processing of such data independent of
the instrument platform involved in their recording. Hence, raw
NMR data deposition is needed urgently, for the following four
key reasons. (i) It is vital to present raw NMR data of substances
isolated from natural sources or synthesized in a total synthesis
approach aiming to verify a structure hypothesis. This obliga-
tion is especially important if a new NP discovery claim is made.
(ii) It is equally important to present raw NMR data of
substances/substance mixtures administered in pharmacolog-
ical in vivo and in vitro studies; especially if isolates from natural
sources are investigated. Only if certied material (with NMR
data) is utilized can this obligation be waived. (iii) Raw NMR
data should also be made available for substances/substance
mixtures that are utilized as calibrants in quantitative
measurement campaigns; especially if isolates from natural
sources are investigated. Only if certied material (with NMR
data) is utilized this obligation can be waived. Finally, (iv)
industry, especially outts that bringmeasurement platforms to
clinical use (under FDA or IVD-CE clearance), monitor drug
(metabolites) and/or raw materials used for calibrant
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 93
























































































production by NMR spectroscopy should always provide the
respective raw data.
10.2 The urgent need for public dissemination of raw NMR
data
This review aims to increase the awareness of NP scientists, and
the entire chemistry community, to the advantages of modern
soware tools to extract meaningful data from raw FIDs and
avoid the loss of information in the process of NMR data
interpretation and documentation. This urgent call for a change
in scientic dissemination practices is supported by a global
group of scientists, who contributed to the present review
(Fig. 38). Specically, this group advocates universal depositing
of these FIDs in free access databases, institutional repositories,
or at least in investigator-initiated ESI† les so that the FIDs will
be available to scientists worldwide, not the least to manuscript
reviewers. Establishing the public sharing of raw NMR data as
a standard practice will create both obligations and opportu-
nities that engage authors, reviewers, and readers equally. This
creates a mutually benecial push–pull relationships that can
only enhance the integrity of science and reduce the occurrence
of incorrect published structures,19,22,23 especially when
considering that researchers essentially serve in all three roles
simultaneous, i.e., as authors, reviewers, and readers.
Although a number of databases exist, there is no univer-
sally accepted format, especially for crucial FID-associated
metadata, such as, solvent, temperature, concentration,
instrument, eld strength, and charge (i.e., pH or more likely
pD) for spectra of compounds with ionizable groups. This
review reports on at least two examples where conclusions
have not yet been reached because spectra of the same (or not)
compound have not been identical, almost certainly
because spectra were taken of samples with different degrees
of ionization. In general, this is particularly a problem with
peptides. Fortunately, the reporting standardization
including metadata aspects may be addressed as IUPAC has
put together a Project Task Force to address just this problem.
A global, universally accepted database is an enormous task.
Its feasibility will depend on an adequate combination of
international coordination, funding, and sustainable mech-
anisms, most likely required by “rst world” countries.
Historically, funding and sustainability have restricted most
existing databases. The rise of distributed databases, linked
data, and data-interoperability consortia could provide alter-
native monolithic data-silos that are difficult to maintain. In
fact, these approaches are more likely to ensure viability,
accessibility, and achievement of overall project scope for
a global, universally accepted database containing raw NMR
data. The availability of metadata for raw NMR data (FIDs)
becomes even more crucial for experiments that involve
randomly generated parameters, such as the randomized t1
sampling schemes in non-uniform sampling (NUS) 2D NMR
experiments. Collectively, metadata is a vital part of the raw
NMR data and responsible for making data sets fully
transparent.
The case is made here that 1H NMR data alone, if mined
thoroughly, can go a long way to overcoming most of our
current problems. Correct structure elucidation is an absolute
necessity for the development of bioactive leads. The pre-
vailing mantra is that absolute structure determination is
only achieved through X-ray diffraction or total synthesis. The
former can have difficulty in distinguishing O and NH and the
latter is both resource intensive and not infallible, as is evi-
denced by the interesting case of elisabethin A, isolated in
1998 from a West Indian Sea Whip and assigned the structure
111.376
Fig. 38 Support for the call for disseminating raw NMR data comes from the global natural product research community, as shown by the
locations of the authors who contributed to the present study.
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In 2004, the total synthesis was claimed,377 to be contradicted
almost immediately,378 as beautifully summed by David
Whitehead at www2.chemistry.msu.edu/courses/CEM958/
FS04_SS05/whitehead.pdf. The structure of elisabethin A
could well be that claimed by the original authors, but it has not
yet been conrmed by synthesis. It seems likely that the
synthetic product is a diastereomer of 111. This case supports
the claim that there is no such thing as absolute structure proof.
Nonetheless careful analysis of all of the data embodied in
a simple, but accurate 1H NMR spectrum can lead to a structure,
in which there can be high condence, even when the spectrum
has been acquired on microgram quantities of highly pure
material.
The availability of raw NMR data would also serve as
a catalyst for the increasing number of studies that utilize
quantum chemical calculations for the purpose of structure
elucidation. The computation of chemical shis and coupling
constants using quantum chemistry is now regularly included
as a key component in the assignment and revision of the
structures of complex NPs. While theoreticians have been
developing methods for computing these values for decades,
many organic chemists rst became aware of the power of
such approaches through Rychnovsky's reassignment of the
structure of hexacyclinol (112 to 113).379 A variety of reviews
have compiled examples (there are many) of similar
studies,380–382 and Hoye and co-workers have even provided
a tutorial for carrying out such studies.383 Several represen-
tative examples have been discussed in this review. The
combination of experimental data and quantum chemical
calculations has the potential to revolutionize structure
determination, both its speed and accuracy.
10.3 Evolution of raw NMR data repositories
The term “database” is used frequently to refer to gathered
digital content of any kind, stored in a binary or text format,
using a more or less pre-dened structure, e.g., that of a rela-
tional or NoSQL database. For the purpose of this discussion,
the “container” is dened as a database, the content as (raw
NMR) data, and the combination of the two as a repository.
Moreover, as the term “data” has a very broad meaning, in the
present review, data refers to the combination of experimental
data (i.e., the information/data obtained during the NMR
experiment, in particular the FID) as well as the metadata that
are necessary to reproduce the experiment (e.g., eld strength,
pulse sequence, solvent, concentration, temperature, etc.).
Oen, additional information is important or helpful, but not
strictly necessary to reproduce an experiment. Such data can be
referred to as ESI† and encompasses, e.g., patient information
from the clinical trial that produced the NMR samples that
enables statistical analysis.
The establishment of a (raw NMR data) repository encom-
passes two principal steps: (i) denition of the information that
is intended to be stored, including which experimental and ESI†
is required and/or optional; (ii) conception, structure, and IT
aspects of the repository itself. Both choices are critical as they
have implications for the maintenance and evolution of
a repository, especially when it is intended for long-term service.
Migration of information from one database (container) to
another is typically possible, with effort depending on the
database technology. Despite this basic exibility, it is not
possible to recover information that has not been stored to start
with. While this may sound trivial, it highlights in fact key
points of the present article: (a) diligence and inclusion are
paramount; (b) data which has not been stored in the past –as is
the case with the majority of the experimental NMR spectra
acquired since the inception of FT-NMR – is irrecoverable; and,
therefore, (c) building of such a repository is a timely and urgent
task.
Another conclusion from the general portability of a data-
base is that, as long as the stored information is in denite
format and structure, annotated, and accessible, the container
itself is irrelevant to the data. However, the container is most
relevant for the users as it is what scientists are interacting with.
The availability of modular and publicly accessible APIs is
mandatory to make the data meaningful. Under these condi-
tions, the development of the repository, its data structure, and
its storage technology can be handled separately, as long as the
scope of each aspect has been dened. This will ensure that the
scientic community, including NP researchers, can build the
tools that can be integrated into the repository and are best
suited for the particular needs of an application.
Some of the essential properties of a global repository are
that it (i) provides the user with the ability to upload informa-
tion and obtain a unique and permanent identier (such as
a DOI [Digital Object Identier]) that points to it; (ii) ensures
efficient access to the data, e.g., via batch downloading and
programmable interfaces (APIs); (ii) guarantees the long-term
availability of the data. The last point has been addressed very
recently by the Organisation for Economic Co-operation and
Development (OECD), which has developed recommendations
for sustainable business models that balance policy regulation
and incentives and can assist researchers, policy makers, and
funders involved in repositories.384 A global repository should
be able to deliver a permanent identier, such as a DOI, for each
This journal is © The Royal Society of Chemistry 2019 Nat. Prod. Rep., 2019, 36, 35–107 | 95
























































































deposited object including the NMR experiment, the relevant
molecule(s), assignments, linked publications, etc. Any objects
based on information that are already stored in the repository
can be used to generate a permanent hyperlink-like structure
that connects, e.g., assignment to the associated spectra and
publications to assignments.
In addition to these fundamental functions, and depending
on the particular research area, databases may offer more
“intelligent” functionality to the repository, such as advanced
browsing or interfaces for novice users. The NP community has
a high demand for tools for dereplication and identication,
including separation, isolation, structure elucidation, and
metabolic proling. As such tools evolve according to commu-
nity needs and will most likely remain under permanent
development, it is necessary to separate their design and
maintenance from the construction of the repository. At the
same time, the repository should foster an enabling environ-
ment for projects that advance NP research.
As the use of soware tools in NMR analysis is becoming
increasingly critical, all data resulting from soware output
should also include a permanent hyperlink that points to the
version and ideally to the underlying code that produced the
output. For instance, almost all FIDs recorded today are subject
to digital ltering, and an error in such a central component of
the soware/hardware workow could have confounding
consequences, especially if the underlying algorithm is undoc-
umented. This again emphasizes the importance of storing
NMR data in an as unmodied form as possible (“raw”), similar
to what is customary in digital photography. Depositing orig-
inal, raw NMR data and obtaining a unique identier for them
is also the most straightforward approach.
Major efforts towards the development of repositories for
raw NMR data have already been expanded. The following list
compiles several of them, in no particular order: NMrb was
launched in 2004 as a repository of raw NMR spectra for
biosciences,385 and apparently has disappeared; SPECTRa
(https://spectradspace.lib.imperial.ac.uk:8443/handle/10042/
25) was a project for the sharing of raw NMR data, but is inactive
since 2008; NMRShiDB (http://nmrshidb.org); SDBSWeb of
the National Institute of Advanced Industrial Science and
Technology, Japan (http://sdbs.db.aist.go.jp) allows down-
loading of peak-picked data, assignments, and bitmap images;
Chemspider (www.chemspider.com) is a free but not open
database of chemical compounds that provides NMR raw les
as subsidiary data for a limited number of compounds; The
Human Metabolome Database (http://www.hmdb.ca/)386
focuses on human metabolites and contains raw NMR data for
selected compounds; Biological Magnetic Resonance Data Bank
(http://www.bmrb.wisc.edu/)387 seeks to provide qualitative and
quantitative NMR data (processed, assigned; not raw) of bio-
logical macromolecules and metabolites; the Open Spectral
Data Base (http://osdb.info/)388 is an open source project
intended to be extended, enhanced, and used for open science
data sharing by its users; C6H6.org is an open source project,
built using recent technologies and running inside a web
browser, offers means to store, share, analyze, and interact with
raw NMR data.
10.4 Action items for implementation
A very recent initiative by the National Center for Complemen-
tary and Integrative Health (NCCIH/NIH) has solicited infor-
mation from the research community regarding the
development of an open-access NMR data repository (NOT-AT-
17-015 at https://grants.nih.gov/grants/guide/notice-les/NOT-
AT-17-015.html). Recognizing the repository gap for NMR data
and the particular importance of NMR as an analytical tech-
nique for NP research, the initiative has been seeking input on
a comprehensive list of topics which exemplify the breadth of
parameters: purity standards for single chemical entities, value
of spectra from complex mixtures and nuclei other than 1H and
13C; nomenclature (spectra, structures) and other key data
standards; minimum metadata requirements; harmonization
of publication standards; association with other analytical such
as LC, UV, and MS; analytical tools required to achieve the most
value; minimum size and diversity for maximum usefulness;
key features and functionality from different perspectives
including users, data contributors, and/or the research
community.
Considering the overwhelming evidence of the cases pre-
sented in this review for urgent need for raw NMR data, an
improvement of the situation can be achieved by taking action
at several different levels, as follows:
10.4.1 Organized data storage. At the very minimum, all
generated NMR data that has been identied as being valid and/
or is essential for a given project should be placed into a secure
storage, with backup, so it can be retrieved later, e.g., for
deposition in a repository. Considering the immense value of
raw data for originally unintended and conrmatory (meta)
analysis, systematic data storage organized at the level of
research groups, centers, or organizations strongly supports
what the scientic community and funding agencies increas-
ingly acknowledge as “good laboratory and research practices”.
10.4.2 Active dissemination and publication. Current
publication mechanisms, in particular classical journal and
book publications, should implement or at least actively
support the active dissemination of raw NMR data, along with
every published article and book. Naturally, authors should
retain ownership of their data. Already existing means of
internet-based mass dissemination enabled global dissemina-
tion by individual, but coordination of individual activities and
sustainability remain as challenges.
Independently from, or in parallel to, classical publications
outlets, authors can take immediate action by depositing raw
NMR data into publicly accessible repositories. Institutional
(e.g., university and research institution based) and global (e.g.,
Harvard Dataverse; dataverse.harvard.edu) solutions exist
already for this purpose and offer sufficient exibility to share
raw NMR data today, while allowing for their inclusion into
a global repository envisioned for the future.
10.4.3 Unied global repository. Envisioned collectively by
all authors of this review, the ultimate action item is the
implementation of a global, ideally unied repository for raw
NMR data. In its ideal implementation, such a repository will
integrate the collective experience, the most suitable features,
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as well as all available data from existing repositories and
projects, as outlined and summarized in Section 10.3. As
rationalized in the same section above, an evolutionary design
should be employed when building this new, open-access
repository, aimed at fullling all the key features.
Such a unied repository should be all-inclusive with regard
to the type of collected NMR data and avoid any bias towards
certain approaches regarding the utility and/or future applica-
tions of the data. Importantly, the repository should support
equally all methods for NMR-based structural dereplication
such as 1D 1H, 1D 13C, 2D HSQC, and any hybrid approaches.
Notably, the foremost feature of the envisioned global
repository is long term sustainability, as it represents the
quintessential challenge research operations in general and
databases in particular for environments that depend on
extramural funding and lack independent revenue streams. The
achievement of sustainability will greatly benet from trans-
institutional, trans-agency, trans-societal, international con-
sortia and processes that actively involve (NMR) data-producing
scientists.
10.4.4 Global coordination. As with previous initiatives in
other elds, the perhaps second most critically decisive factor
for success in moving forward is to reach consensus in the
global scientic community. Majority consensus is a require-
ment for broad acceptance, and reaching such a general
agreement requires a balanced process that addresses and
prioritizes all parameters and involves stakeholders broadly and
equitably.
Predictably, the designation of actual sharing mechanisms
and data formats are more likely to produce controversial
discussion than the identication of wish-list features. Whether
the establishment of the sharing mechanisms is driven by
a (predictably) lengthier consensus process or a balanced group
of representative experts, the utilization of existing resources is
a lesser consideration than the modularity of the chosen
approach and, foremost, that lack of any further delay.
The pre-determined data formats of current NMR instru-
ments have evolved and are widely supported by third party
soware tools. While they likely will be replaced, or at least be
used in parallel with, standardized and open formats, they still
represent a good start for data sharing, and there is no reason to
wait for the development of standards as data can be shared
right now.
10.4.5 Utility follows availability. As is typical for situations
where a major change in the modus operandi needs to be
implemented to achieve progress, certain levels of activation
energy and patience are required before a stream of (major)
benets can follow. Accordingly, it shall be emphasized that,
while the raw data (FID) archive proposed by this Raw Data
Initiative is both a prerequisite and a major undertaking, it still
represents a minimalist version of a greater NMR data collec-
tion for all kinds of purposes, including dereplication. A
subsequent evolutionary development of methods is still
needed to make (additional) use of the raw data, producing new
insights and/or accelerating current processes. For example,
while making a 1D 1H NMR FID publicly available today
provides a highly conclusive means of dereplication, it still
requires a tool that translates the non human-readable FID into
a human readable spectrum. While more rapid and/or human
intuitive methods can be developed in subsequent steps to
achieve the same goal, they will most likely depend on the same
and/or additional raw NMR data. Collectively, this re-
emphasizes the recent call for making NMR information
accessible for both humans and computers.366
10.5 Raw NMR and other data enhance the future of natural
product research
10.5.1 Raw data sharing as enabling technology. This
review identied a multitude of rationales, why and how raw
NMR data can provide useful and/or unprecedented insights.
Presented cases exemplify the importance of sharing raw NMR
data in NP research and fall into seven areas of broader impact:
(i) the enhancement of the integrity of structure elucidation,
which has major implications on downstream activities; (ii) the
ability to document the purity status of a given material and
enable future meta-analysis and/or renement of the evalua-
tion; notably, the (semi-)quantitative evaluations are oen
feasible even if the more rigorous conditions of quantitative
NMR (qNMR)29,389–391 were not satised during data acquisition,
and even if no internal calibration was used (feasibility of the
100% qNMR method);29,390 (iii) the enhancement of the accu-
racy and general capabilities of dereplication methods, thereby
addressing one of the major challenges in metabolomics; (iv)
enhancement of the amount of information obtained from
NMR spectra and the speed of the mining process, by
employing newly emerging soware tools that depend on the
availability of larger data sets; (v) the catalysis of developments
in the eld of the less studied NMR-accessible nuclei, offering
new opportunities for the study of NPs and their analogues, of
these elds; (vi) the promotion of the proven capabilities of
existing repositories; (vii) the prospects of extending NP and
metabolomic knowledge into clinical applications, e.g., by
using magnetic resonance spectroscopy (MRS). In all these
instances, the raw NMR data can serve as the common
denominator for progress.
10.5.2 Learning from experience. In both analytical and NP
chemistry, experience has shown that classical bulk analysis
methods such as microanalytical and (mixed) melting point
determinations are muchmore sensitive to minor impurities than
many of the contemporary spectroscopic methods. Notably,
despite a clear trend away from the classical methods employing
chemical degradation, towards modern spectroscopy, the actual
demand on the level of purity required for the meaningful
bioactivity evaluation of NPs and other chemicals has not changed
when considering the rigor and reproducibility of research
outcomes. In this regard, raw NMR data can play important roles,
e.g., in the documentation of the constitution of a compound or
material, and/or by potentially enabling the retrospective deter-
mination of the purity of previously investigated materials.
10.5.3 Value of open science. As shown in this review,
shared raw NMR data can generate new insight that otherwise is
impossible to achieve. This value proposition can be transferred
to other types of raw data, and has already been recognized for
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several, such as gene sequences, MS data (via GNPS) and X-ray
diffraction data.
It is highly likely that the availability of a global repository of
raw NMR data will potentiate productivity. Representing
a tangential aspect of the call for raw NMR data sharing,
recognition of the immense value of the information contained
in raw (NMR) data triggers questions regarding intellectual
property and data ownership. Notwithstanding the potential
impact of the answers, which likely will vary by project, insti-
tution, and other factors, the body of evidence compiled in this
review demonstrates that, at least from a scientic point-of-
view, open sharing of raw data can generate an extraordinary
amount of added scientic value. This benet can apply to both,
the sharing and the receiving scientists.
In the context of potential mutual benet, the present ndings
provide support for the principles of Open Science, which seeks to
enhance the accessibility of scientic research, data, and dissem-
ination to the various levels of a society, including amateurs and
professionals. While consideration of the benet of access to
shared resources vs. the desire of individual entities to prot is an
open-ended discussion, the widely acknowledged complexity of
research questions and endeavors, as well as global experience
with multi-disciplinary research teams and approaches, indicate
that availability and access to larger andmore varied data sets bear
major potential in advancing research outcomes.
11 Conflicts of interest
The authors declare the following competing nancial
interest(s): M. N. is founder of NMR Solutions Limited. Craig M.
Williams is a consultant to EcoBiotics Ltd. The other authors
declare no competing nancial interest.
12 Note added after first publication
This article replaces the version published on 13th July 2018,
which contained errors in the reference details of ref. 83–85.
13 Acknowledgements
The lead authors (JBM and GFP) and the CENAPT co-authors
wish to acknowledge support through grant U41 AT008706
from NCCIH and ODS/NIH. We are also grateful to Ms. Sara
Weber and Isoo Youn for valuable help with electronic literature
management, as well as to Giulia K. Pauli for assistance with
artwork. JBMcM and RGL and co-workers are grateful for
support through the HiFAN grant U41 AT008718.
14 References
1 J. Bisson, C. Simmler, S.-N. Chen, J. B. Friesen, D. C. Lankin,
J. B. McAlpine and G. F. Pauli, Nat. Prod. Rep., 2016, 33,
1028–1033.
2 M. Elyashberg, A. J. Williams and K. Blinov, Contemporary
Computer-Assisted Approaches to Molecular Structure
Elucidation, The Royal Society of Chemistry, Cambridge,
2012.
3 A. V. Buevich and M. E. Elyashberg, J. Nat. Prod., 2016, 79,
3105–3116.
4 M. W. Lodewyk, C. Soldi, P. B. Jones, M. M. Olmstead,
J. Rita, J. T. Shaw and D. J. Tantillo, J. Am. Chem. Soc.,
2012, 134, 18550–18553.
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